(+)-(S)-ar-turmerone affects binding ISO RGD:69168 6480464 ar-turmerone binds to PPARG protein CTD PMID:15713005 (+)-catechin multiple interactions EXP 6480464 Catechin inhibits the reaction [Dietary Fats results in increased expression of PPARG mRNA] CTD PMID:23365609 (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PPARG mRNA] CTD PMID:31150632 (-)-citrinin decreases activity ISO RGD:69168 6480464 Citrinin results in decreased activity of PPARG protein CTD PMID:27481073 (-)-epigallocatechin 3-gallate decreases expression ISO RGD:69168 6480464 epigallocatechin gallate results in decreased expression of PPARG mRNA CTD PMID:20706672 (1->4)-beta-D-glucan multiple interactions ISO RGD:69169 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PPARG mRNA CTD PMID:36331819 (20S)-ginsenoside Rh1 multiple interactions ISO RGD:69169 6480464 ginsenoside Rh1 inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA], ginsenoside Rh1 inhibits the reaction [bisphenol A results in increased expression of PPARG protein] CTD PMID:32623698 (25R)-cholest-5-ene-3beta,26-diol increases expression EXP 6480464 27-hydroxycholesterol results in increased expression of PPARG mRNA, 27-hydroxycholesterol results in increased expression of PPARG protein CTD PMID:28167099 (3-phenoxyphenyl)methanol multiple interactions ISO RGD:69169 6480464 3-phenoxybenzylalcohol binds to and results in increased activity of PPARG protein CTD PMID:33049310 (3-phenoxyphenyl)methanol multiple interactions ISO RGD:69168 6480464 3-phenoxybenzylalcohol binds to and results in increased activity of PPARG protein CTD PMID:33049310 (4Z,7Z,10Z,13Z,15E,19Z)-17-hydroxydocosahexaenoic acid multiple interactions ISO RGD:69169 6480464 17-hydroxy-4 more ... CTD PMID:17056761 (9E,11E)-octadecadienoic acid affects binding ISO RGD:69168 6480464 9, 11-linoleic acid binds to PPARG protein CTD PMID:23843199 (9E,11E)-octadecadienoic acid increases activity ISO RGD:69168 6480464 9, 11-linoleic acid results in increased activity of PPARG protein CTD PMID:18155510 (R)-carnitine increases expression EXP 6480464 Carnitine results in increased expression of PPARG protein CTD PMID:30256492 (R)-carnitine multiple interactions EXP 6480464 Carnitine inhibits the reaction [[Dietary Fats co-treated with Fructose] results in decreased expression of PPARG protein] CTD PMID:30256492 (R)-lipoic acid multiple interactions EXP 6480464 [Thioctic Acid co-treated with Dietary Fats] results in increased expression of PPARG mRNA CTD PMID:22464149 (R)-noradrenaline increases expression EXP 6480464 Norepinephrine results in increased expression of PPARG mRNA CTD PMID:19109942 (R,R,R)-alpha-tocopherol multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA], [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein] CTD PMID:22389237 (R,R,R)-alpha-tocopherol increases expression EXP 6480464 alpha-Tocopherol results in increased expression of PPARG protein CTD PMID:11752099 (R,R,R)-alpha-tocopherol increases expression ISO RGD:69168 6480464 alpha-Tocopherol results in increased expression of PPARG mRNA, alpha-Tocopherol results in increased expression of PPARG protein CTD PMID:14521714 , PMID:28062356 (R,R,R)-alpha-tocopherol increases activity ISO RGD:69168 6480464 alpha-Tocopherol results in increased activity of PPARG protein CTD PMID:19083475 (S)-naringenin multiple interactions EXP 6480464 HET0016 inhibits the reaction [naringenin inhibits the reaction [Glucose results in decreased expression of PPARG protein]] more ... CTD PMID:29223569 , PMID:31063766 (S)-naringenin multiple interactions ISO RGD:69169 6480464 naringenin inhibits the reaction [[Streptozocin co-treated with Dietary Fats co-treated with Carboxymethylcellulose Sodium] results in decreased expression of PPARG protein] CTD PMID:31063766 (S)-nicotine decreases expression ISO RGD:69169 6480464 Nicotine results in decreased expression of PPARG protein CTD PMID:33082140 (S)-nicotine increases expression ISO RGD:69169 6480464 Nicotine results in increased expression of PPARG mRNA CTD PMID:31622651 (Z)-ligustilide multiple interactions ISO RGD:69169 6480464 ligustilide inhibits the reaction [Dextran Sulfate affects the localization of PPARG protein] more ... CTD PMID:33130971 1,1-dichloroethene increases expression ISO RGD:69169 6480464 vinylidene chloride results in increased expression of PPARG mRNA CTD PMID:26682919 1,2-dimethylhydrazine decreases expression ISO RGD:69169 6480464 1, 2-Dimethylhydrazine results in decreased expression of PPARG mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:69169 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PPARG mRNA CTD PMID:22206623 1,3-thiazolidine-2,4-dione increases expression EXP 6480464 2, 4-thiazolidinedione results in increased expression of PPARG mRNA CTD PMID:20724125 1,3-thiazolidine-2,4-dione multiple interactions ISO RGD:69168 6480464 2, 4-thiazolidinedione binds to and results in increased activity of PPARG protein CTD PMID:15521013 1,3-thiazolidine-2,4-dione affects binding ISO RGD:69168 6480464 2, 4-thiazolidinedione binds to PPARG protein CTD PMID:15916743 1,4-bis(2-ethylhexyl) sulfosuccinate increases activity ISO RGD:69169 6480464 Dioctyl Sulfosuccinic Acid results in increased activity of PPARG protein CTD PMID:26135921 1,4-bis(2-ethylhexyl) sulfosuccinate multiple interactions ISO RGD:69168 6480464 Dioctyl Sulfosuccinic Acid binds to and results in increased activity of PPARG protein CTD PMID:26135921 1,4-phenylenediamine increases expression ISO RGD:69168 6480464 4-phenylenediamine results in increased expression of PPARG mRNA CTD PMID:16314067 1-Hydroxypyrene multiple interactions ISO RGD:69169 6480464 1-hydroxypyrene binds to and results in increased activity of PPARG protein CTD PMID:33049310 1-Hydroxypyrene multiple interactions ISO RGD:69168 6480464 1-hydroxypyrene binds to and results in increased activity of PPARG protein CTD PMID:33049310 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of PPARG mRNA CTD PMID:30723492 10H-phenothiazine multiple interactions ISO RGD:69169 6480464 phenothiazine binds to and results in increased activity of PPARG protein CTD PMID:33049310 10H-phenothiazine multiple interactions ISO RGD:69168 6480464 phenothiazine binds to and results in increased activity of PPARG protein CTD PMID:33049310 13-HPODE increases expression EXP 6480464 13-hydroperoxy-9, 11-octadecadienoic acid results in increased expression of PPARG protein CTD PMID:22135674 14-Deoxy-11,12-didehydroandrographolide multiple interactions ISO RGD:69169 6480464 14-deoxy-11 more ... CTD PMID:30248417 15-acetyldeoxynivalenol decreases activity ISO RGD:69168 6480464 15-acetyldeoxynivalenol results in decreased activity of PPARG protein CTD PMID:27481073 15-deoxy-Delta(12,14)-prostaglandin J2 multiple interactions ISO RGD:69168 6480464 15-deoxy-delta(12 more ... CTD PMID:11030710 more ... 15-deoxy-Delta(12,14)-prostaglandin J2 increases activity ISO RGD:69168 6480464 15-deoxy-delta(12, 14)-prostaglandin J2 results in increased activity of PPARG protein CTD PMID:15707588 more ... 15-deoxy-Delta(12,14)-prostaglandin J2 decreases expression ISO RGD:69168 6480464 15-deoxy-delta(12, 14)-prostaglandin J2 results in decreased expression of PPARG protein CTD PMID:17341418 15-deoxy-Delta(12,14)-prostaglandin J2 affects expression ISO RGD:69168 6480464 15-deoxy-delta(12, 14)-prostaglandin J2 affects the expression of PPARG CTD PMID:15254749 15-deoxy-Delta(12,14)-prostaglandin J2 decreases response to substance ISO RGD:69168 6480464 PPARG protein mutant form results in decreased susceptibility to 15-deoxy-delta(12, 14)-prostaglandin J2 CTD PMID:19922793 15-deoxy-Delta(12,14)-prostaglandin J2 increases expression EXP 6480464 15-deoxy-delta(12 more ... CTD PMID:10662598 more ... 15-deoxy-Delta(12,14)-prostaglandin J2 increases activity ISO RGD:69169 6480464 15-deoxy-delta(12, 14)-prostaglandin J2 results in increased activity of PPARG protein CTD PMID:15322177 15-deoxy-Delta(12,14)-prostaglandin J2 multiple interactions EXP 6480464 15-deoxy-delta(12 more ... CTD PMID:15994020 , PMID:18278065 15-deoxy-Delta(12,14)-prostaglandin J2 multiple interactions ISO RGD:69169 6480464 15-deoxy-delta(12 more ... CTD PMID:12847270 , PMID:16324150 17alpha-ethynylestradiol increases expression ISO RGD:69169 6480464 Ethinyl Estradiol results in increased expression of PPARG mRNA CTD PMID:29112739 17alpha-ethynylestradiol multiple interactions ISO RGD:69169 6480464 ESR1 gene mutant form inhibits the reaction [Ethinyl Estradiol results in increased expression of PPARG mRNA] CTD PMID:29112739 17beta-estradiol multiple interactions ISO RGD:69168 6480464 [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Bezafibrate promotes the reaction [TNF protein inhibits the reaction [FSHB protein results in increased secretion of Estradiol]]] more ... CTD PMID:19619570 more ... 17beta-estradiol multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA], [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein] CTD PMID:22389237 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of PPARG mRNA, Estradiol affects the expression of PPARG protein CTD PMID:22389237 17beta-estradiol increases expression ISO RGD:69168 6480464 Estradiol results in increased expression of PPARG mRNA CTD PMID:19619570 more ... 17beta-estradiol increases expression ISO RGD:69169 6480464 Estradiol results in increased expression of PPARG mRNA CTD PMID:18359623 17beta-estradiol decreases expression ISO RGD:69168 6480464 Estradiol results in decreased expression of PPARG mRNA CTD PMID:21632903 more ... 17beta-hydroxy-5alpha-androstan-3-one decreases expression ISO RGD:69168 6480464 Dihydrotestosterone results in decreased expression of PPARG mRNA, Dihydrotestosterone results in decreased expression of PPARG protein CTD PMID:18801408 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:69169 6480464 Dihydrotestosterone results in increased expression of PPARG mRNA CTD PMID:16990341 17beta-hydroxy-5alpha-androstan-3-one decreases expression ISO RGD:69169 6480464 Dihydrotestosterone results in decreased expression of PPARG mRNA, Dihydrotestosterone results in decreased expression of PPARG protein CTD PMID:12960001 1H-pyrazole increases expression ISO RGD:69169 6480464 pyrazole results in increased expression of PPARG mRNA CTD PMID:17945193 2,2',4,4',5,5'-hexachlorobiphenyl decreases expression ISO RGD:69169 6480464 2 more ... CTD PMID:31449830 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:69169 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:30722647 , PMID:31449830 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions ISO RGD:69169 6480464 2 more ... CTD PMID:29112739 , PMID:29523931 2,2',4,4'-Tetrabromodiphenyl ether increases activity ISO RGD:69168 6480464 2 more ... CTD PMID:26172262 , PMID:28282128 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions ISO RGD:69168 6480464 2 more ... CTD PMID:23398518 2,2',4,4'-Tetrabromodiphenyl ether decreases methylation ISO RGD:69169 6480464 2 more ... CTD PMID:24559133 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:69169 6480464 2 more ... CTD PMID:24559133 more ... 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:69168 6480464 2 more ... CTD PMID:23146750 2,2',4,4'-Tetrabromodiphenyl ether affects binding ISO RGD:69168 6480464 2 more ... CTD PMID:25314719 2,2'-Bisphenol F multiple interactions ISO RGD:69169 6480464 2, 2'-bisphenol F binds to and results in increased activity of PPARG protein CTD PMID:33049310 2,2'-Bisphenol F multiple interactions ISO RGD:69168 6480464 2, 2'-bisphenol F binds to and results in increased activity of PPARG protein CTD PMID:33049310 2,2'-Dihydroxy-4-methoxybenzophenone multiple interactions ISO RGD:69168 6480464 dioxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA], dioxybenzone promotes the reaction [NCOA2 protein binds to PPARG protein] CTD PMID:32407875 2,2'-Dihydroxy-4-methoxybenzophenone affects binding ISO RGD:69168 6480464 dioxybenzone binds to PPARG protein CTD PMID:32407875 2,2'-Dihydroxy-4-methoxybenzophenone increases expression ISO RGD:69168 6480464 dioxybenzone results in increased expression of PPARG mRNA CTD PMID:32407875 2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9-hexadecafluorononanoic acid increases expression ISO RGD:69169 6480464 hexadecafluoro-nonanoic acid results in increased expression of PPARG mRNA CTD PMID:18583369 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:69169 6480464 Tetrachlorodibenzodioxin results in increased expression of PPARG mRNA CTD PMID:24058054 , PMID:27713108 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:69169 6480464 Tetrachlorodibenzodioxin affects the expression of PPARG mRNA CTD PMID:36222588 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:69168 6480464 Tetrachlorodibenzodioxin results in increased expression of PPARG mRNA CTD PMID:19619570 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:69169 6480464 Tetrachlorodibenzodioxin results in decreased expression of PPARG mRNA, Tetrachlorodibenzodioxin results in decreased expression of PPARG protein CTD PMID:12758056 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:69168 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of PPARG mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:69169 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG protein] more ... CTD PMID:12758056 more ... 2,4,5-trichlorophenol multiple interactions ISO RGD:69169 6480464 2 more ... CTD PMID:33049310 2,4,5-trichlorophenol multiple interactions ISO RGD:69168 6480464 2 more ... CTD PMID:33049310 2,4,6-tribromophenol affects binding ISO RGD:69168 6480464 2 more ... CTD PMID:25314719 2,4,6-trichlorophenol affects binding ISO RGD:69168 6480464 2 more ... CTD PMID:25314719 2,4,6-trinitrobenzenesulfonic acid multiple interactions EXP 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA] more ... CTD PMID:16782535 more ... 2,4,6-trinitrobenzenesulfonic acid decreases expression ISO RGD:69169 6480464 Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA CTD PMID:21829567 2,4,6-trinitrobenzenesulfonic acid decreases expression EXP 6480464 Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA, Trinitrobenzenesulfonic Acid results in decreased expression of PPARG protein CTD PMID:16782535 more ... 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects binding ISO RGD:69168 6480464 2 more ... CTD PMID:25314719 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases methylation ISO RGD:69169 6480464 2 more ... CTD PMID:30903904 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:69169 6480464 2 more ... CTD PMID:30903904 2,4-dibromophenyl 2,4,5-tribromophenyl ether multiple interactions ISO RGD:69169 6480464 2 more ... CTD PMID:30903904 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:69168 6480464 2 more ... CTD PMID:30903904 2,4-dinitrotoluene increases expression ISO RGD:69169 6480464 2, 4-dinitrotoluene results in increased expression of PPARG mRNA CTD PMID:24893713 2,4-dinitrotoluene increases activity ISO RGD:69169 6480464 2, 4-dinitrotoluene results in increased activity of PPARG protein CTD PMID:24893713 2,5-di-tert-butylbenzene-1,4-diol multiple interactions ISO RGD:69169 6480464 2, 5-di-tert-butylhydroquinone binds to and results in increased activity of PPARG protein CTD PMID:33049310 2,5-di-tert-butylbenzene-1,4-diol multiple interactions ISO RGD:69168 6480464 2, 5-di-tert-butylhydroquinone binds to and results in increased activity of PPARG protein CTD PMID:33049310 2,6-di-tert-butyl-4-methylphenol increases expression ISO RGD:69169 6480464 Butylated Hydroxytoluene results in increased expression of PPARG mRNA CTD PMID:19925653 2,6-di-tert-butyl-4-methylphenol multiple interactions ISO RGD:69168 6480464 Butylated Hydroxytoluene inhibits the reaction [iron(II)-ascorbic acid complex results in decreased expression of PPARG mRNA] CTD PMID:17070507 2,6-diisopropylnaphthalene multiple interactions ISO RGD:69168 6480464 2, 6-diisopropylnaphthalene binds to and results in increased activity of PPARG protein CTD PMID:27633901 2-amino-2-deoxy-D-galactopyranose multiple interactions ISO RGD:69169 6480464 [lipopolysaccharide more ... CTD PMID:30236599 , PMID:30550845 2-amino-2-deoxy-D-glucopyranose multiple interactions ISO RGD:69168 6480464 Glucosamine promotes the reaction [IL1B results in increased expression of PPARG] CTD PMID:22089456 2-amino-2-deoxy-D-glucopyranose increases expression EXP 6480464 Glucosamine results in increased expression of PPARG mRNA CTD PMID:15694357 2-amino-2-deoxy-D-glucopyranose increases expression ISO RGD:69169 6480464 Glucosamine results in increased expression of PPARG mRNA CTD PMID:15694357 2-amino-2-deoxy-D-glucopyranose increases expression ISO RGD:69168 6480464 Glucosamine results in increased expression of PPARG CTD PMID:22089456 2-amino-2-deoxy-D-glucopyranose 6-phosphate decreases expression ISO RGD:69169 6480464 glucosamine 6-phosphate results in decreased expression of PPARG protein CTD PMID:19427183 2-arachidonoylglycerol affects binding ISO RGD:69168 6480464 glyceryl 2-arachidonate metabolite binds to PPARG protein CTD PMID:21511917 2-arachidonoylglycerol multiple interactions ISO RGD:69169 6480464 glyceryl 2-arachidonate inhibits the reaction [Sulfur Dioxide results in decreased expression of PPARG protein] more ... CTD PMID:26209559 2-arachidonoylglycerol multiple interactions ISO RGD:69168 6480464 T 0070907 inhibits the reaction [glyceryl 2-arachidonate metabolite results in increased expression of PPARG mRNA] CTD PMID:21511917 2-arachidonoylglycerol increases expression ISO RGD:69168 6480464 glyceryl 2-arachidonate metabolite results in increased expression of PPARG mRNA CTD PMID:21511917 2-bromohexadecanoic acid increases expression EXP 6480464 2-bromopalmitate results in increased expression of PPARG protein CTD PMID:10650946 2-deoxy-D-glucose affects uptake ISO RGD:69169 6480464 PPARG protein affects the uptake of Deoxyglucose CTD PMID:18083318 2-deoxy-D-glucose increases uptake ISO RGD:69169 6480464 PPARG gene polymorphism results in increased uptake of Deoxyglucose CTD PMID:18083318 2-Ethylhexanoic acid increases expression EXP 6480464 2-ethylhexanoic acid results in increased expression of PPARG mRNA, 2-ethylhexanoic acid results in increased expression of PPARG protein CTD PMID:15647598 2-Ethylhexyl acrylate multiple interactions ISO RGD:69168 6480464 2-ethylhexyl acrylate binds to and results in increased activity of PPARG protein CTD PMID:27633901 2-tert-butylhydroquinone multiple interactions ISO RGD:69169 6480464 2-tert-butylhydroquinone binds to and results in increased activity of PPARG protein CTD PMID:33049310 2-tert-butylhydroquinone multiple interactions ISO RGD:69168 6480464 2-tert-butylhydroquinone binds to and results in increased activity of PPARG protein CTD PMID:33049310 2-trans,6-trans,10-trans-geranylgeranyl diphosphate multiple interactions EXP 6480464 geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of PPARG mRNA] CTD PMID:20578043 25-hydroxycholesterol multiple interactions ISO RGD:69168 6480464 [9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein] promotes the reaction [[25-hydroxycholesterol binds to and results in increased activity of NR1H3 protein] which results in increased expression of ABCA1 mRNA], [9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein] promotes the reaction [[25-hydroxycholesterol binds to and results in increased activity of NR1H3 protein] which results in increased transport of Cholesterol] CTD PMID:12595494 26-hydroxycholesterol increases expression EXP 6480464 27-hydroxycholesterol results in increased expression of PPARG mRNA, 27-hydroxycholesterol results in increased expression of PPARG protein CTD PMID:28167099 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine multiple interactions EXP 6480464 pioglitazone affects the reaction [Puromycin Aminonucleoside results in increased expression of PPARG protein] CTD PMID:16598202 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine increases expression EXP 6480464 Puromycin Aminonucleoside results in increased expression of PPARG protein CTD PMID:16598202 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:69168 6480464 3 more ... CTD PMID:25304490 , PMID:35618242 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO RGD:69169 6480464 3 more ... CTD PMID:28973532 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO RGD:69168 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [3 more ... CTD PMID:25304490 3,3',4,4'-tetrachlorobiphenyl increases expression ISO RGD:69169 6480464 3 more ... CTD PMID:30935970 3,3',5,5'-tetrabromobisphenol A multiple interactions ISO RGD:69168 6480464 [PPARG protein results in increased susceptibility to tetrabromobisphenol A] which results in decreased expression of DHRS2 mRNA more ... CTD PMID:21561829 more ... 3,3',5,5'-tetrabromobisphenol A increases response to substance ISO RGD:69168 6480464 PPARG protein results in increased susceptibility to tetrabromobisphenol A CTD PMID:35734227 3,3',5,5'-tetrabromobisphenol A multiple interactions EXP 6480464 tetrabromobisphenol A inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of PPARG mRNA] CTD PMID:25048947 3,3',5,5'-tetrabromobisphenol A multiple interactions ISO RGD:69169 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [tetrabromobisphenol A results in decreased expression of PPARG protein] more ... CTD PMID:24132472 more ... 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:69169 6480464 tetrabromobisphenol A results in decreased expression of PPARG protein CTD PMID:24132472 3,3',5,5'-tetrabromobisphenol A affects binding ISO RGD:69168 6480464 tetrabromobisphenol A binds to PPARG protein CTD PMID:25314719 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:69168 6480464 tetrabromobisphenol A results in increased expression of PPARG mRNA CTD PMID:32473317 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:69169 6480464 tetrabromobisphenol A results in increased expression of PPARG mRNA CTD PMID:25863188 , PMID:30496566 3,3',5,5'-tetrabromobisphenol A increases activity ISO RGD:69169 6480464 tetrabromobisphenol A results in increased activity of PPARG protein CTD PMID:25777084 more ... 3,3',5,5'-tetrabromobisphenol A decreases expression EXP 6480464 tetrabromobisphenol A results in decreased expression of PPARG mRNA CTD PMID:26988606 3,3',5,5'-tetrabromobisphenol A increases activity ISO RGD:69168 6480464 tetrabromobisphenol A results in increased activity of PPARG protein CTD PMID:24591153 more ... 3,3',5,5'-tetraiodothyroacetic acid multiple interactions ISO RGD:69168 6480464 tetraiodothyroacetic acid binds to and results in increased activity of PPARG protein CTD PMID:33049310 3,3',5,5'-tetraiodothyroacetic acid multiple interactions ISO RGD:69169 6480464 tetraiodothyroacetic acid binds to and results in increased activity of PPARG protein CTD PMID:33049310 3,3',5-triiodo-L-thyronine multiple interactions ISO RGD:69169 6480464 Triiodothyronine binds to and results in increased activity of PPARG protein CTD PMID:33049310 3,3',5-triiodo-L-thyronine multiple interactions EXP 6480464 Triiodothyronine inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of PPARG mRNA] CTD PMID:25048947 3,3',5-triiodo-L-thyronine multiple interactions ISO RGD:69168 6480464 [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARG mRNA more ... CTD PMID:33049310 , PMID:33476690 3,3'-Dimethylbenzidine multiple interactions ISO RGD:69169 6480464 2-tolidine binds to and results in increased activity of PPARG protein CTD PMID:33049310 3,3'-Dimethylbenzidine multiple interactions ISO RGD:69168 6480464 2-tolidine binds to and results in increased activity of PPARG protein CTD PMID:33049310 3,4-Dimethylbenzaldehyde multiple interactions ISO RGD:69168 6480464 3, 4-dimethylbenzaldehyde binds to and results in decreased activity of PPARG protein CTD PMID:27633901 3,5,6-trichloro-2-pyridinol multiple interactions ISO RGD:69169 6480464 3 more ... CTD PMID:32017950 3,5,6-trichloropyridine-2-one multiple interactions ISO RGD:69169 6480464 3 more ... CTD PMID:32017950 3,5-di-tert-Butyl-4-hydroxybenzaldehyde multiple interactions ISO RGD:69168 6480464 3, 5-di-tert-butyl-4-hydroxybenzaldehyde binds to and results in decreased activity of PPARG protein CTD PMID:27633901 3,6-diaminoacridine multiple interactions ISO RGD:69168 6480464 Proflavine inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein] CTD PMID:30818834 3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(propan-2-yl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid increases activity ISO RGD:69168 6480464 MK-886 results in increased activity of PPARG protein CTD PMID:15899809 3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(propan-2-yl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid increases expression ISO RGD:69168 6480464 MK-886 results in increased expression of PPARG mRNA CTD PMID:15899809 3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(propan-2-yl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid affects localization ISO RGD:69168 6480464 MK-886 affects the localization of PPARG protein CTD PMID:15899809 3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(propan-2-yl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid multiple interactions ISO RGD:69168 6480464 [Indomethacin co-treated with MK-886] affects the localization of PPARG protein, Indomethacin promotes the reaction [MK-886 results in increased activity of PPARG protein] CTD PMID:15899809 3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione multiple interactions ISO RGD:69168 6480464 bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PPARG protein] CTD PMID:16945329 3-acetyldeoxynivalenol decreases activity ISO RGD:69168 6480464 3-acetyldeoxynivalenol results in decreased activity of PPARG protein CTD PMID:27481073 3-aminobenzamide increases activity EXP 6480464 3-aminobenzamide results in increased activity of PPARG protein CTD PMID:18815186 3-aminobenzamide decreases ADP-ribosylation EXP 6480464 3-aminobenzamide results in decreased ADP-ribosylation of PPARG protein CTD PMID:18815186 3-aminobenzamide multiple interactions EXP 6480464 3-aminobenzamide inhibits the reaction [NAD results in decreased activity of PPARG protein] CTD PMID:18815186 3-iodoprop-2-yn-1-yl butylcarbamate multiple interactions ISO RGD:69168 6480464 3-iodo-2-propynylbutylcarbamate binds to and results in increased activity of PPARG protein CTD PMID:33049310 3-iodoprop-2-yn-1-yl butylcarbamate multiple interactions ISO RGD:69169 6480464 3-iodo-2-propynylbutylcarbamate binds to and results in increased activity of PPARG protein CTD PMID:33049310 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:69169 6480464 (+)-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of PPARG protein] more ... CTD PMID:11101056 more ... 3-isobutyl-1-methyl-7H-xanthine increases expression ISO RGD:69168 6480464 1-Methyl-3-isobutylxanthine results in increased expression of PPARG mRNA CTD PMID:22645054 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [INS co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of PPARG mRNA CTD PMID:21350315 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:69168 6480464 [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Firemaster 550] results in increased expression of PPARG mRNA more ... CTD PMID:19186324 more ... 3-Methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one multiple interactions ISO RGD:69168 6480464 alpha-isomethylionone binds to and results in increased activity of PPARG protein CTD PMID:33049310 3-Methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one multiple interactions ISO RGD:69169 6480464 alpha-isomethylionone binds to and results in increased activity of PPARG protein CTD PMID:33049310 3-phenylprop-2-enal decreases expression ISO RGD:69169 6480464 cinnamaldehyde results in decreased expression of PPARG mRNA CTD PMID:21401097 4'-Methoxychalcone increases expression ISO RGD:69169 6480464 4'-methoxychalcone analog results in increased expression of PPARG mRNA CTD PMID:28528971 4'-Methoxychalcone multiple interactions ISO RGD:69169 6480464 4'-methoxychalcone analog inhibits the reaction [TNF protein results in decreased expression of PPARG mRNA], 4'-methoxychalcone analog results in increased expression of and results in increased activity of PPARG protein CTD PMID:28528971 4,4'-sulfonyldiphenol increases expression ISO RGD:69168 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of PPARG mRNA, bis(4-hydroxyphenyl)sulfone results in increased expression of PPARG protein CTD PMID:27003841 more ... 4,4'-sulfonyldiphenol increases expression ISO RGD:69169 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of PPARG mRNA CTD PMID:30951980 , PMID:30959087 4,4'-sulfonyldiphenol increases activity ISO RGD:69168 6480464 bis(4-hydroxyphenyl)sulfone analog results in increased activity of PPARG protein, bis(4-hydroxyphenyl)sulfone results in increased activity of PPARG protein CTD PMID:29331639 4,4'-sulfonyldiphenol multiple interactions ISO RGD:69168 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] affects the expression of PPARG protein more ... CTD PMID:27633901 more ... 4,4'-sulfonyldiphenol increases activity ISO RGD:69169 6480464 bis(4-hydroxyphenyl)sulfone results in increased activity of PPARG protein CTD PMID:27273607 4,4'-sulfonyldiphenol multiple interactions ISO RGD:69169 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA more ... CTD PMID:27241191 more ... 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression ISO RGD:69169 6480464 Oxazolone results in increased expression of PPARG protein CTD PMID:22200888 4-(ethoxymethylene)-2-phenyloxazol-5-one multiple interactions ISO RGD:69169 6480464 tetramethylpyrazine inhibits the reaction [Oxazolone results in increased expression of PPARG protein] CTD PMID:22200888 4-chloro-3,5-dimethylphenol multiple interactions ISO RGD:69169 6480464 chloroxylenol binds to and results in increased activity of PPARG protein CTD PMID:33049310 4-chloro-3,5-dimethylphenol multiple interactions ISO RGD:69168 6480464 chloroxylenol binds to and results in increased activity of PPARG protein CTD PMID:33049310 4-hydroxynon-2-enal decreases expression ISO RGD:69168 6480464 4-hydroxy-2-nonenal results in decreased expression of PPARG protein CTD PMID:27417252 4-hydroxyphenyl retinamide decreases expression ISO RGD:69169 6480464 Fenretinide results in decreased expression of PPARG mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide increases activity ISO RGD:69168 6480464 Fenretinide results in increased activity of PPARG protein CTD PMID:16274795 4-Methyl-3-penten-2-one, 9CI multiple interactions ISO RGD:69168 6480464 mesityl oxide binds to and results in decreased activity of PPARG protein CTD PMID:33049310 4-nonylphenol increases expression EXP 6480464 4-nonylphenol results in increased expression of PPARG mRNA CTD PMID:24388992 5-aza-2'-deoxycytidine increases expression ISO RGD:69168 6480464 Decitabine results in increased expression of PPARG mRNA CTD PMID:16763620 5-aza-2'-deoxycytidine affects expression ISO RGD:69168 6480464 Decitabine affects the expression of PPARG mRNA CTD PMID:23300844 5-azacytidine decreases methylation ISO RGD:69169 6480464 Azacitidine results in decreased methylation of PPARG promoter CTD PMID:19589179 5-azacytidine increases expression ISO RGD:69169 6480464 Azacitidine results in increased expression of PPARG mRNA CTD PMID:19589179 5-fluorouracil decreases expression ISO RGD:69168 6480464 Fluorouracil results in decreased expression of PPARG protein CTD PMID:15352031 5-fluorouracil affects response to substance ISO RGD:69168 6480464 PPARG protein affects the susceptibility to Fluorouracil CTD PMID:15352031 5-formyltetrahydrofolic acid multiple interactions EXP 6480464 [Methotrexate co-treated with Leucovorin] results in increased expression of PPARG mRNA, [Methotrexate co-treated with Leucovorin] results in increased expression of PPARG protein CTD PMID:25187349 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of PPARG mRNA CTD PMID:24780913 7,12-dimethyltetraphene multiple interactions ISO RGD:69168 6480464 9 more ... CTD PMID:33049310 7,12-dimethyltetraphene multiple interactions ISO RGD:69169 6480464 9 more ... CTD PMID:33049310 8-(4-chlorophenylthio)-cGMP multiple interactions ISO RGD:69169 6480464 8-(4-chlorophenylthio)guanosine 3' more ... CTD PMID:20471953 8-(4-chlorophenylthio)-cGMP increases expression ISO RGD:69169 6480464 8-((4-chlorophenyl)thio)cyclic-3', 5'-GMP results in increased expression of PPARG protein CTD PMID:20471953 8-Br-cAMP decreases expression EXP 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PPARG mRNA CTD PMID:15994020 8-Br-cAMP multiple interactions EXP 6480464 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [ochratoxin A results in increased expression of PPARG mRNA] CTD PMID:15994020 9,10-epoxy-12-octadecenoic acid affects binding ISO RGD:69169 6480464 9, 10-epoxy-12-octadecenoic acid binds to PPARG protein CTD PMID:12021203 9,11,13-octadecatrienoic acid increases expression ISO RGD:69168 6480464 eleostearic acid results in increased expression of PPARG mRNA, eleostearic acid results in increased expression of PPARG protein CTD PMID:15961301 9-cis-retinoic acid multiple interactions ISO RGD:69169 6480464 [Pioglitazone co-treated with Alitretinoin] inhibits the reaction [PPARG protein results in increased susceptibility to Methamphetamine], PPARG protein promotes the reaction [Alitretinoin results in increased expression of PPARGC1A mRNA] CTD PMID:16513826 , PMID:17019405 9-cis-retinoic acid multiple interactions EXP 6480464 [9-deoxy-delta-9-prostaglandin D2 co-treated with Alitretinoin] promotes the reaction [[PPARG protein binds to RXRA protein] which binds to GSTA2 promoter], Alitretinoin binds to and results in increased activity of PPARG protein CTD PMID:15150131 , PMID:18063688 9-cis-retinoic acid multiple interactions ISO RGD:69168 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Alitretinoin results in increased activity of PPARG protein], MG 262 promotes the reaction [Alitretinoin results in increased activity of PPARG protein] CTD PMID:15707588 9-cis-retinoic acid increases activity ISO RGD:69168 6480464 Alitretinoin results in increased activity of PPARG protein CTD PMID:15707588 9-HODE increases expression ISO RGD:69168 6480464 9-hydroxy-10, 12-octadecadienoic acid results in increased expression of PPARG CTD PMID:16647253 9-phenanthrol multiple interactions ISO RGD:69169 6480464 9-phenanthrol binds to and affects the activity of PPARG protein CTD PMID:33049310 9-phenanthrol multiple interactions ISO RGD:69168 6480464 9-phenanthrol binds to and results in increased activity of PPARG protein CTD PMID:33049310 [4-(4-HYDROXY-3-IODO-PHENOXY)-3,5-DIIODO-PHENYL]-ACETIC ACID multiple interactions ISO RGD:69169 6480464 3 more ... CTD PMID:33049310 [4-(4-HYDROXY-3-IODO-PHENOXY)-3,5-DIIODO-PHENYL]-ACETIC ACID multiple interactions ISO RGD:69168 6480464 3 more ... CTD PMID:33049310 [6]-Shogaol increases activity ISO RGD:69169 6480464 shogaol results in increased activity of PPARG protein CTD PMID:18577375 AACOCF3 multiple interactions ISO RGD:69169 6480464 arachidonyltrifluoromethane inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG mRNA] CTD PMID:19063610 acetaldehyde multiple interactions ISO RGD:69168 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Acetaldehyde inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]] more ... CTD PMID:17030193 acetic acid multiple interactions EXP 6480464 Gliclazide inhibits the reaction [Acetic Acid results in decreased expression of PPARG protein] CTD PMID:32045587 acetic acid decreases expression EXP 6480464 Acetic Acid results in decreased expression of PPARG protein CTD PMID:32045587 acetochlor multiple interactions ISO RGD:69169 6480464 acetochlor binds to and results in increased activity of PPARG protein CTD PMID:33049310 acetochlor multiple interactions ISO RGD:69168 6480464 acetochlor binds to and results in increased activity of PPARG protein CTD PMID:33049310 acetophenone multiple interactions ISO RGD:69168 6480464 acetophenone binds to and results in decreased activity of PPARG protein CTD PMID:27633901 acetylsalicylic acid decreases activity ISO RGD:69168 6480464 Aspirin results in decreased activity of PPARG protein CTD PMID:15646027 acetylsalicylic acid decreases expression EXP 6480464 Aspirin results in decreased expression of PPARG mRNA CTD PMID:18222077 acetylsalicylic acid increases expression ISO RGD:69169 6480464 Aspirin results in increased expression of PPARG mRNA CTD PMID:19462226 acetylsalicylic acid increases expression ISO RGD:69168 6480464 Aspirin results in increased expression of PPARG more ... CTD PMID:18971601 , PMID:19880272 acetylsalicylic acid multiple interactions ISO RGD:69168 6480464 Aspirin inhibits the reaction [Niacin results in increased activity of PPARG protein] CTD PMID:16386710 acrolein multiple interactions ISO RGD:69168 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of PPARG mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of PPARG mRNA CTD PMID:32699268 acrolein multiple interactions ISO RGD:69169 6480464 [Acrolein promotes the reaction [DDIT3 protein binds to PPARG promoter]] which results in decreased expression of PPARG protein more ... CTD PMID:34813903 acrolein decreases expression ISO RGD:69169 6480464 Acrolein results in decreased expression of PPARG protein CTD PMID:34813903 acrylamide multiple interactions ISO RGD:69169 6480464 Acrylamide promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG mRNA] more ... CTD PMID:30409764 adefovir pivoxil affects activity ISO RGD:69168 6480464 adefovir dipivoxil affects the activity of PPARG protein CTD PMID:25596134 afimoxifene multiple interactions ISO RGD:69169 6480464 afimoxifene binds to and results in increased activity of PPARG protein, PPARG mRNA promotes the reaction [afimoxifene results in decreased expression of CD36 protein] CTD PMID:27358406 , PMID:33049310 afimoxifene multiple interactions ISO RGD:69168 6480464 afimoxifene binds to and results in increased activity of PPARG protein more ... CTD PMID:27358406 , PMID:33049310 aflatoxin B1 increases expression ISO RGD:69169 6480464 Aflatoxin B1 results in increased expression of PPARG mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO RGD:69168 6480464 Aflatoxin B1 results in decreased methylation of PPARG gene CTD PMID:27153756 AICA ribonucleotide multiple interactions EXP 6480464 AICA ribonucleotide inhibits the reaction [Palmitic Acid results in decreased expression of PPARG mRNA] CTD PMID:25108154 AICA ribonucleotide multiple interactions ISO RGD:69168 6480464 AICA ribonucleotide inhibits the reaction [TGFB1 protein results in decreased expression of PPARG protein] CTD PMID:27688165 AL 8810 increases expression ISO RGD:69169 6480464 AL 8810 results in increased expression of PPARG mRNA CTD PMID:21236357 aldehydo-D-glucosamine multiple interactions ISO RGD:69168 6480464 Glucosamine promotes the reaction [IL1B results in increased expression of PPARG] CTD PMID:22089456 aldehydo-D-glucosamine increases expression EXP 6480464 Glucosamine results in increased expression of PPARG mRNA CTD PMID:15694357 aldehydo-D-glucosamine increases expression ISO RGD:69169 6480464 Glucosamine results in increased expression of PPARG mRNA CTD PMID:15694357 aldehydo-D-glucosamine increases expression ISO RGD:69168 6480464 Glucosamine results in increased expression of PPARG CTD PMID:22089456 aldehydo-D-glucosamine 6-phosphate decreases expression ISO RGD:69169 6480464 glucosamine 6-phosphate results in decreased expression of PPARG protein CTD PMID:19427183 aldehydo-D-glucose multiple interactions ISO RGD:69168 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Glucose results in decreased expression of PPARG protein]] more ... CTD PMID:21333731 more ... aldehydo-D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of PPARG mRNA, Glucose results in decreased expression of PPARG protein CTD PMID:19609456 , PMID:31063766 aldehydo-D-glucose multiple interactions EXP 6480464 [ciglitazone binds to and results in increased activity of PPARG protein] which results in increased transport of Glucose more ... CTD PMID:15878969 more ... aldehydo-D-glucose decreases expression ISO RGD:69168 6480464 Glucose results in decreased expression of PPARG protein CTD PMID:21333731 aldosterone affects abundance ISO RGD:69169 6480464 PPARG protein affects the abundance of Aldosterone CTD PMID:16007095 all-trans-retinoic acid multiple interactions ISO RGD:69168 6480464 [Chir 99021 co-treated with BMP4 protein co-treated with FGF10 protein co-treated with FGF7 protein co-treated with Tretinoin] results in increased expression of PPARG mRNA more ... CTD PMID:16982809 more ... all-trans-retinoic acid multiple interactions ISO RGD:69169 6480464 Tretinoin inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA] CTD PMID:32473317 all-trans-retinoic acid increases expression ISO RGD:69168 6480464 Tretinoin results in increased expression of PPARG mRNA CTD PMID:21934132 , PMID:23724009 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of PPARG mRNA, Tretinoin results in increased expression of PPARG protein CTD PMID:14568882 all-trans-retinoic acid increases expression ISO RGD:69169 6480464 Tretinoin results in increased expression of PPARG mRNA CTD PMID:17198874 all-trans-retinoic acid decreases expression ISO RGD:69169 6480464 Tretinoin results in decreased expression of PPARG mRNA CTD PMID:11237167 all-trans-retinol multiple interactions EXP 6480464 Vitamin A inhibits the reaction [Safflower Oil results in increased expression of PPARG mRNA] CTD PMID:15203375 all-trans-retinol increases expression EXP 6480464 Vitamin A results in increased expression of PPARG mRNA CTD PMID:16180333 allethrin increases activity ISO RGD:69168 6480464 Allethrins results in increased activity of PPARG protein CTD PMID:20143881 allethrin increases expression ISO RGD:69168 6480464 Allethrins results in increased expression of PPARG mRNA CTD PMID:32473317 allyl isothiocyanate multiple interactions EXP 6480464 allyl isothiocyanate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of PPARG protein], allyl isothiocyanate inhibits the reaction [Dietary Fats results in decreased expression of PPARG protein] CTD PMID:30927557 Aloe emodin multiple interactions ISO RGD:69168 6480464 aloe emodin inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased expression of PPARG mRNA] CTD PMID:22645054 alpha-linolenic acid increases expression ISO RGD:69169 6480464 alpha-Linolenic Acid results in increased expression of PPARG mRNA CTD PMID:18154422 alpha-linolenic acid increases activity ISO RGD:69168 6480464 alpha-Linolenic Acid results in increased activity of PPARG protein CTD PMID:20696231 alpha-linolenic acid multiple interactions ISO RGD:69168 6480464 alpha-Linolenic Acid binds to and results in increased activity of PPARG protein CTD PMID:16731579 alpha-linolenic acid multiple interactions ISO RGD:69169 6480464 alpha-Linolenic Acid binds to and results in increased activity of PPARG protein CTD PMID:16731579 alpha-linolenic acid multiple interactions EXP 6480464 alpha-Linolenic Acid binds to and results in increased activity of PPARG protein CTD PMID:16731579 alpha-pinene multiple interactions ISO RGD:69168 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of PPARG mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of PPARG mRNA CTD PMID:32699268 amentoflavone multiple interactions ISO RGD:69168 6480464 amentoflavone inhibits the reaction [malondialdehyde-low density lipoprotein more ... CTD PMID:34599948 amiodarone multiple interactions ISO RGD:69168 6480464 [2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] inhibits the reaction [Amiodarone results in increased expression of FADS2 mRNA] more ... CTD PMID:21123845 , PMID:24489787 amiodarone decreases expression ISO RGD:69168 6480464 Amiodarone results in decreased expression of PPARG mRNA CTD PMID:35641671 amiodarone increases expression ISO RGD:69168 6480464 Amiodarone results in increased expression of PPARG mRNA CTD PMID:21123845 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PPARG mRNA CTD PMID:16483693 andrographolide multiple interactions ISO RGD:69169 6480464 andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein] CTD PMID:27475717 androst-4-ene-3,17-dione multiple interactions ISO RGD:69168 6480464 Androstenedione binds to and results in decreased activity of PPARG protein CTD PMID:33049310 androst-4-ene-3,17-dione multiple interactions ISO RGD:69169 6480464 Androstenedione binds to and results in decreased activity of PPARG protein CTD PMID:33049310 anthra[1,9-cd]pyrazol-6(2H)-one increases expression EXP 6480464 pyrazolanthrone results in increased expression of PPARG mRNA, pyrazolanthrone results in increased expression of PPARG protein CTD PMID:17372590 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP 6480464 pyrazolanthrone inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of PPARG protein] CTD PMID:28283887 apigenin multiple interactions ISO RGD:69169 6480464 Apigenin binds to and results in increased activity of PPARG protein more ... CTD PMID:11343698 , PMID:33049310 apigenin multiple interactions ISO RGD:69168 6480464 Apigenin binds to and results in increased activity of PPARG protein CTD PMID:33049310 apigenin decreases expression ISO RGD:69169 6480464 Apigenin results in decreased expression of PPARG mRNA CTD PMID:18359623 arachidonic acid decreases expression ISO RGD:69168 6480464 Arachidonic Acid results in decreased expression of PPARG mRNA, Arachidonic Acid results in decreased expression of PPARG protein CTD PMID:11172467 arachidonic acid multiple interactions ISO RGD:69169 6480464 Arachidonic Acid promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG mRNA] CTD PMID:19063610 arachidonic acid increases expression EXP 6480464 Arachidonic Acid results in increased expression of PPARG protein CTD PMID:12604186 Aroclor 1254 increases expression ISO RGD:69168 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of PPARG mRNA CTD PMID:16934159 Aroclor 1254 multiple interactions ISO RGD:69169 6480464 [Diethylhexyl Phthalate co-treated with Chlorodiphenyl (54% Chlorine)] results in increased expression of PPARG mRNA CTD PMID:23804495 arsane decreases expression ISO RGD:69168 6480464 Arsenic results in decreased expression of PPARG mRNA, Arsenic results in decreased expression of PPARG protein CTD PMID:23108036 arsane affects expression ISO RGD:69168 6480464 Arsenic affects the expression of PPARG mRNA CTD PMID:28793237 arsane multiple interactions ISO RGD:69168 6480464 [Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of PPARG mRNA more ... CTD PMID:23108036 , PMID:28793237 arsenic atom decreases expression ISO RGD:69168 6480464 Arsenic results in decreased expression of PPARG mRNA, Arsenic results in decreased expression of PPARG protein CTD PMID:23108036 arsenic atom affects expression ISO RGD:69168 6480464 Arsenic affects the expression of PPARG mRNA CTD PMID:28793237 arsenic atom multiple interactions ISO RGD:69168 6480464 [Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of PPARG mRNA more ... CTD PMID:23108036 , PMID:28793237 arsenite(3-) increases expression ISO RGD:69169 6480464 arsenite results in increased expression of PPARG mRNA CTD PMID:15868481 arsenous acid increases expression ISO RGD:69168 6480464 Arsenic Trioxide results in increased expression of PPARG mRNA, Arsenic Trioxide results in increased expression of PPARG protein CTD PMID:22684020 arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of PPARG mRNA CTD PMID:31258454 arsenous acid decreases expression ISO RGD:69168 6480464 Arsenic Trioxide results in decreased expression of PPARG protein CTD PMID:30362509 arsenous acid decreases expression ISO RGD:69169 6480464 Arsenic Trioxide results in decreased expression of PPARG protein CTD PMID:15916724 , PMID:30362509 arsenous acid decreases response to substance ISO RGD:69168 6480464 PPARG protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 arsenous acid multiple interactions ISO RGD:69169 6480464 Arsenic Trioxide inhibits the reaction [AKT1 protein binds to PPARG protein] more ... CTD PMID:15916724 , PMID:30362509 arsenous acid multiple interactions ISO RGD:69168 6480464 [Rosiglitazone binds to and results in increased activity of PPARG protein] which results in increased susceptibility to Arsenic Trioxide more ... CTD PMID:22684020 more ... aspartame multiple interactions ISO RGD:69169 6480464 [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PPARG mRNA CTD PMID:23783067 ATP multiple interactions ISO RGD:69168 6480464 FASN protein promotes the reaction [rosiglitazone promotes the reaction [PPARG protein results in decreased abundance of Adenosine Triphosphate]] more ... CTD PMID:26670611 ATP decreases abundance ISO RGD:69168 6480464 PPARG protein mutant form results in decreased abundance of Adenosine Triphosphate, PPARG protein results in decreased abundance of Adenosine Triphosphate CTD PMID:26670611 atrazine multiple interactions ISO RGD:69169 6480464 [Lycopene co-treated with Atrazine] results in increased expression of PPARG mRNA, Atrazine promotes the reaction [[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of PPARG mRNA] CTD PMID:24440342 , PMID:36216167 atrazine increases expression ISO RGD:69169 6480464 Atrazine results in increased expression of PPARG mRNA CTD PMID:36216167 atrazine multiple interactions ISO RGD:69168 6480464 [Atrazine co-treated with Arsenates] results in increased expression of PPARG mRNA CTD PMID:18585445 Aurothioglucose multiple interactions ISO RGD:69169 6480464 [Dietary Fats co-treated with Aurothioglucose] results in decreased expression of PPARG protein CTD PMID:21382165 avobenzone multiple interactions ISO RGD:69168 6480464 avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA], avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA] CTD PMID:31016361 , PMID:32407875 avobenzone increases expression ISO RGD:69168 6480464 avobenzone results in increased expression of PPARG mRNA CTD PMID:31016361 , PMID:32407875 azinphos-methyl multiple interactions ISO RGD:69169 6480464 Azinphosmethyl binds to and results in increased activity of PPARG protein CTD PMID:33049310 azinphos-methyl multiple interactions ISO RGD:69168 6480464 Azinphosmethyl binds to and results in increased activity of PPARG protein CTD PMID:33049310 baicalein decreases expression ISO RGD:69169 6480464 baicalein results in decreased expression of PPARG protein CTD PMID:24560969 baicalin multiple interactions EXP 6480464 baicalin inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased phosphorylation of and results in decreased activity of PPARG protein] CTD PMID:24312512 Bardoxolone methyl increases expression ISO RGD:69169 6480464 bardoxolone methyl results in increased expression of PPARG mRNA, bardoxolone methyl results in increased expression of PPARG protein CTD PMID:21289052 benzbromarone affects expression ISO RGD:69169 6480464 Benzbromarone affects the expression of PPARG mRNA CTD PMID:19048458 benzene increases expression ISO RGD:69168 6480464 Benzene results in increased expression of PPARG mRNA CTD PMID:19162166 benzo[a]pyrene decreases expression ISO RGD:69168 6480464 Benzo(a)pyrene results in decreased expression of PPARG mRNA CTD PMID:20064835 , PMID:30453624 benzo[a]pyrene affects expression ISO RGD:69168 6480464 Benzo(a)pyrene affects the expression of PPARG mRNA CTD PMID:35641671 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of PPARG protein CTD PMID:34999049 benzo[a]pyrene multiple interactions ISO RGD:69168 6480464 [Soot co-treated with Benzo(a)pyrene] results in decreased activity of PPARG protein CTD PMID:24464499 benzo[a]pyrene multiple interactions ISO RGD:69169 6480464 Benzo(a)pyrene promotes the reaction [Lipopolysaccharides results in increased activity of PPARG protein] more ... CTD PMID:27329536 benzo[a]pyrene increases activity ISO RGD:69169 6480464 Benzo(a)pyrene results in increased activity of PPARG protein CTD PMID:27329536 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of PPARG mRNA, Benzo(a)pyrene results in increased expression of PPARG protein CTD PMID:20920559 , PMID:22374506 benzo[a]pyrene increases expression ISO RGD:69169 6480464 Benzo(a)pyrene results in increased expression of PPARG mRNA CTD PMID:22228805 benzo[a]pyrene decreases expression ISO RGD:69169 6480464 Benzo(a)pyrene results in decreased expression of PPARG mRNA CTD PMID:19770486 benzo[a]pyrene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with Diethylhexyl Phthalate] results in increased expression of PPARG mRNA more ... CTD PMID:20920559 , PMID:34999049 benzo[a]pyrene increases expression ISO RGD:69168 6480464 Benzo(a)pyrene results in increased expression of PPARG mRNA CTD PMID:15735009 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:69168 6480464 7 more ... CTD PMID:19150397 benzofurans decreases expression ISO RGD:69169 6480464 Benzofurans results in decreased expression of PPARG mRNA, Benzofurans results in decreased expression of PPARG protein CTD PMID:20863820 Benzyl parahydroxybenzoate increases expression ISO RGD:69169 6480464 benzylparaben results in increased expression of PPARG mRNA CTD PMID:22956630 , PMID:27659731 Benzyl parahydroxybenzoate increases activity ISO RGD:69169 6480464 benzylparaben results in increased activity of PPARG protein CTD PMID:28527915 berberine multiple interactions ISO RGD:69169 6480464 Berberine inhibits the reaction [Clozapine results in increased expression of PPARG mRNA] more ... CTD PMID:20564506 berberine multiple interactions ISO RGD:69168 6480464 15-deoxyprostaglandin J2 promotes the reaction [Berberine affects the localization of and results in increased activity of PPARG protein] more ... CTD PMID:29408570 berberine increases expression ISO RGD:69168 6480464 Berberine results in increased expression of PPARG mRNA CTD PMID:29408570 berberine increases response to substance ISO RGD:69168 6480464 PPARG mRNA results in increased susceptibility to Berberine CTD PMID:29408570 berberine decreases expression ISO RGD:69168 6480464 Berberine results in decreased expression of PPARG mRNA CTD PMID:26478571 Bergenin multiple interactions EXP 6480464 bergenin inhibits the reaction [Iron-Dextran Complex results in decreased expression of PPARG protein] CTD PMID:36207002 Bergenin multiple interactions ISO RGD:69168 6480464 bergenin inhibits the reaction [Hydrogen Peroxide results in decreased expression of PPARG protein], PPARG protein promotes the reaction [bergenin inhibits the reaction [Hydrogen Peroxide results in decreased activity of CAT protein]] CTD PMID:34499403 beta-carotene decreases expression ISO RGD:69169 6480464 beta Carotene results in decreased expression of PPARG mRNA CTD PMID:21569430 beta-D-glucosamine multiple interactions ISO RGD:69168 6480464 Glucosamine promotes the reaction [IL1B results in increased expression of PPARG] CTD PMID:22089456 beta-D-glucosamine increases expression EXP 6480464 Glucosamine results in increased expression of PPARG mRNA CTD PMID:15694357 beta-D-glucosamine increases expression ISO RGD:69169 6480464 Glucosamine results in increased expression of PPARG mRNA CTD PMID:15694357 beta-D-glucosamine increases expression ISO RGD:69168 6480464 Glucosamine results in increased expression of PPARG CTD PMID:22089456 beta-D-glucosamine 6-sulfate decreases expression ISO RGD:69169 6480464 glucosamine 6-O-sulfate results in decreased expression of PPARG mRNA, glucosamine 6-O-sulfate results in decreased expression of PPARG protein CTD PMID:19520133 beta-naphthoflavone multiple interactions ISO RGD:69169 6480464 beta-Naphthoflavone inhibits the reaction [Triclosan results in increased expression of PPARG protein] CTD PMID:33722737 beta-tocopherol multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA], [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein] CTD PMID:22389237 bezafibrate multiple interactions ISO RGD:69169 6480464 PPARA protein affects the reaction [Bezafibrate results in increased expression of PPARG mRNA] CTD PMID:21324916 bezafibrate increases expression ISO RGD:69168 6480464 Bezafibrate results in increased expression of PPARG mRNA CTD PMID:19201410 , PMID:24759758 bezafibrate affects binding ISO RGD:69168 6480464 Bezafibrate binds to PPARG protein CTD PMID:11779144 , PMID:23843199 bezafibrate increases expression ISO RGD:69169 6480464 Bezafibrate results in increased expression of PPARG mRNA CTD PMID:19201410 , PMID:21324916 bezafibrate increases activity ISO RGD:69169 6480464 Bezafibrate results in increased activity of PPARG protein CTD PMID:12401884 bezafibrate decreases expression ISO RGD:69168 6480464 Bezafibrate results in decreased expression of PPARG mRNA CTD PMID:15708366 bezafibrate multiple interactions ISO RGD:69168 6480464 [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Bezafibrate promotes the reaction [TNF protein inhibits the reaction [FSHB protein results in increased secretion of Estradiol]]] more ... CTD PMID:11779144 , PMID:21734263 bezafibrate multiple interactions EXP 6480464 Bezafibrate inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA] CTD PMID:12967931 bezafibrate decreases expression EXP 6480464 Bezafibrate results in decreased expression of PPARG mRNA CTD PMID:11473052 bicalutamide multiple interactions ISO RGD:69169 6480464 bicalutamide binds to and results in increased activity of PPARG protein CTD PMID:33049310 bicalutamide multiple interactions ISO RGD:69168 6480464 bicalutamide binds to and results in increased activity of PPARG protein CTD PMID:33049310 bifenthrin multiple interactions ISO RGD:69168 6480464 bifenthrin binds to and results in increased activity of PPARG protein CTD PMID:33049310 bifenthrin increases expression ISO RGD:69168 6480464 bifenthrin results in increased expression of PPARG mRNA CTD PMID:29554630 bifenthrin multiple interactions ISO RGD:69169 6480464 bifenthrin binds to and results in increased activity of PPARG protein CTD PMID:33049310 biochanin A multiple interactions ISO RGD:69169 6480464 biochanin A binds to and results in increased activity of PPARG protein CTD PMID:33049310 biphenyl-4-ol multiple interactions ISO RGD:69168 6480464 4-phenylphenol binds to and results in increased activity of PPARG protein CTD PMID:33049310 biphenyl-4-ol multiple interactions ISO RGD:69169 6480464 4-phenylphenol binds to and results in increased activity of PPARG protein CTD PMID:33049310 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with Diethylhexyl Phthalate] results in increased expression of PPARG mRNA, [Benzo(a)pyrene co-treated with Diethylhexyl Phthalate] results in increased expression of PPARG protein CTD PMID:20920559 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:69169 6480464 Diethylhexyl Phthalate results in decreased expression of PPARG mRNA, Diethylhexyl Phthalate results in decreased expression of PPARG protein CTD PMID:29669060 , PMID:31211961 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:69168 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Diethylhexyl Phthalate results in increased expression of PPARG protein] more ... CTD PMID:27633901 more ... bis(2-ethylhexyl) phthalate increases expression ISO RGD:69168 6480464 Diethylhexyl Phthalate results in increased expression of PPARG mRNA, Diethylhexyl Phthalate results in increased expression of PPARG protein CTD PMID:28025108 more ... bis(2-ethylhexyl) phthalate affects binding ISO RGD:69168 6480464 Diethylhexyl Phthalate binds to PPARG protein, Diethylhexyl Phthalate metabolite binds to PPARG protein CTD PMID:23843199 more ... bis(2-ethylhexyl) phthalate affects expression ISO RGD:69169 6480464 Diethylhexyl Phthalate affects the expression of PPARG mRNA CTD PMID:22588786 , PMID:25351189 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of PPARG mRNA, Diethylhexyl Phthalate results in increased expression of PPARG protein CTD PMID:15647598 more ... bis(2-ethylhexyl) phthalate increases expression ISO RGD:69169 6480464 Diethylhexyl Phthalate results in increased expression of PPARG mRNA, Diethylhexyl Phthalate results in increased expression of PPARG protein CTD PMID:21856391 more ... bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:69169 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:22197818 more ... bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of PPARG protein CTD PMID:16690193 , PMID:29669060 bisdemethoxycurcumin affects binding ISO RGD:69168 6480464 bisdemethoxycurcumin binds to PPARG protein CTD PMID:15713005 bismuth atom multiple interactions ISO RGD:69168 6480464 [Bismuth affects the susceptibility to [INS protein co-treated with Dexamethasone co-treated with Indomethacin co-treated with 1-Methyl-3-isobutylxanthine]] which results in decreased expression of PPARG mRNA CTD PMID:34560244 bismuthane multiple interactions ISO RGD:69168 6480464 [Bismuth affects the susceptibility to [INS protein co-treated with Dexamethasone co-treated with Indomethacin co-treated with 1-Methyl-3-isobutylxanthine]] which results in decreased expression of PPARG mRNA CTD PMID:34560244 bisphenol A increases localization ISO RGD:69168 6480464 bisphenol A results in increased localization of PPARG protein CTD PMID:20064783 bisphenol A decreases methylation ISO RGD:69168 6480464 bisphenol A results in decreased methylation of PPARG gene CTD PMID:31601247 bisphenol A decreases methylation ISO RGD:69169 6480464 bisphenol A results in decreased methylation of PPARG promoter CTD PMID:33203037 bisphenol A decreases methylation EXP 6480464 bisphenol A results in decreased methylation of PPARG gene CTD PMID:32701268 bisphenol A decreases expression ISO RGD:69169 6480464 bisphenol A results in decreased expression of PPARG mRNA CTD PMID:30133442 bisphenol A affects expression ISO RGD:69169 6480464 bisphenol A affects the expression of PPARG protein CTD PMID:31319301 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of PPARG gene CTD PMID:28505145 bisphenol A increases activity ISO RGD:69169 6480464 bisphenol A results in increased activity of PPARG protein CTD PMID:27273607 bisphenol A affects methylation ISO RGD:69169 6480464 bisphenol A affects the methylation of PPARG promoter CTD PMID:27334623 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PPARG mRNA CTD PMID:23399309 more ... bisphenol A affects binding ISO RGD:69168 6480464 bisphenol A analog binds to PPARG protein, bisphenol A binds to PPARG protein CTD PMID:23843199 more ... bisphenol A increases expression ISO RGD:69168 6480464 bisphenol A analog results in increased expression of PPARG mRNA more ... CTD PMID:20064783 more ... bisphenol A increases expression ISO RGD:69169 6480464 bisphenol A results in increased expression of PPARG more ... CTD PMID:18359623 more ... bisphenol A multiple interactions ISO RGD:69168 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA] more ... CTD PMID:21622942 more ... bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with tributyltin] results in increased expression of PPARG protein more ... CTD PMID:23399309 more ... bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PPARG mRNA CTD PMID:20019905 more ... bisphenol A decreases expression ISO RGD:69168 6480464 bisphenol A results in decreased expression of PPARG mRNA CTD PMID:28711546 bisphenol A multiple interactions ISO RGD:69169 6480464 [1-Methyl-3-isobutylxanthine co-treated with bisphenol A co-treated with INS protein] results in increased expression of PPARG protein more ... CTD PMID:22197818 more ... Bisphenol A diglycidyl ether multiple interactions ISO RGD:69169 6480464 2 more ... CTD PMID:11991651 more ... Bisphenol A diglycidyl ether decreases activity EXP 6480464 2, 2-bis(4-glycidyloxyphenyl)propane results in decreased activity of PPARG protein CTD PMID:27363640 , PMID:34553211 Bisphenol A diglycidyl ether decreases expression EXP 6480464 2, 2-bis(4-glycidyloxyphenyl)propane results in decreased expression of PPARG protein CTD PMID:22726273 Bisphenol A diglycidyl ether multiple interactions EXP 6480464 2 more ... CTD PMID:19903033 more ... Bisphenol A diglycidyl ether increases expression ISO RGD:69169 6480464 2, 2-bis(4-glycidyloxyphenyl)propane results in increased expression of PPARG mRNA CTD PMID:11991651 Bisphenol A diglycidyl ether multiple interactions ISO RGD:69168 6480464 2 more ... CTD PMID:11030710 more ... Bisphenol A diglycidyl ether decreases activity ISO RGD:69168 6480464 2, 2-bis(4-glycidyloxyphenyl)propane results in decreased activity of PPARG protein CTD PMID:21543282 Bisphenol B multiple interactions ISO RGD:69168 6480464 bisphenol B binds to and results in decreased activity of PPARG protein CTD PMID:34186270 bisphenol F multiple interactions ISO RGD:69168 6480464 4 more ... CTD PMID:30138673 more ... bisphenol F diglycidyl ether multiple interactions ISO RGD:69168 6480464 bisphenol F diglycidyl ether inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein] CTD PMID:30138673 bleomycin A2 decreases expression ISO RGD:69169 6480464 Bleomycin results in decreased expression of PPARG mRNA, Bleomycin results in decreased expression of PPARG protein CTD PMID:19147827 , PMID:27153807 bleomycin A2 multiple interactions ISO RGD:69168 6480464 Berberine inhibits the reaction [Bleomycin binds to PPARG protein] CTD PMID:29408570 bleomycin A2 multiple interactions ISO RGD:69169 6480464 lenabasum inhibits the reaction [Bleomycin results in decreased expression of PPARG protein], Rosiglitazone inhibits the reaction [Bleomycin results in decreased expression of PPARG mRNA] CTD PMID:19147827 , PMID:27153807 bongkrekic acid increases activity ISO RGD:69168 6480464 Bongkrekic Acid analog results in increased activity of PPARG protein, Bongkrekic Acid results in increased activity of PPARG protein CTD PMID:25786526 boric acid multiple interactions ISO RGD:69169 6480464 boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA] more ... CTD PMID:28285642 bosentan decreases expression ISO RGD:69168 6480464 Bosentan results in decreased expression of PPARG mRNA CTD PMID:29761207 Bromadiolone multiple interactions ISO RGD:69168 6480464 bromadiolone binds to and results in increased activity of PPARG protein CTD PMID:33049310 Bromadiolone multiple interactions ISO RGD:69169 6480464 bromadiolone binds to and results in increased activity of PPARG protein CTD PMID:33049310 bromuconazole multiple interactions ISO RGD:69168 6480464 bromuconazole binds to and results in increased activity of PPARG protein CTD PMID:33049310 bromuconazole multiple interactions ISO RGD:69169 6480464 bromuconazole binds to and results in increased activity of PPARG protein CTD PMID:33049310 bucladesine increases expression ISO RGD:69169 6480464 Bucladesine results in increased expression of PPARG protein CTD PMID:19698295 bucladesine multiple interactions ISO RGD:69169 6480464 [ciglitazone co-treated with Bucladesine] affects the expression of PPARG mRNA, [ciglitazone co-treated with Bucladesine] results in increased expression of PPARG protein CTD PMID:19698295 busulfan affects expression ISO RGD:69168 6480464 Busulfan affects the expression of PPARG mRNA CTD PMID:35641671 Butylbenzyl phthalate multiple interactions ISO RGD:69169 6480464 [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of PPARG mRNA more ... CTD PMID:24155963 more ... Butylbenzyl phthalate increases activity ISO RGD:69168 6480464 butylbenzyl phthalate results in increased activity of PPARG protein CTD PMID:26172262 Butylbenzyl phthalate increases expression ISO RGD:69169 6480464 butylbenzyl phthalate results in increased expression of PPARG mRNA CTD PMID:27923775 , PMID:34520170 Butylbenzyl phthalate affects binding ISO RGD:69168 6480464 butylbenzyl phthalate binds to PPARG protein CTD PMID:23843199 , PMID:32407875 Butylbenzyl phthalate multiple interactions ISO RGD:69168 6480464 butylbenzyl phthalate binds to and results in increased activity of PPARG protein, butylbenzyl phthalate inhibits the reaction [GW 1929 binds to PPARG protein] CTD PMID:24155963 more ... Butylparaben increases expression ISO RGD:69168 6480464 butylparaben results in increased expression of PPARG mRNA CTD PMID:22956630 Butylparaben increases response to substance ISO RGD:69169 6480464 PPARG protein results in increased susceptibility to butylparaben CTD PMID:28527915 Butylparaben multiple interactions ISO RGD:69169 6480464 2 more ... CTD PMID:22956630 more ... Butylparaben increases activity ISO RGD:69169 6480464 butylparaben results in increased activity of PPARG protein CTD PMID:28527915 Butylparaben increases expression ISO RGD:69169 6480464 butylparaben results in increased expression of PPARG mRNA CTD PMID:22956630 more ... Butylparaben multiple interactions ISO RGD:69168 6480464 butylparaben binds to and results in increased activity of PPARG protein CTD PMID:24155963 butyric acid increases expression ISO RGD:69168 6480464 Butyric Acid results in increased expression of PPARG mRNA, Butyric Acid results in increased expression of PPARG protein CTD PMID:10833422 butyric acid multiple interactions ISO RGD:69169 6480464 Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of PPARG mRNA] CTD PMID:29751049 butyric acid multiple interactions ISO RGD:69168 6480464 [Butyric Acid co-treated with Lipopolysaccharides] results in increased expression of PPARG mRNA CTD PMID:29751049 cadmium atom decreases expression ISO RGD:69169 6480464 Cadmium results in decreased expression of PPARG protein CTD PMID:21848503 cadmium atom multiple interactions ISO RGD:69168 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PPARG mRNA CTD PMID:35301059 cadmium atom multiple interactions ISO RGD:69169 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PPARG mRNA CTD PMID:36200916 cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of PPARG mRNA CTD PMID:25388156 cadmium dichloride decreases expression ISO RGD:69169 6480464 Cadmium Chloride results in decreased expression of PPARG mRNA, Cadmium Chloride results in decreased expression of PPARG protein CTD PMID:23921151 , PMID:31152847 cadmium dichloride multiple interactions ISO RGD:69168 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PPARG mRNA CTD PMID:35301059 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of PPARG protein CTD PMID:28283887 cadmium dichloride increases expression ISO RGD:69169 6480464 Cadmium Chloride results in increased expression of PPARG mRNA CTD PMID:26352046 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of PPARG mRNA CTD PMID:25993096 cadmium dichloride affects activity ISO RGD:69168 6480464 Cadmium Chloride affects the activity of PPARG protein CTD PMID:25596134 cadmium dichloride multiple interactions EXP 6480464 [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of and results in increased activity of PPARG protein] which results in decreased expression of GFAP protein more ... CTD PMID:24481447 , PMID:28283887 cadmium dichloride multiple interactions ISO RGD:69169 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PPARG mRNA more ... CTD PMID:23921151 , PMID:36200916 cadmium sulfate multiple interactions ISO RGD:69169 6480464 cadmium sulfate affects the reaction [MTF1 affects the expression of PPARG mRNA] CTD PMID:16221973 caffeine decreases expression EXP 6480464 Caffeine results in decreased expression of PPARG mRNA CTD PMID:23727198 caffeine decreases phosphorylation ISO RGD:69168 6480464 Caffeine results in decreased phosphorylation of PPARG protein CTD PMID:35688186 caffeine decreases expression ISO RGD:69169 6480464 Caffeine results in decreased expression of PPARG mRNA CTD PMID:23727198 calcitriol decreases expression ISO RGD:69169 6480464 Calcitriol results in decreased expression of PPARG mRNA, Calcitriol results in decreased expression of PPARG protein CTD PMID:15036392 more ... calcitriol multiple interactions EXP 6480464 2 more ... CTD PMID:29953732 cannabidiol increases expression ISO RGD:69168 6480464 Cannabidiol results in increased expression of PPARG mRNA CTD PMID:23220503 cannabidiol increases activity ISO RGD:69169 6480464 Cannabidiol analog results in increased activity of PPARG protein CTD PMID:30033591 cannabidiol increases expression ISO RGD:69169 6480464 Cannabidiol analog results in increased expression of PPARG mRNA alternative form CTD PMID:30382123 cannabidiol affects binding ISO RGD:69168 6480464 Cannabidiol analog binds to PPARG protein CTD PMID:30033591 cannabidiol decreases expression ISO RGD:69168 6480464 Cannabidiol results in decreased expression of PPARG protein CTD PMID:28853159 cannabidiol multiple interactions ISO RGD:69169 6480464 [lipopolysaccharide more ... CTD PMID:30033591 more ... cannabidiol affects binding ISO RGD:69169 6480464 Cannabidiol binds to PPARG protein CTD PMID:19285060 cannabidiol increases expression EXP 6480464 Cannabidiol results in increased expression of PPARG mRNA CTD PMID:19285060 cannabidiol multiple interactions ISO RGD:69168 6480464 Cannabidiol analog binds to and results in increased activity of PPARG protein more ... CTD PMID:23220503 more ... cannabidiolic acid increases expression ISO RGD:69168 6480464 cannabidiolic acid results in increased expression of PPARG mRNA CTD PMID:28853159 cannabidiolic acid multiple interactions ISO RGD:69169 6480464 cannabidiolic acid binds to and results in increased activity of PPARG protein, cannabidiolic acid promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA] CTD PMID:30611848 cannabidiolic acid increases expression ISO RGD:69169 6480464 cannabidiolic acid results in increased expression of PPARG mRNA CTD PMID:30611848 cannabidiolic acid multiple interactions ISO RGD:69168 6480464 cannabidiolic acid binds to and results in increased activity of PPARG protein CTD PMID:30611848 cannabidiolic acid decreases expression ISO RGD:69168 6480464 cannabidiolic acid results in decreased expression of PPARG protein CTD PMID:28853159 cannabigerol decreases expression ISO RGD:69168 6480464 cannabigerol results in decreased expression of PPARG protein CTD PMID:28853159 cannabigerol multiple interactions ISO RGD:69169 6480464 cannabigerol binds to and results in increased activity of PPARG protein, cannabigerol promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA] CTD PMID:30611848 cannabigerol multiple interactions ISO RGD:69168 6480464 cannabigerol binds to and results in increased activity of PPARG protein CTD PMID:30611848 cannabigerol increases expression ISO RGD:69168 6480464 cannabigerol results in increased expression of PPARG mRNA CTD PMID:28853159 cannabigerolic acid increases expression ISO RGD:69168 6480464 cannabigerolic acid results in increased expression of PPARG mRNA CTD PMID:28853159 cannabigerolic acid multiple interactions ISO RGD:69168 6480464 cannabigerolic acid binds to and results in increased activity of PPARG protein CTD PMID:30611848 cannabigerolic acid increases expression ISO RGD:69169 6480464 cannabigerolic acid results in increased expression of PPARG mRNA CTD PMID:30611848 cannabigerolic acid multiple interactions ISO RGD:69169 6480464 cannabigerolic acid binds to and results in increased activity of PPARG protein, cannabigerolic acid promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA] CTD PMID:30611848 cannabigerolic acid decreases expression ISO RGD:69168 6480464 cannabigerolic acid results in decreased expression of PPARG protein CTD PMID:28853159 capsaicin multiple interactions EXP 6480464 Capsaicin inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA] CTD PMID:20359164 capsaicin increases activity ISO RGD:69168 6480464 Capsaicin results in increased activity of PPARG protein CTD PMID:15383218 capsaicin decreases expression ISO RGD:69169 6480464 Capsaicin results in decreased expression of PPARG protein CTD PMID:17295509 capsaicin decreases expression ISO RGD:69168 6480464 Capsaicin results in decreased expression of PPARG mRNA CTD PMID:18769453 capsaicin multiple interactions ISO RGD:69168 6480464 2, 2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Capsaicin results in increased activity of PPARG protein] CTD PMID:15383218 carbamazepine affects expression ISO RGD:69168 6480464 Carbamazepine affects the expression of PPARG mRNA CTD PMID:24752500 carbon monoxide multiple interactions ISO RGD:69169 6480464 [Carbon Monoxide results in increased abundance of Reactive Oxygen Species] which results in increased sumoylation of PPARG protein more ... CTD PMID:22046279 carbon nanotube multiple interactions ISO RGD:69168 6480464 PPARG protein affects the reaction [Nanotubes, Carbon results in increased expression of PLIN2 protein] CTD PMID:32649966 carbon nanotube increases expression ISO RGD:69169 6480464 Nanotubes more ... CTD PMID:25620056 , PMID:25926378 carbon nanotube decreases expression ISO RGD:69169 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube increases expression ISO RGD:69168 6480464 Nanotubes more ... CTD PMID:23634900 , PMID:32649966 carnosic acid increases activity ISO RGD:69168 6480464 salvin results in increased activity of PPARG protein CTD PMID:20696231 carotenoid decreases expression ISO RGD:69169 6480464 Carotenoids results in decreased expression of PPARG mRNA CTD PMID:11237167 casticin increases expression ISO RGD:69168 6480464 casticin results in increased expression of PPARG mRNA CTD PMID:27862857 celastrol affects expression ISO RGD:69169 6480464 celastrol affects the expression of PPARG mRNA, celastrol affects the expression of PPARG protein CTD PMID:27085773 celecoxib multiple interactions ISO RGD:69168 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Celecoxib affects the localization of PPARG protein] more ... CTD PMID:19522023 , PMID:23943857 celecoxib multiple interactions ISO RGD:69169 6480464 [Celecoxib co-treated with docetaxel] results in increased expression of PPARG protein CTD PMID:16052515 celecoxib multiple interactions EXP 6480464 Celecoxib inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA] CTD PMID:19247274 celecoxib increases expression ISO RGD:69168 6480464 Celecoxib results in increased expression of PPARG mRNA, Celecoxib results in increased expression of PPARG protein CTD PMID:23943857 celecoxib affects localization ISO RGD:69168 6480464 Celecoxib affects the localization of PPARG protein CTD PMID:23943857 cerium decreases expression ISO RGD:69168 6480464 Cerium results in decreased expression of PPARG mRNA CTD PMID:35641671 cerulenin decreases expression ISO RGD:69169 6480464 Cerulenin results in decreased expression of PPARG mRNA CTD PMID:15707987 ceruletide multiple interactions ISO RGD:69169 6480464 PPARG affects the reaction [Ceruletide results in increased expression of CCL2 mRNA], PPARG affects the reaction [Ceruletide results in increased expression of CXCL1 mRNA] CTD PMID:17463185 chalcone increases expression ISO RGD:69169 6480464 Chalcone analog results in increased expression of PPARG mRNA CTD PMID:28528971 chenodeoxycholic acid increases expression EXP 6480464 Chenodeoxycholic Acid results in increased expression of PPARG mRNA CTD PMID:15980055 chenodeoxycholic acid multiple interactions ISO RGD:69169 6480464 Chenodeoxycholic Acid inhibits the reaction [tris(chloroethyl)phosphate results in increased expression of PPARG mRNA], Chenodeoxycholic Acid inhibits the reaction [tris(chloroethyl)phosphate results in increased expression of PPARG protein] CTD PMID:35780845 chenodeoxycholic acid increases expression ISO RGD:69168 6480464 Chenodeoxycholic Acid results in increased expression of PPARG mRNA CTD PMID:27174168 CHIR 99021 multiple interactions ISO RGD:69168 6480464 [Chir 99021 co-treated with BMP4 protein co-treated with FGF10 protein co-treated with FGF7 protein co-treated with Tretinoin] results in increased expression of PPARG mRNA CTD PMID:35267148 chloroacetaldehyde affects activity ISO RGD:69168 6480464 chloroacetaldehyde affects the activity of PPARG protein CTD PMID:25596134 Chlorobenzilate multiple interactions ISO RGD:69169 6480464 chlorobenzilate binds to and results in increased activity of PPARG protein CTD PMID:33049310 Chlorobenzilate multiple interactions ISO RGD:69168 6480464 chlorobenzilate binds to and results in increased activity of PPARG protein CTD PMID:33049310 chlorogenic acid increases expression ISO RGD:69169 6480464 Chlorogenic Acid results in increased expression of PPARG mRNA CTD PMID:21870829 chlorogenic acid decreases expression ISO RGD:69168 6480464 Chlorogenic Acid results in decreased expression of PPARG mRNA CTD PMID:20706672 chlorothalonil decreases expression ISO RGD:69169 6480464 tetrachloroisophthalonitrile results in decreased expression of PPARG mRNA CTD PMID:33246813 chlorothalonil multiple interactions ISO RGD:69169 6480464 [procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of PPARG mRNA CTD PMID:33246813 chlorpromazine affects activity EXP 6480464 Chlorpromazine affects the activity of PPARG protein CTD PMID:25596134 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of PPARG mRNA CTD PMID:33994353 chlorpyrifos multiple interactions ISO RGD:69169 6480464 [Chlorpyrifos co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG protein, Chlorpyrifos promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA] CTD PMID:32017950 chlorpyrifos multiple interactions ISO RGD:69168 6480464 rosiglitazone inhibits the reaction [Chlorpyrifos results in decreased expression of PPARG protein] CTD PMID:24793810 chlorpyrifos decreases expression ISO RGD:69168 6480464 Chlorpyrifos results in decreased expression of PPARG mRNA, Chlorpyrifos results in decreased expression of PPARG protein CTD PMID:24793810 , PMID:31509763 chlorpyrifos-methyl multiple interactions ISO RGD:69168 6480464 chlorpyrifos-methyl binds to and results in increased activity of PPARG protein CTD PMID:33049310 chlorpyrifos-methyl multiple interactions ISO RGD:69169 6480464 chlorpyrifos-methyl binds to and results in increased activity of PPARG protein CTD PMID:33049310 cholesterol multiple interactions ISO RGD:69168 6480464 [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [resveratrol results in decreased abundance of Cholesterol] more ... CTD PMID:12044893 more ... cholesterol multiple interactions ISO RGD:69169 6480464 [Dietary Fats co-treated with Cholesterol] results in increased expression of PPARG mRNA more ... CTD PMID:18302760 more ... choline multiple interactions ISO RGD:69169 6480464 3 more ... CTD PMID:18991162 , PMID:28973532 chrysin multiple interactions ISO RGD:69169 6480464 chrysin binds to and results in increased activity of PPARG protein more ... CTD PMID:11343698 , PMID:33049310 chrysin multiple interactions ISO RGD:69168 6480464 chrysin binds to and results in increased activity of PPARG protein CTD PMID:33049310 cidofovir anhydrous affects activity ISO RGD:69168 6480464 Cidofovir affects the activity of PPARG protein CTD PMID:25596134 ciglitazone multiple interactions ISO RGD:69169 6480464 [ciglitazone co-treated with Bucladesine] affects the expression of PPARG mRNA more ... CTD PMID:12847270 more ... ciglitazone affects localization EXP 6480464 ciglitazone affects the localization of PPARG protein CTD PMID:20578043 ciglitazone increases expression ISO RGD:69169 6480464 ciglitazone results in increased expression of PPARG protein CTD PMID:19698295 ciglitazone decreases response to substance ISO RGD:69168 6480464 PPARG protein mutant form results in decreased susceptibility to ciglitazone CTD PMID:19922793 ciglitazone affects binding ISO RGD:69168 6480464 ciglitazone binds to PPARG protein CTD PMID:12839938 , PMID:21511917 ciglitazone increases localization ISO RGD:69168 6480464 ciglitazone results in increased localization of PPARG protein CTD PMID:12517972 ciglitazone increases activity ISO RGD:69168 6480464 ciglitazone results in increased activity of PPARG protein CTD PMID:12517972 more ... ciglitazone increases activity ISO RGD:69169 6480464 ciglitazone results in increased activity of PPARG protein CTD PMID:11683414 , PMID:16023420 ciglitazone multiple interactions EXP 6480464 [ciglitazone binds to and results in increased activity of PPARG protein] which results in increased transport of Glucose more ... CTD PMID:16820301 , PMID:18063688 ciglitazone increases expression ISO RGD:69168 6480464 ciglitazone results in increased expression of PPARG mRNA, ciglitazone results in increased expression of PPARG protein CTD PMID:11840453 more ... ciglitazone multiple interactions ISO RGD:69168 6480464 [ciglitazone binds to PPARG protein alternative form] which results in increased expression of ABHD3 mRNA more ... CTD PMID:11030710 more ... cilnidipine decreases activity ISO RGD:69168 6480464 cilnidipine results in decreased activity of PPARG protein CTD PMID:25257666 cilostazol increases activity ISO RGD:69168 6480464 cilostazol results in increased activity of PPARG protein CTD PMID:21660147 cilostazol multiple interactions ISO RGD:69168 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [cilostazol results in increased activity of PPARG protein] more ... CTD PMID:21660147 cis-caffeic acid increases expression ISO RGD:69169 6480464 caffeic acid results in increased expression of PPARG mRNA CTD PMID:21870829 cisplatin multiple interactions ISO RGD:69168 6480464 [rosiglitazone binds to and results in increased activity of PPARG protein] which results in decreased susceptibility to Cisplatin more ... CTD PMID:21781307 , PMID:27417252 cisplatin decreases expression ISO RGD:69169 6480464 Cisplatin results in decreased expression of PPARG protein CTD PMID:34428482 cisplatin multiple interactions ISO RGD:69169 6480464 Melatonin inhibits the reaction [Cisplatin results in decreased expression of PPARG protein] CTD PMID:34428482 cisplatin affects activity ISO RGD:69168 6480464 Cisplatin affects the activity of PPARG protein CTD PMID:25596134 cisplatin decreases expression ISO RGD:69168 6480464 Cisplatin results in decreased expression of PPARG protein CTD PMID:27417252 cisplatin affects expression ISO RGD:69168 6480464 Cisplatin affects the expression of PPARG mRNA CTD PMID:23300844 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of PPARG mRNA, Cisplatin results in decreased expression of PPARG protein CTD PMID:22989705 more ... cisplatin multiple interactions EXP 6480464 2 more ... CTD PMID:22989705 more ... Citreoviridin decreases activity EXP 6480464 citreoviridin results in decreased activity of PPARG protein CTD PMID:31419397 Citreoviridin multiple interactions EXP 6480464 Sodium Selenite inhibits the reaction [citreoviridin results in decreased activity of PPARG protein], Thiamine inhibits the reaction [citreoviridin results in decreased activity of PPARG protein] CTD PMID:31419397 citronellol increases activity ISO RGD:69168 6480464 citronellol results in increased activity of PPARG protein CTD PMID:21597168 citronellol multiple interactions ISO RGD:69168 6480464 citronellol inhibits the reaction [PPARG protein results in increased expression of PTGS2 mRNA] CTD PMID:21597168 Clinofibrate affects binding ISO RGD:69168 6480464 clinofibrate binds to PPARG protein CTD PMID:11779144 clodronic acid affects activity ISO RGD:69168 6480464 Clodronic Acid affects the activity of PPARG protein CTD PMID:25596134 clofazimine increases expression EXP 6480464 Clofazimine results in increased expression of PPARG mRNA, Clofazimine results in increased expression of PPARG protein CTD PMID:31393584 clofibrate multiple interactions ISO RGD:69169 6480464 [Clofibrate co-treated with PPARG] results in increased expression of FABP4 mRNA more ... CTD PMID:9543393 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of PPARG mRNA, Clofibrate results in increased expression of PPARG protein CTD PMID:12604186 , PMID:12699904 clofibrate multiple interactions EXP 6480464 PPARG protein promotes the reaction [Clofibrate results in decreased expression of ALDH3A1 mRNA] CTD PMID:12604186 clofibrate affects response to substance EXP 6480464 PPARG protein affects the susceptibility to Clofibrate CTD PMID:12604186 clofibrate multiple interactions ISO RGD:69168 6480464 Clofibrate results in increased activity of [PPARG protein alternative form binds to RXRA protein] CTD PMID:11779144 clofibrate increases response to substance EXP 6480464 PPARG results in increased susceptibility to Clofibrate CTD PMID:12699904 clofibric acid affects binding ISO RGD:69168 6480464 Clofibric Acid binds to PPARG protein CTD PMID:11779144 , PMID:35752307 clofibric acid affects binding EXP 6480464 Clofibric Acid binds to PPARG protein CTD PMID:35752307 Clofop increases activity ISO RGD:69168 6480464 fenofibric acid results in increased activity of PPARG protein CTD PMID:15273253 Clofop multiple interactions ISO RGD:69168 6480464 fenofibric acid results in increased activity of [PPARG protein alternative form binds to RXRA protein] CTD PMID:11779144 Clofop affects binding ISO RGD:69168 6480464 fenofibric acid binds to PPARG protein CTD PMID:11779144 clozapine multiple interactions ISO RGD:69169 6480464 Berberine inhibits the reaction [Clozapine results in increased expression of PPARG mRNA], Berberine inhibits the reaction [Clozapine results in increased expression of PPARG protein] CTD PMID:20564506 clozapine increases expression ISO RGD:69169 6480464 Clozapine results in increased expression of PPARG mRNA, Clozapine results in increased expression of PPARG protein CTD PMID:20564506 cobalt dichloride decreases expression ISO RGD:69168 6480464 cobaltous chloride results in decreased expression of PPARG mRNA CTD PMID:15708366 cobalt dichloride multiple interactions ISO RGD:69169 6480464 2 more ... CTD PMID:32408695 cobalt dichloride decreases expression ISO RGD:69169 6480464 cobaltous chloride results in decreased expression of PPARG mRNA CTD PMID:20594416 colforsin daropate hydrochloride decreases expression ISO RGD:69168 6480464 Colforsin results in decreased expression of PPARG mRNA CTD PMID:31278978 conjugated linoleic acid increases expression ISO RGD:69168 6480464 Linoleic Acids more ... CTD PMID:15961301 conjugated linoleic acid increases expression ISO RGD:69169 6480464 Linoleic Acids, Conjugated results in increased expression of PPARG mRNA CTD PMID:17322064 conjugated linoleic acid multiple interactions ISO RGD:69168 6480464 Linoleic Acids more ... CTD PMID:18776171 conjugated linoleic acid decreases expression ISO RGD:69168 6480464 Linoleic Acids, Conjugated results in decreased expression of PPARG protein CTD PMID:16933788 conjugated linoleic acid decreases activity ISO RGD:69168 6480464 Linoleic Acids, Conjugated results in decreased activity of PPARG protein CTD PMID:18776171 copper atom multiple interactions ISO RGD:69168 6480464 [Chelating Agents binds to Copper] which affects the expression of PPARG mRNA CTD PMID:30911355 copper(0) multiple interactions ISO RGD:69168 6480464 [Chelating Agents binds to Copper] which affects the expression of PPARG mRNA CTD PMID:30911355 corilagin multiple interactions EXP 6480464 corilagin inhibits the reaction [Doxorubicin results in increased expression of PPARG protein] CTD PMID:34605098 corticosterone multiple interactions ISO RGD:69169 6480464 [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of PPARG mRNA, Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of PPARG mRNA] CTD PMID:29751049 cortisol multiple interactions ISO RGD:69168 6480464 [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARG mRNA more ... CTD PMID:33476690 cortisone multiple interactions ISO RGD:69169 6480464 2-(3-benzoyl)-4-hydroxy-1 more ... CTD PMID:21315688 cortisone increases expression ISO RGD:69169 6480464 Cortisone results in increased expression of PPARG mRNA CTD PMID:21315688 coumaphos multiple interactions ISO RGD:69169 6480464 Coumaphos binds to and results in increased activity of PPARG protein CTD PMID:33049310 coumaphos multiple interactions ISO RGD:69168 6480464 Coumaphos binds to and results in increased activity of PPARG protein CTD PMID:33049310 crocidolite asbestos increases expression ISO RGD:69168 6480464 Asbestos more ... CTD PMID:23634900 cucurbitacin B multiple interactions ISO RGD:69169 6480464 STAT3 protein affects the reaction [cucurbitacin B results in decreased expression of PPARG mRNA] CTD PMID:24316209 cucurbitacin B decreases expression ISO RGD:69169 6480464 cucurbitacin B results in decreased expression of PPARG mRNA CTD PMID:24316209 cucurbitacin I decreases expression ISO RGD:69169 6480464 cucurbitacin I results in decreased expression of PPARG mRNA CTD PMID:24316209 curcumin affects binding ISO RGD:69168 6480464 Curcumin binds to PPARG protein CTD PMID:15713005 curcumin decreases expression ISO RGD:69169 6480464 Curcumin results in decreased expression of PPARG mRNA CTD PMID:23603106 curcumin increases expression EXP 6480464 Curcumin results in increased expression of PPARG mRNA, Curcumin results in increased expression of PPARG protein CTD PMID:16959952 more ... curcumin increases activity EXP 6480464 Curcumin results in increased activity of PPARG protein CTD PMID:18332871 curcumin decreases expression EXP 6480464 Curcumin results in decreased expression of PPARG protein CTD PMID:19225048 curcumin affects localization EXP 6480464 Curcumin affects the localization of PPARG protein CTD PMID:17531121 curcumin multiple interactions ISO RGD:69169 6480464 Curcumin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA] more ... CTD PMID:19297423 more ... curcumin multiple interactions EXP 6480464 2 more ... CTD PMID:16782535 more ... curcumin multiple interactions ISO RGD:69168 6480464 PPARG protein promotes the reaction [Curcumin results in decreased expression of CCN2 mRNA] CTD PMID:17965732 curcumin increases activity ISO RGD:69168 6480464 Curcumin results in increased activity of PPARG protein CTD PMID:15486348 curcumin decreases expression ISO RGD:69168 6480464 Curcumin results in decreased expression of PPARG protein modified form CTD PMID:15486348 cyanamide multiple interactions ISO RGD:69168 6480464 Cyanamide inhibits the reaction [Ethanol inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]] CTD PMID:17030193 cyanocob(III)alamin multiple interactions EXP 6480464 [Folic Acid co-treated with Vitamin B 12] inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA], Vitamin B 12 inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA] CTD PMID:23935743 cyclophosphamide increases expression EXP 6480464 Cyclophosphamide results in increased expression of PPARG mRNA CTD PMID:27281708 cyclophosphamide multiple interactions EXP 6480464 Plant Extracts inhibits the reaction [Cyclophosphamide results in decreased expression of PPARG mRNA] CTD PMID:25446862 cyclophosphamide decreases expression EXP 6480464 Cyclophosphamide results in decreased expression of PPARG mRNA CTD PMID:25446862 cyclosporin A multiple interactions ISO RGD:69168 6480464 [Sirolimus co-treated with Cyclosporine] results in decreased expression of PPARG protein CTD PMID:17016853 cyclosporin A affects activity EXP 6480464 Cyclosporine affects the activity of PPARG protein CTD PMID:25596134 cyclosporin A affects activity ISO RGD:69168 6480464 Cyclosporine affects the activity of PPARG protein CTD PMID:25596134 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of PPARG mRNA, Cyclosporine results in decreased expression of PPARG protein CTD PMID:17461532 cyclosporin A multiple interactions EXP 6480464 Cyclosporine inhibits the reaction [rosiglitazone results in increased expression of PPARG protein] more ... CTD PMID:17461532 cyclosporin A increases expression ISO RGD:69168 6480464 Cyclosporine results in increased expression of PPARG mRNA CTD PMID:20106945 cyfluthrin multiple interactions ISO RGD:69169 6480464 cyfluthrin binds to and results in increased activity of PPARG protein CTD PMID:33049310 cyfluthrin multiple interactions ISO RGD:69168 6480464 cyfluthrin binds to and results in increased activity of PPARG protein CTD PMID:33049310 cyhalothrin increases expression EXP 6480464 cyhalothrin results in increased expression of PPARG mRNA CTD PMID:27348886 cyhalothrin affects expression ISO RGD:69169 6480464 cyhalothrin affects the expression of PPARG protein CTD PMID:36529352 cyhalothrin decreases expression ISO RGD:69169 6480464 cyhalothrin results in decreased expression of PPARG mRNA CTD PMID:36529352 cyhalothrin multiple interactions ISO RGD:69168 6480464 [cyhalothrin co-treated with Oleic Acid] results in increased expression of PPARG protein, Metformin inhibits the reaction [[cyhalothrin co-treated with Oleic Acid] results in increased expression of PPARG protein] CTD PMID:36529352 cypermethrin multiple interactions ISO RGD:69168 6480464 cypermethrin binds to and results in increased activity of PPARG protein CTD PMID:33049310 cypermethrin multiple interactions ISO RGD:69169 6480464 cypermethrin binds to and results in increased activity of PPARG protein CTD PMID:33049310 cyproterone acetate multiple interactions ISO RGD:69169 6480464 Cyproterone Acetate binds to and results in increased activity of PPARG protein CTD PMID:33049310 cyproterone acetate multiple interactions ISO RGD:69168 6480464 Cyproterone Acetate binds to and results in increased activity of PPARG protein CTD PMID:33049310 cytarabine multiple interactions ISO RGD:69169 6480464 2, 2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Cytarabine results in increased expression of PPARG mRNA] CTD PMID:23264188 cytarabine increases expression ISO RGD:69169 6480464 Cytarabine results in increased expression of PPARG mRNA CTD PMID:23264188 D-glucose multiple interactions EXP 6480464 [ciglitazone binds to and results in increased activity of PPARG protein] which results in increased transport of Glucose more ... CTD PMID:15878969 more ... D-glucose decreases expression ISO RGD:69168 6480464 Glucose results in decreased expression of PPARG protein CTD PMID:21333731 D-glucose multiple interactions ISO RGD:69168 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Glucose results in decreased expression of PPARG protein]] more ... CTD PMID:21333731 more ... D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of PPARG mRNA, Glucose results in decreased expression of PPARG protein CTD PMID:19609456 , PMID:31063766 daunorubicin decreases activity ISO RGD:69168 6480464 Daunorubicin results in decreased activity of PPARG protein CTD PMID:25257666 daunorubicin increases expression EXP 6480464 Daunorubicin results in increased expression of PPARG protein CTD PMID:20888384 daunorubicin multiple interactions EXP 6480464 telmisartan promotes the reaction [Daunorubicin results in increased expression of PPARG protein] CTD PMID:20888384 DDD multiple interactions ISO RGD:69169 6480464 Dichlorodiphenyldichloroethane binds to and results in increased activity of PPARG protein CTD PMID:33049310 DDE multiple interactions ISO RGD:69168 6480464 [Dichlorodiphenyl Dichloroethylene co-treated with [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein]] results in increased expression of PPARG mRNA CTD PMID:26200599 DDT increases expression ISO RGD:69168 6480464 DDT results in increased expression of PPARG mRNA CTD PMID:25014179 DDT multiple interactions ISO RGD:69168 6480464 DDT binds to and results in increased activity of PPARG protein CTD PMID:33049310 DDT multiple interactions ISO RGD:69169 6480464 DDT binds to and results in increased activity of PPARG protein, DDT results in increased activity of and results in increased localization of PPARG protein CTD PMID:11911853 , PMID:33049310 decabromodiphenyl ether increases expression ISO RGD:69169 6480464 decabromobiphenyl ether results in increased expression of PPARG protein CTD PMID:30743236 decanoic acid affects binding ISO RGD:69168 6480464 decanoic acid binds to PPARG protein CTD PMID:24998974 decanoic acid increases activity ISO RGD:69168 6480464 decanoic acid results in increased activity of PPARG protein CTD PMID:24998974 Delta(9)-tetrahydrocannabinolic acid multiple interactions ISO RGD:69168 6480464 delta(9)-tetrahydrocannabinolic acid inhibits the reaction [Rosiglitazone results in increased expression of PPARG mRNA] CTD PMID:28853159 Delta(9)-tetrahydrocannabinolic acid decreases expression ISO RGD:69168 6480464 delta(9)-tetrahydrocannabinolic acid results in decreased expression of PPARG protein CTD PMID:28853159 Delta(9)-tetrahydrocannabinolic acid increases expression ISO RGD:69168 6480464 delta(9)-tetrahydrocannabinolic acid results in increased expression of PPARG mRNA CTD PMID:28853159 delta-tocopherol multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA], [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein] CTD PMID:22389237 demethoxycurcumin affects binding ISO RGD:69168 6480464 demethoxycurcumin binds to PPARG protein CTD PMID:15713005 deoxycholic acid decreases expression ISO RGD:69169 6480464 Deoxycholic Acid results in decreased expression of PPARG mRNA CTD PMID:23911798 deoxynivalenol multiple interactions ISO RGD:69168 6480464 15-deoxy-delta(12 more ... CTD PMID:18485432 deoxynivalenol decreases activity ISO RGD:69168 6480464 deoxynivalenol results in decreased activity of PPARG protein CTD PMID:27481073 deoxynivalenol increases expression ISO RGD:69168 6480464 deoxynivalenol results in increased expression of PPARG mRNA CTD PMID:18485432 dexamethasone multiple interactions ISO RGD:69169 6480464 (+)-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of PPARG protein] more ... CTD PMID:11101056 more ... dexamethasone increases expression ISO RGD:69168 6480464 Dexamethasone results in increased expression of PPARG mRNA, Dexamethasone results in increased expression of PPARG protein CTD PMID:16569937 more ... dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of PPARG mRNA, Dexamethasone results in increased expression of PPARG protein CTD PMID:14568882 , PMID:19118567 dexamethasone increases expression ISO RGD:69169 6480464 Dexamethasone results in increased expression of PPARG mRNA more ... CTD PMID:16814746 more ... dexamethasone multiple interactions EXP 6480464 [INS co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of PPARG mRNA more ... CTD PMID:16782535 , PMID:21350315 dexamethasone decreases expression ISO RGD:69169 6480464 Dexamethasone results in decreased expression of PPARG mRNA CTD PMID:16889531 dexamethasone multiple interactions ISO RGD:69168 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA more ... CTD PMID:17290005 more ... dextran sulfate increases expression ISO RGD:69169 6480464 Dextran Sulfate results in increased expression of PPARG protein CTD PMID:23261717 dextran sulfate multiple interactions ISO RGD:69169 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PPARG mRNA more ... CTD PMID:29950665 , PMID:33130971 dextran sulfate affects localization ISO RGD:69169 6480464 Dextran Sulfate affects the localization of PPARG protein CTD PMID:33130971 Di-n-decyl phthalate affects binding ISO RGD:69168 6480464 didecyl phthalate binds to PPARG protein CTD PMID:23843199 Di-n-hexyl phthalate affects binding ISO RGD:69168 6480464 di-n-hexyl phthalate binds to PPARG protein CTD PMID:23843199 diallyl trisulfide decreases expression ISO RGD:69169 6480464 diallyl trisulfide results in decreased expression of PPARG mRNA, diallyl trisulfide results in decreased expression of PPARG protein CTD PMID:22137902 diallyl trisulfide multiple interactions ISO RGD:69169 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [diallyl trisulfide results in decreased expression of and results in decreased activity of PPARG protein] more ... CTD PMID:22137902 diallyl trisulfide decreases activity ISO RGD:69169 6480464 diallyl trisulfide results in decreased activity of PPARG protein CTD PMID:22137902 diarsenic trioxide decreases expression ISO RGD:69168 6480464 Arsenic Trioxide results in decreased expression of PPARG protein CTD PMID:30362509 diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of PPARG mRNA CTD PMID:31258454 diarsenic trioxide multiple interactions ISO RGD:69169 6480464 Arsenic Trioxide inhibits the reaction [AKT1 protein binds to PPARG protein] more ... CTD PMID:15916724 , PMID:30362509 diarsenic trioxide decreases expression ISO RGD:69169 6480464 Arsenic Trioxide results in decreased expression of PPARG protein CTD PMID:15916724 , PMID:30362509 diarsenic trioxide increases expression ISO RGD:69168 6480464 Arsenic Trioxide results in increased expression of PPARG mRNA, Arsenic Trioxide results in increased expression of PPARG protein CTD PMID:22684020 diarsenic trioxide decreases response to substance ISO RGD:69168 6480464 PPARG protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 diarsenic trioxide multiple interactions ISO RGD:69168 6480464 [Rosiglitazone binds to and results in increased activity of PPARG protein] which results in increased susceptibility to Arsenic Trioxide more ... CTD PMID:22684020 more ... diazinon increases activity ISO RGD:69168 6480464 Diazinon results in increased activity of PPARG protein CTD PMID:28728110 dibutyl phthalate multiple interactions ISO RGD:69168 6480464 Dibutyl Phthalate binds to and results in increased activity of PPARG protein CTD PMID:24155963 more ... dibutyl phthalate increases expression ISO RGD:69168 6480464 Dibutyl Phthalate results in increased expression of PPARG protein CTD PMID:29061543 dibutyl phthalate increases activity ISO RGD:69168 6480464 Dibutyl Phthalate results in increased activity of PPARG protein CTD PMID:26172262 dibutyl phthalate multiple interactions ISO RGD:69169 6480464 Dibutyl Phthalate binds to and results in increased activity of PPARG protein CTD PMID:33049310 dibutyl phthalate affects binding ISO RGD:69168 6480464 Dibutyl Phthalate binds to PPARG protein CTD PMID:23843199 dibutylstannane increases expression ISO RGD:69169 6480464 di-n-butyltin results in increased expression of PPARG mRNA CTD PMID:29787037 dibutylstannane multiple interactions ISO RGD:69168 6480464 T 0070907 inhibits the reaction [di-n-butyltin results in increased expression of PPARG mRNA] CTD PMID:29787037 dibutylstannane increases expression ISO RGD:69168 6480464 di-n-butyltin results in increased expression of PPARG mRNA CTD PMID:29787037 dichloroacetic acid increases expression ISO RGD:69169 6480464 Dichloroacetic Acid results in increased expression of PPARG mRNA CTD PMID:28962523 diclofenac affects expression ISO RGD:69168 6480464 Diclofenac affects the expression of PPARG mRNA CTD PMID:24752500 diclofenac multiple interactions ISO RGD:69168 6480464 Diclofenac inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein] CTD PMID:30138673 diclofenac increases activity ISO RGD:69168 6480464 Diclofenac results in increased activity of PPARG protein CTD PMID:12065695 more ... diethyl phthalate affects binding ISO RGD:69168 6480464 diethyl phthalate binds to PPARG protein CTD PMID:23843199 diethylstilbestrol multiple interactions ISO RGD:69169 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Diethylstilbestrol results in increased expression of PPARG protein] more ... CTD PMID:22710028 , PMID:26944108 diethylstilbestrol increases activity ISO RGD:69169 6480464 Diethylstilbestrol results in increased activity of PPARG protein CTD PMID:22710028 diethylstilbestrol increases expression ISO RGD:69169 6480464 Diethylstilbestrol results in increased expression of PPARG mRNA, Diethylstilbestrol results in increased expression of PPARG protein CTD PMID:22710028 diheptyl phthalate affects binding ISO RGD:69168 6480464 diheptyl phthalate binds to PPARG protein CTD PMID:23843199 diisobutyl phthalate multiple interactions ISO RGD:69168 6480464 diisobutyl phthalate binds to and results in increased activity of PPARG protein CTD PMID:24155963 , PMID:27633901 diisobutyl phthalate increases expression ISO RGD:69168 6480464 diisobutyl phthalate results in increased expression of PPARG protein CTD PMID:29061543 diisobutyl phthalate increases activity ISO RGD:69168 6480464 diisobutyl phthalate results in increased activity of PPARG protein CTD PMID:26172262 Diisodecyl phthalate affects binding ISO RGD:69168 6480464 diisodecyl phthalate binds to PPARG protein CTD PMID:23843199 Diisodecyl phthalate increases expression ISO RGD:69169 6480464 diisodecyl phthalate results in increased expression of PPARG mRNA CTD PMID:29410257 Diisodecyl phthalate multiple interactions ISO RGD:69168 6480464 diisodecyl phthalate binds to and results in increased activity of PPARG protein CTD PMID:29410257 diisononyl phthalate affects binding ISO RGD:69168 6480464 diisononyl phthalate binds to PPARG protein CTD PMID:23843199 diisononyl phthalate multiple interactions ISO RGD:69168 6480464 diisononyl phthalate binds to and results in increased activity of PPARG protein CTD PMID:29410257 diisononyl phthalate increases expression ISO RGD:69169 6480464 diisononyl phthalate results in increased expression of PPARG mRNA CTD PMID:29410257 diisononyl phthalate affects activity ISO RGD:69168 6480464 diisononyl phthalate affects the activity of PPARG protein CTD PMID:26172262 dimethomorph multiple interactions ISO RGD:69169 6480464 dimethomorph binds to and results in increased activity of PPARG protein CTD PMID:33049310 dimethomorph multiple interactions ISO RGD:69168 6480464 dimethomorph binds to and results in increased activity of PPARG protein CTD PMID:33049310 Dimethyl phthalate affects binding ISO RGD:69168 6480464 dimethyl phthalate binds to PPARG protein CTD PMID:23843199 dimethyl sulfoxide decreases expression ISO RGD:69168 6480464 Dimethyl Sulfoxide results in decreased expression of PPARG mRNA CTD PMID:21878375 dimethylarsinic acid decreases expression ISO RGD:69168 6480464 Cacodylic Acid results in decreased expression of PPARG mRNA CTD PMID:23221991 dimethylarsinic acid multiple interactions ISO RGD:69168 6480464 [Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of PPARG mRNA CTD PMID:28793237 dimethylarsinic acid decreases expression ISO RGD:69169 6480464 Cacodylic Acid results in decreased expression of PPARG mRNA CTD PMID:23221991 diniconazole multiple interactions ISO RGD:69168 6480464 diniconazole binds to and results in increased activity of PPARG protein CTD PMID:33049310 diniconazole multiple interactions ISO RGD:69169 6480464 diniconazole binds to and results in increased activity of PPARG protein CTD PMID:33049310 diosgenin increases expression ISO RGD:69169 6480464 Diosgenin results in increased expression of PPARG protein CTD PMID:24001619 diosgenin increases expression ISO RGD:69168 6480464 Diosgenin results in increased expression of PPARG mRNA CTD PMID:32347045 diosgenin decreases response to substance ISO RGD:69169 6480464 PPARG protein results in decreased susceptibility to Diosgenin CTD PMID:26408789 diosgenin multiple interactions ISO RGD:69169 6480464 [Diosgenin inhibits the reaction [RXRA protein binds to PPARG protein]] which results in decreased activity of PPARG protein more ... CTD PMID:26408789 diosgenin decreases expression ISO RGD:69169 6480464 Diosgenin results in decreased expression of PPARG mRNA CTD PMID:26408789 dioxygen decreases expression ISO RGD:69168 6480464 Oxygen deficiency results in decreased expression of PPARG protein CTD PMID:19520921 dioxygen multiple interactions ISO RGD:69168 6480464 [Oxygen deficiency co-treated with Oxygen] results in decreased expression of PPARG mRNA more ... CTD PMID:34995009 dioxygen increases expression ISO RGD:69168 6480464 Oxygen deficiency results in increased expression of PPARG mRNA CTD PMID:26516004 dioxygen affects activity ISO RGD:69168 6480464 Oxygen deficiency affects the activity of PPARG protein CTD PMID:25596134 dioxygen increases expression ISO RGD:69169 6480464 Oxygen deficiency results in increased expression of PPARG protein, Oxygen results in increased expression of PPARG mRNA CTD PMID:21113404 , PMID:22535284 dioxygen decreases expression EXP 6480464 Oxygen results in decreased expression of PPARG mRNA, Oxygen results in decreased expression of PPARG protein CTD PMID:16617452 dioxygen multiple interactions EXP 6480464 2 more ... CTD PMID:16617452 more ... dioxygen multiple interactions ISO RGD:69169 6480464 [Dexamethasone co-treated with Oxygen deficiency] results in increased expression of PPARG mRNA alternative form more ... CTD PMID:16814746 more ... dioxygen decreases expression ISO RGD:69169 6480464 Oxygen deficiency results in decreased expression of PPARG mRNA, Oxygen deficiency results in decreased expression of PPARG protein CTD PMID:21531777 dipentyl phthalate affects binding ISO RGD:69168 6480464 di-n-pentyl phthalate binds to PPARG protein CTD PMID:23843199 dipentyl phthalate multiple interactions ISO RGD:69168 6480464 di-n-pentyl phthalate binds to and results in increased activity of PPARG protein CTD PMID:33049310 dipentyl phthalate multiple interactions ISO RGD:69169 6480464 di-n-pentyl phthalate binds to and results in increased activity of PPARG protein CTD PMID:33049310 Diphenolic acid multiple interactions ISO RGD:69168 6480464 diphenolic acid binds to and results in decreased activity of PPARG protein CTD PMID:33049310 dipropyl phthalate affects binding ISO RGD:69168 6480464 di-n-propylphthalate binds to PPARG protein CTD PMID:23843199 disodium selenite multiple interactions EXP 6480464 Sodium Selenite inhibits the reaction [2-cresol results in increased expression of PPARG mRNA], Sodium Selenite inhibits the reaction [citreoviridin results in decreased activity of PPARG protein] CTD PMID:21705299 , PMID:31419397 disodium selenite increases activity EXP 6480464 Sodium Selenite results in increased activity of PPARG protein CTD PMID:31419397 disodium selenite increases expression EXP 6480464 Sodium Selenite results in increased expression of PPARG protein CTD PMID:24140496 disulfiram multiple interactions ISO RGD:69168 6480464 Disulfiram binds to and results in increased activity of PPARG protein CTD PMID:33049310 disulfiram affects expression ISO RGD:69168 6480464 Disulfiram affects the expression of PPARG mRNA CTD PMID:32712770 disulfiram multiple interactions ISO RGD:69169 6480464 Disulfiram binds to and results in increased activity of PPARG protein CTD PMID:33049310 Dithiopyr multiple interactions ISO RGD:69169 6480464 dithiopyr binds to and results in increased activity of PPARG protein CTD PMID:33049310 Dithiopyr multiple interactions ISO RGD:69168 6480464 dithiopyr binds to and results in increased activity of PPARG protein CTD PMID:33049310 diuron increases expression EXP 6480464 Diuron results in increased expression of PPARG mRNA CTD PMID:21551480 diuron multiple interactions ISO RGD:69169 6480464 Diuron binds to and results in increased activity of PPARG protein CTD PMID:33049310 dodecylamine multiple interactions ISO RGD:69168 6480464 dodecylamine binds to and results in increased activity of PPARG protein CTD PMID:33049310 dodecylamine multiple interactions ISO RGD:69169 6480464 dodecylamine binds to and results in increased activity of PPARG protein CTD PMID:33049310 doramapimod increases expression ISO RGD:69169 6480464 doramapimod results in increased expression of PPARG mRNA CTD PMID:21328587 dorsomorphin multiple interactions EXP 6480464 dorsomorphin inhibits the reaction [25-hydroxyprotopanaxadiol results in increased phosphorylation of PPARG protein] CTD PMID:33676887 dorsomorphin multiple interactions ISO RGD:69169 6480464 dorsomorphin inhibits the reaction [rotenoisin A inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]] CTD PMID:30446312 dorsomorphin multiple interactions ISO RGD:69168 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:24584901 , PMID:27188386 doxorubicin decreases activity ISO RGD:69168 6480464 Doxorubicin results in decreased activity of PPARG protein CTD PMID:25257666 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of PPARG protein CTD PMID:34605098 doxorubicin multiple interactions EXP 6480464 caryophyllene inhibits the reaction [Doxorubicin results in decreased expression of PPARG protein] more ... CTD PMID:30836069 , PMID:34605098 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of PPARG protein CTD PMID:30836069 doxorubicin decreases expression ISO RGD:69168 6480464 Doxorubicin results in decreased expression of PPARG mRNA, Doxorubicin results in decreased expression of PPARG protein CTD PMID:27417252 , PMID:29803840 doxorubicin multiple interactions ISO RGD:69168 6480464 [15-deoxyprostaglandin J2 results in increased activity of PPARG protein] which results in increased susceptibility to Doxorubicin, [nimesulide co-treated with Doxorubicin] results in increased expression of PPARG CTD PMID:14567645 , PMID:23964924 efavirenz decreases expression ISO RGD:69168 6480464 efavirenz results in decreased expression of PPARG mRNA CTD PMID:21619898 elemental selenium multiple interactions ISO RGD:69169 6480464 PPARG protein promotes the reaction [Selenium inhibits the reaction [lipopolysaccharide more ... CTD PMID:17439952 ellagic acid increases expression ISO RGD:69168 6480464 Ellagic Acid results in increased expression of PPARG protein CTD PMID:23811531 emodin increases expression ISO RGD:69168 6480464 Emodin results in increased expression of PPARG protein CTD PMID:25448808 emodin multiple interactions ISO RGD:69168 6480464 Emodin results in increased stability of and results in increased expression of PPARG mRNA CTD PMID:25448808 enalapril decreases expression EXP 6480464 Enalapril results in decreased expression of PPARG protein CTD PMID:19225048 enalapril multiple interactions EXP 6480464 Enalapril inhibits the reaction [Isoproterenol results in decreased expression of PPARG protein] CTD PMID:30623541 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of PPARG mRNA CTD PMID:29391264 endrin decreases expression ISO RGD:69169 6480464 Endrin results in decreased expression of PPARG protein CTD PMID:10385688 endrin multiple interactions ISO RGD:69169 6480464 MK 2206 inhibits the reaction [Endrin results in increased expression of PPARG mRNA], Sirolimus inhibits the reaction [Endrin results in increased expression of PPARG mRNA] CTD PMID:34801515 endrin increases expression ISO RGD:69169 6480464 Endrin results in increased expression of PPARG mRNA CTD PMID:34801515 enilconazole multiple interactions ISO RGD:69169 6480464 enilconazole binds to and results in increased activity of PPARG protein CTD PMID:33049310 enilconazole multiple interactions ISO RGD:69168 6480464 enilconazole binds to and results in increased activity of PPARG protein CTD PMID:33049310 epoxiconazole affects expression ISO RGD:69169 6480464 epoxiconazole affects the expression of PPARG mRNA CTD PMID:35436446 epoxomicin multiple interactions ISO RGD:69169 6480464 epoxomicin inhibits the reaction [resveratrol results in decreased expression of PPARG protein], epoxomicin inhibits the reaction [rosiglitazone results in decreased expression of PPARG protein] CTD PMID:18555852 equilin multiple interactions ISO RGD:69169 6480464 Equilin binds to and results in decreased activity of PPARG protein CTD PMID:33049310 esculetin multiple interactions EXP 6480464 esculetin inhibits the reaction [Streptozocin results in decreased expression of PPARG protein], esculetin inhibits the reaction [Streptozocin results in increased expression of PPARG protein] CTD PMID:21450970 esculetin multiple interactions ISO RGD:69169 6480464 esculetin inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of PPARG mRNA] CTD PMID:27769711 Ethalfluralin multiple interactions ISO RGD:69169 6480464 ethafluralin binds to and results in increased activity of PPARG protein CTD PMID:33049310 Ethalfluralin multiple interactions ISO RGD:69168 6480464 ethafluralin binds to and results in increased activity of PPARG protein CTD PMID:33049310 ethanol multiple interactions ISO RGD:69168 6480464 Cyanamide inhibits the reaction [Ethanol inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]] more ... CTD PMID:17030193 more ... ethanol decreases expression ISO RGD:69168 6480464 Ethanol results in decreased expression of PPARG mRNA, Ethanol results in decreased expression of PPARG protein CTD PMID:28062356 , PMID:34192554 ethanol decreases expression EXP 6480464 [Ethanol results in decreased expression of PPARG protein] which results in decreased expression of ADIPOQ protein more ... CTD PMID:24412557 ethanol increases expression EXP 6480464 Ethanol results in increased expression of PPARG mRNA CTD PMID:18793633 more ... ethanol increases expression ISO RGD:69169 6480464 Ethanol results in increased expression of PPARG mRNA, Ethanol results in increased expression of PPARG protein CTD PMID:18620774 more ... ethanol increases expression ISO RGD:69168 6480464 Ethanol results in increased expression of PPARG mRNA CTD PMID:24144995 ethanol affects expression ISO RGD:69169 6480464 Ethanol affects the expression of PPARG mRNA CTD PMID:19167417 ethanol multiple interactions ISO RGD:69169 6480464 [ADORA1 gene mutant form results in increased susceptibility to Ethanol] which results in increased expression of PPARG mRNA more ... CTD PMID:18755807 more ... ethanol decreases expression ISO RGD:69169 6480464 Ethanol results in decreased expression of PPARG mRNA, Ethanol results in decreased expression of PPARG protein CTD PMID:22173916 , PMID:34192554 ethanol multiple interactions EXP 6480464 [Ethanol co-treated with Lipopolysaccharides] results in decreased expression of PPARG mRNA more ... CTD PMID:15318101 more ... ethyl 3,4-dihydroxybenzoate multiple interactions ISO RGD:69169 6480464 ethyl protocatechuate inhibits the reaction [rosiglitazone results in increased expression of PPARG mRNA] CTD PMID:24338020 ethyl myristate multiple interactions ISO RGD:69168 6480464 ethyl myristate binds to and results in decreased activity of PPARG protein CTD PMID:27633901 ethylparaben increases expression ISO RGD:69169 6480464 ethyl-p-hydroxybenzoate results in increased expression of PPARG mRNA CTD PMID:22956630 eugenol multiple interactions ISO RGD:69168 6480464 Eugenol analog binds to and results in increased activity of PPARG protein CTD PMID:20064974 eugenol increases expression ISO RGD:69169 6480464 Eugenol results in increased expression of PPARG mRNA CTD PMID:21870829 eugenol multiple interactions ISO RGD:69169 6480464 2 more ... CTD PMID:20064974 Evodiamine decreases expression ISO RGD:69169 6480464 evodiamine results in decreased expression of PPARG CTD PMID:17884939 farnesol multiple interactions ISO RGD:69168 6480464 [Farnesol analog co-treated with Oleic Acid] results in increased expression of PPARG mRNA CTD PMID:30611723 farnesol increases expression ISO RGD:69168 6480464 Farnesol analog results in increased expression of PPARG mRNA CTD PMID:30611723 fenamiphos multiple interactions ISO RGD:69168 6480464 fenamiphos binds to and results in increased activity of PPARG protein CTD PMID:33049310 fenamiphos multiple interactions ISO RGD:69169 6480464 fenamiphos binds to and results in increased activity of PPARG protein CTD PMID:33049310 fenarimol multiple interactions ISO RGD:69169 6480464 fenarimol binds to and results in increased activity of PPARG protein CTD PMID:33049310 fenarimol multiple interactions ISO RGD:69168 6480464 fenarimol binds to and results in increased activity of PPARG protein CTD PMID:33049310 fenchone multiple interactions ISO RGD:69168 6480464 fenchone binds to and results in decreased activity of PPARG protein CTD PMID:27633901 fenitrothion multiple interactions ISO RGD:69169 6480464 Fenitrothion binds to and results in increased activity of PPARG protein CTD PMID:33049310 fenitrothion multiple interactions ISO RGD:69168 6480464 Fenitrothion binds to and results in increased activity of PPARG protein CTD PMID:33049310 fenofibrate increases expression ISO RGD:69168 6480464 Fenofibrate results in increased expression of PPARG mRNA CTD PMID:19201410 , PMID:28034800 fenofibrate affects activity EXP 6480464 Fenofibrate affects the activity of PPARG protein CTD PMID:25596134 fenofibrate affects activity ISO RGD:69168 6480464 Fenofibrate affects the activity of PPARG protein CTD PMID:25596134 fenofibrate multiple interactions ISO RGD:69168 6480464 [Oleic Acid co-treated with Fenofibrate] results in increased expression of PPARG mRNA CTD PMID:24534255 fenofibrate increases expression ISO RGD:69169 6480464 Fenofibrate results in increased expression of PPARG mRNA CTD PMID:19201410 fenoprofen multiple interactions ISO RGD:69168 6480464 Fenoprofen binds to and results in increased activity of PPARG protein CTD PMID:9013583 fenthion multiple interactions ISO RGD:69169 6480464 Fenthion binds to and results in increased activity of PPARG protein CTD PMID:33049310 fenthion increases expression ISO RGD:69168 6480464 Fenthion results in increased expression of PPARG mRNA CTD PMID:32473317 fenthion multiple interactions ISO RGD:69168 6480464 Fenthion binds to and results in increased activity of PPARG protein CTD PMID:33049310 fentin chloride multiple interactions ISO RGD:69168 6480464 diphenyltin chloride inhibits the reaction [triphenyltin chloride binds to PPARG protein] more ... CTD PMID:19497422 , PMID:33049310 fentin chloride increases activity ISO RGD:69168 6480464 triphenyltin chloride results in increased activity of PPARG protein CTD PMID:26172262 fentin chloride multiple interactions ISO RGD:69169 6480464 triphenyltin chloride binds to and results in increased activity of PPARG protein CTD PMID:33049310 fentin hydroxide increases expression ISO RGD:69168 6480464 triphenyltin hydroxide results in increased expression of PPARG mRNA CTD PMID:32473317 ferulic acid increases expression ISO RGD:69169 6480464 ferulic acid results in increased expression of PPARG mRNA CTD PMID:21870829 finasteride multiple interactions ISO RGD:69169 6480464 Finasteride binds to and results in increased activity of PPARG protein CTD PMID:33049310 fipronil increases expression ISO RGD:69169 6480464 fipronil results in increased expression of PPARG mRNA, fipronil results in increased expression of PPARG protein CTD PMID:27103584 flavanone increases expression ISO RGD:69168 6480464 flavanone results in increased expression of PPARG protein CTD PMID:22056764 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of PPARG mRNA CTD PMID:23238999 fluconazole increases expression EXP 6480464 Fluconazole results in increased expression of PPARG mRNA CTD PMID:20623750 fludioxonil multiple interactions ISO RGD:69168 6480464 fludioxonil binds to and results in increased activity of PPARG protein CTD PMID:33049310 fludioxonil multiple interactions ISO RGD:69169 6480464 fludioxonil binds to and results in increased activity of PPARG protein CTD PMID:33049310 flufenamic acid multiple interactions ISO RGD:69168 6480464 [Flufenamic Acid results in increased activity of PPARG protein] which results in increased expression of PTGS2 protein, Flufenamic Acid binds to and results in increased activity of PPARG protein CTD PMID:10866999 , PMID:9013583 flufenamic acid increases activity ISO RGD:69168 6480464 Flufenamic Acid results in increased activity of PPARG protein CTD PMID:10866999 Flumetralin multiple interactions ISO RGD:69169 6480464 flumetralin binds to and results in increased activity of PPARG protein CTD PMID:33049310 fluoranthene multiple interactions ISO RGD:69168 6480464 fluoranthene binds to and results in increased activity of PPARG protein CTD PMID:33049310 fluoxastrobin multiple interactions ISO RGD:69168 6480464 fluoxastrobin inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein] CTD PMID:30818834 fluoxetine multiple interactions ISO RGD:69168 6480464 Fluoxetine inhibits the reaction [Serotonin results in increased localization of PPARG protein] CTD PMID:25766885 fluprostenol multiple interactions ISO RGD:69169 6480464 fluprostenol inhibits the reaction [Niacin results in increased expression of PPARG mRNA] CTD PMID:21236357 flutamide multiple interactions ISO RGD:69169 6480464 Flutamide binds to and results in increased activity of PPARG protein CTD PMID:33049310 flutamide multiple interactions ISO RGD:69168 6480464 Flutamide binds to and results in increased activity of PPARG protein CTD PMID:33049310 fluticasone multiple interactions ISO RGD:69168 6480464 Fluticasone promotes the reaction [15-deoxyprostaglandin J2 promotes the reaction [NR3C1 protein binds to PPARG protein]] CTD PMID:15531761 flutolanil increases activity ISO RGD:69168 6480464 flutolanil results in increased activity of PPARG protein CTD PMID:20143881 folic acid multiple interactions EXP 6480464 [Folic Acid co-treated with Vitamin B 12] inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA], Folic Acid inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA] CTD PMID:23935743 folic acid multiple interactions ISO RGD:69169 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PPARG mRNA CTD PMID:22206623 fomepizole multiple interactions ISO RGD:69168 6480464 fomepizole inhibits the reaction [Ethanol inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]] CTD PMID:17030193 fructose increases expression EXP 6480464 Fructose results in increased expression of PPARG mRNA CTD PMID:19196556 fructose decreases activity EXP 6480464 Fructose results in decreased activity of PPARG protein CTD PMID:25679220 fructose multiple interactions EXP 6480464 [Dietary Fats co-treated with Fructose] results in decreased expression of PPARG protein more ... CTD PMID:19196556 more ... fucoxanthin decreases expression ISO RGD:69169 6480464 fucoxanthin results in decreased expression of PPARG mRNA CTD PMID:20519145 fulvestrant multiple interactions ISO RGD:69169 6480464 fulvestrant inhibits the reaction [Diethylstilbestrol results in increased activity of PPARG protein], fulvestrant inhibits the reaction [Diosgenin results in decreased expression of PPARG mRNA] CTD PMID:22710028 , PMID:26408789 fulvestrant multiple interactions ISO RGD:69168 6480464 Fulvestrant inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA], PPARG protein affects the reaction [Fulvestrant inhibits the reaction [bisphenol A inhibits the reaction [INS protein results in increased uptake of Glucose]]] CTD PMID:32623698 fumonisin B2 decreases activity ISO RGD:69168 6480464 fumonisin B2 results in decreased activity of PPARG protein CTD PMID:27481073 furan decreases expression EXP 6480464 furan results in decreased expression of PPARG mRNA CTD PMID:25539665 , PMID:26194646 Fusarenone X decreases activity ISO RGD:69168 6480464 fusarenon-X results in decreased activity of PPARG protein CTD PMID:27481073 gallic acid increases expression ISO RGD:69169 6480464 Gallic Acid results in increased expression of PPARG protein CTD PMID:24036142 gallic acid increases activity EXP 6480464 Gallic Acid results in increased activity of PPARG protein CTD PMID:24433871 gallocatechin decreases expression EXP 6480464 gallocatechol results in decreased expression of PPARG mRNA CTD PMID:21877759 gamma-linolenic acid multiple interactions ISO RGD:69168 6480464 gamma-Linolenic Acid binds to and results in increased activity of PPARG protein CTD PMID:15318936 gamma-tocopherol increases expression ISO RGD:69168 6480464 gamma-Tocopherol results in increased expression of PPARG mRNA, gamma-Tocopherol results in increased expression of PPARG protein CTD PMID:14521714 gamma-tocopherol multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA], [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein] CTD PMID:22389237 Ganoderic acid A multiple interactions ISO RGD:69169 6480464 [Dietary Fats co-treated with ganoderic acid A] affects the expression of PPARG mRNA CTD PMID:29852127 gemcitabine affects expression ISO RGD:69169 6480464 Gemcitabine affects the expression of PPARG mRNA CTD PMID:19427843 gemfibrozil increases expression ISO RGD:69168 6480464 Gemfibrozil results in increased expression of PPARG mRNA CTD PMID:19201410 gemfibrozil increases expression ISO RGD:69169 6480464 Gemfibrozil results in increased expression of PPARG mRNA CTD PMID:19201410 genistein decreases expression ISO RGD:69169 6480464 Genistein results in decreased expression of PPARG mRNA CTD PMID:18359623 genistein increases expression EXP 6480464 Genistein results in increased expression of PPARG mRNA CTD PMID:24361872 genistein decreases expression ISO RGD:69168 6480464 Genistein results in decreased expression of PPARG mRNA CTD PMID:20706672 genistein increases activity EXP 6480464 Genistein results in increased activity of PPARG protein CTD PMID:19903033 genistein multiple interactions EXP 6480464 2 more ... CTD PMID:19903033 , PMID:27171397 geraniol decreases expression ISO RGD:69168 6480464 geraniol results in decreased expression of PPARG mRNA CTD PMID:27683099 geraniol multiple interactions ISO RGD:69169 6480464 geraniol inhibits the reaction [[lipopolysaccharide more ... CTD PMID:30550845 geraniol multiple interactions EXP 6480464 geraniol inhibits the reaction [Fructose results in decreased activity of PPARG protein] more ... CTD PMID:25679220 , PMID:26165751 geraniol increases activity ISO RGD:69168 6480464 geraniol results in increased activity of PPARG protein CTD PMID:21597168 gingerol multiple interactions ISO RGD:69169 6480464 gingerol inhibits the reaction [sodium arsenite results in decreased expression of PPARG mRNA] more ... CTD PMID:22285432 , PMID:26498061 gingerol decreases expression ISO RGD:69169 6480464 gingerol results in decreased expression of PPARG mRNA, gingerol results in decreased expression of PPARG protein CTD PMID:26498061 ginsenoside Re increases expression ISO RGD:69169 6480464 ginsenoside Re results in increased expression of PPARG mRNA CTD PMID:23545455 Ginsenoside Rh4 multiple interactions ISO RGD:69169 6480464 ginsenoside Rh4 inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of PPARG mRNA] CTD PMID:33359794 gliclazide multiple interactions EXP 6480464 Gliclazide inhibits the reaction [Acetic Acid results in decreased expression of PPARG protein] CTD PMID:32045587 glucose multiple interactions EXP 6480464 [ciglitazone binds to and results in increased activity of PPARG protein] which results in increased transport of Glucose more ... CTD PMID:15878969 more ... glucose decreases expression ISO RGD:69168 6480464 Glucose results in decreased expression of PPARG protein CTD PMID:21333731 glucose multiple interactions ISO RGD:69168 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Glucose results in decreased expression of PPARG protein]] more ... CTD PMID:21333731 more ... glucose decreases expression EXP 6480464 Glucose results in decreased expression of PPARG mRNA, Glucose results in decreased expression of PPARG protein CTD PMID:19609456 , PMID:31063766 Glutathione ethyl ester multiple interactions ISO RGD:69169 6480464 S-ethyl glutathione inhibits the reaction [Buthionine Sulfoximine results in increased expression of PPARG mRNA] CTD PMID:21520053 glyburide multiple interactions EXP 6480464 Glyburide inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA], Glyburide inhibits the reaction [Streptozocin results in decreased expression of PPARG protein] CTD PMID:29223569 glycerol multiple interactions EXP 6480464 ciglitazone inhibits the reaction [Glycerol results in decreased expression of PPARG protein] CTD PMID:16820301 glycerol decreases expression EXP 6480464 Glycerol results in decreased expression of PPARG protein CTD PMID:16820301 glycerol 2-phosphate multiple interactions ISO RGD:69169 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA more ... CTD PMID:14505802 , PMID:32473317 glycerol 2-phosphate multiple interactions ISO RGD:69168 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA CTD PMID:25932594 glycine increases expression ISO RGD:69169 6480464 Glycine results in increased expression of PPARG mRNA CTD PMID:18930730 glycycoumarin affects binding ISO RGD:69168 6480464 glycycoumarin binds to PPARG protein CTD PMID:14608046 glycyrrhetinate multiple interactions EXP 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of PPARG mRNA], 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of PPARG protein] CTD PMID:28414158 glycyrrhetinic acid multiple interactions EXP 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of PPARG mRNA], 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of PPARG protein] CTD PMID:28414158 glycyrrhizinic acid multiple interactions ISO RGD:69169 6480464 Glycyrrhizic Acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA] CTD PMID:34302803 gossypetin affects response to substance ISO RGD:69169 6480464 PPARG protein affects the susceptibility to gossypetin CTD PMID:23845592 griseofulvin increases expression ISO RGD:69169 6480464 Griseofulvin results in increased expression of PPARG mRNA CTD PMID:9548566 GW 1929 affects binding ISO RGD:69168 6480464 GW 1929 binds to PPARG protein CTD PMID:20008677 more ... GW 1929 increases activity ISO RGD:69168 6480464 GW 1929 results in increased activity of PPARG protein CTD PMID:21543282 GW 1929 increases expression EXP 6480464 GW 1929 results in increased expression of PPARG mRNA CTD PMID:19420904 GW 1929 multiple interactions ISO RGD:69169 6480464 4-chloro-N-(2-((5-trifluoromethyl-2-pyridyl)sulfonyl)ethyl)benzamide inhibits the reaction [GW 1929 results in increased expression of PPARG mRNA] more ... CTD PMID:12847270 more ... GW 1929 increases expression ISO RGD:69169 6480464 GW 1929 results in increased expression of PPARG mRNA CTD PMID:20516370 GW 1929 multiple interactions ISO RGD:69168 6480464 [GW 1929 binds to and results in increased activity of PPARG protein] promotes the reaction [TNF protein results in decreased susceptibility to FSHB protein] more ... CTD PMID:20008677 more ... GW 4064 increases expression EXP 6480464 GW 4064 results in increased expression of PPARG mRNA CTD PMID:15980055 GW 4064 multiple interactions ISO RGD:69168 6480464 [GW 4064 co-treated with Oleic Acid] results in decreased expression of PPARG mRNA CTD PMID:30611723 GW 4064 increases expression ISO RGD:69168 6480464 GW 4064 results in increased expression of PPARG mRNA CTD PMID:30611723 GW 501516 increases expression ISO RGD:69168 6480464 GW 501516 results in increased expression of PPARG mRNA CTD PMID:19201410 GW 501516 increases expression ISO RGD:69169 6480464 GW 501516 results in increased expression of PPARG mRNA CTD PMID:19201410 GW 501516 increases activity ISO RGD:69168 6480464 GW 501516 results in increased activity of PPARG protein CTD PMID:16386710 GW 7647 multiple interactions ISO RGD:69168 6480464 GW 7647 binds to and results in increased activity of PPARG protein, PPARG protein promotes the reaction [GW 7647 results in increased activity of DIO2 protein] CTD PMID:19036883 GW 7647 multiple interactions ISO RGD:69169 6480464 [PPARA protein co-treated with GW 7647] results in increased expression of PPARG mRNA CTD PMID:21324916 GW 7647 increases activity ISO RGD:69168 6480464 GW 7647 results in increased activity of PPARG protein CTD PMID:20143881 harmine multiple interactions ISO RGD:69169 6480464 [phenylamil co-treated with Harmine] results in increased expression of PPARG mRNA CTD PMID:20519739 harmine increases expression ISO RGD:69169 6480464 Harmine results in increased expression of PPARG protein CTD PMID:27805061 hesperetin decreases expression ISO RGD:69168 6480464 hesperetin results in decreased expression of PPARG mRNA, hesperetin results in decreased expression of PPARG protein CTD PMID:25345581 hesperetin multiple interactions ISO RGD:69169 6480464 [hesperetin analog co-treated with PPARG protein] affects the reaction [Lipopolysaccharides results in increased expression of TNF protein] more ... CTD PMID:28428136 hesperidin multiple interactions EXP 6480464 Hesperidin inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of PPARG protein]] more ... CTD PMID:24954035 more ... hesperidin multiple interactions ISO RGD:69169 6480464 Hesperidin affects the reaction [LEPR protein affects the expression of PPARG protein] CTD PMID:16427799 HET0016 multiple interactions EXP 6480464 HET0016 inhibits the reaction [naringenin inhibits the reaction [Glucose results in decreased expression of PPARG protein]] CTD PMID:31063766 hexadecanoic acid increases expression ISO RGD:69169 6480464 Palmitic Acid results in increased expression of PPARG mRNA, Palmitic Acid results in increased expression of PPARG protein CTD PMID:18154422 , PMID:30208301 hexadecanoic acid multiple interactions ISO RGD:69169 6480464 [Palmitic Acid co-treated with sodium arsenite] results in decreased expression of PPARG mRNA more ... CTD PMID:30208301 , PMID:34968464 hexadecanoic acid multiple interactions ISO RGD:69168 6480464 [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of PPARG mRNA more ... CTD PMID:30208301 , PMID:32613381 hexadecanoic acid increases expression ISO RGD:69168 6480464 Palmitic Acid results in increased expression of PPARG protein CTD PMID:30208301 hexadecanoic acid multiple interactions EXP 6480464 [Oleic Acid co-treated with Palmitic Acid] inhibits the reaction [Ethanol results in increased expression of PPARG mRNA] more ... CTD PMID:25048947 more ... hexadecanoic acid decreases expression EXP 6480464 Palmitic Acid results in decreased expression of PPARG mRNA CTD PMID:25108154 hispidulin multiple interactions ISO RGD:69169 6480464 hispidulin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of PPARG mRNA], hispidulin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of PPARG protein] CTD PMID:30055130 Honokiol multiple interactions ISO RGD:69168 6480464 ALOX15 protein promotes the reaction [honokiol results in decreased expression of PPARG protein], honokiol binds to and results in increased activity of PPARG protein CTD PMID:20649594 , PMID:23811337 Honokiol decreases expression ISO RGD:69169 6480464 honokiol results in decreased expression of PPARG protein CTD PMID:20649594 Honokiol decreases expression ISO RGD:69168 6480464 honokiol results in decreased expression of PPARG mRNA, honokiol results in decreased expression of PPARG protein CTD PMID:20649594 hydrazine decreases expression EXP 6480464 hydrazine results in decreased expression of PPARG mRNA CTD PMID:15370871 hydrazines decreases expression ISO RGD:69169 6480464 Hydrazines results in decreased expression of PPARG mRNA, Hydrazines results in decreased expression of PPARG protein CTD PMID:21647536 hydrogen peroxide multiple interactions ISO RGD:69168 6480464 bergenin inhibits the reaction [Hydrogen Peroxide results in decreased expression of PPARG protein] more ... CTD PMID:17030193 more ... hydrogen peroxide increases degradation ISO RGD:69168 6480464 Hydrogen Peroxide results in increased degradation of PPARG protein CTD PMID:25305479 hydrogen peroxide decreases expression ISO RGD:69168 6480464 Hydrogen Peroxide results in decreased expression of PPARG protein CTD PMID:27417252 , PMID:34499403 hydrogen peroxide affects abundance ISO RGD:69169 6480464 PPARG protein affects the abundance of Hydrogen Peroxide CTD PMID:18083318 hydrogen peroxide decreases abundance ISO RGD:69169 6480464 PPARG gene polymorphism results in decreased abundance of Hydrogen Peroxide CTD PMID:18083318 hydrogen peroxide multiple interactions EXP 6480464 stearic acid inhibits the reaction [Hydrogen Peroxide results in decreased expression of PPARG protein] CTD PMID:17302992 hydrogen peroxide decreases expression EXP 6480464 Hydrogen Peroxide results in decreased expression of PPARG protein CTD PMID:17302992 hydrogen peroxide affects expression ISO RGD:69168 6480464 Hydrogen Peroxide affects the expression of PPARG mRNA CTD PMID:20044591 hydrogen peroxide increases expression ISO RGD:69168 6480464 Hydrogen Peroxide results in increased expression of PPARG mRNA CTD PMID:25130202 hydroxyflutamide multiple interactions ISO RGD:69169 6480464 hydroxyflutamide binds to and results in increased activity of PPARG protein CTD PMID:33049310 hydroxyflutamide multiple interactions ISO RGD:69168 6480464 hydroxyflutamide binds to and results in increased activity of PPARG protein CTD PMID:33049310 hydroxysafflor yellow A multiple interactions EXP 6480464 hydroxysafflor yellow A inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [Particulate Matter results in decreased expression of PPARG protein]] more ... CTD PMID:24192212 hydroxytyrosol decreases expression ISO RGD:69169 6480464 3, 4-dihydroxyphenylethanol results in decreased expression of PPARG mRNA CTD PMID:21569430 ibuprofen multiple interactions ISO RGD:69169 6480464 Ibuprofen inhibits the reaction [[TNF protein co-treated with IFNG protein] results in decreased expression of PPARG mRNA], Ibuprofen inhibits the reaction [Methamphetamine results in decreased expression of PPARG protein] CTD PMID:16407166 , PMID:18946735 ibuprofen affects activity ISO RGD:69168 6480464 Ibuprofen affects the activity of PPARG protein CTD PMID:25596134 ibuprofen affects activity EXP 6480464 Ibuprofen affects the activity of PPARG protein CTD PMID:25596134 ibuprofen increases expression ISO RGD:69169 6480464 Ibuprofen results in increased expression of PPARG mRNA CTD PMID:16407166 ibuprofen increases activity EXP 6480464 Ibuprofen analog results in increased activity of PPARG protein CTD PMID:11755111 ibuprofen multiple interactions ISO RGD:69168 6480464 Ibuprofen binds to and results in increased activity of PPARG protein CTD PMID:9013583 idarubicin decreases activity ISO RGD:69168 6480464 Idarubicin results in decreased activity of PPARG protein CTD PMID:25257666 ifosfamide affects activity ISO RGD:69168 6480464 Ifosfamide affects the activity of PPARG protein CTD PMID:25596134 indinavir decreases expression ISO RGD:69169 6480464 Indinavir results in decreased expression of PPARG mRNA CTD PMID:17926646 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of PPARG mRNA CTD PMID:21396975 indometacin multiple interactions ISO RGD:69168 6480464 2 more ... CTD PMID:12485869 more ... indometacin multiple interactions ISO RGD:69169 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of PPARG mRNA more ... CTD PMID:30055130 , PMID:33412187 indometacin increases activity ISO RGD:69168 6480464 Indomethacin analog results in increased activity of PPARG protein, Indomethacin results in increased activity of PPARG protein CTD PMID:12065695 more ... indometacin increases activity EXP 6480464 Indomethacin results in increased activity of PPARG protein CTD PMID:11755111 indometacin multiple interactions EXP 6480464 Indomethacin inhibits the reaction [rosiglitazone binds to and affects the activity of PPARG protein] CTD PMID:12897060 indometacin increases activity ISO RGD:69169 6480464 Indomethacin results in increased activity of PPARG protein CTD PMID:11683414 indometacin increases expression ISO RGD:69168 6480464 Indomethacin results in increased expression of PPARG mRNA, Indomethacin results in increased expression of PPARG protein CTD PMID:12483719 more ... indometacin affects localization ISO RGD:69168 6480464 Indomethacin affects the localization of PPARG protein CTD PMID:15899809 Ingenol 3,20-dibenzoate increases activity ISO RGD:69168 6480464 ingenol dibenzoate results in increased activity of PPARG protein CTD PMID:15707588 iohexol increases expression ISO RGD:69168 6480464 Iohexol results in increased expression of PPARG mRNA CTD PMID:29705293 iprodione increases activity ISO RGD:69168 6480464 iprodione results in increased activity of PPARG protein CTD PMID:20143881 iprodione multiple interactions ISO RGD:69168 6480464 iprodione binds to and results in increased activity of PPARG protein CTD PMID:33049310 iprodione multiple interactions ISO RGD:69169 6480464 iprodione binds to and results in increased activity of PPARG protein CTD PMID:33049310 irinotecan decreases expression ISO RGD:69168 6480464 Irinotecan results in decreased expression of PPARG mRNA CTD PMID:34699766 irinotecan multiple interactions ISO RGD:69168 6480464 Luteolin inhibits the reaction [Irinotecan results in decreased expression of PPARG mRNA] more ... CTD PMID:34699766 iron atom increases expression ISO RGD:69168 6480464 Iron deficiency results in increased expression of PPARG mRNA CTD PMID:20368581 iron dextran multiple interactions EXP 6480464 bergenin inhibits the reaction [Iron-Dextran Complex results in decreased expression of PPARG protein] CTD PMID:36207002 iron dextran decreases expression EXP 6480464 Iron-Dextran Complex results in decreased expression of PPARG protein CTD PMID:36207002 iron(0) increases expression ISO RGD:69168 6480464 Iron deficiency results in increased expression of PPARG mRNA CTD PMID:20368581 isoliquiritigenin multiple interactions ISO RGD:69169 6480464 isoliquiritigenin inhibits the reaction [INS1 protein results in increased expression of PPARG protein] CTD PMID:27117918 isoniazide decreases expression ISO RGD:69168 6480464 Isoniazid results in decreased expression of PPARG mRNA CTD PMID:24128855 isoniazide decreases expression ISO RGD:69169 6480464 Isoniazid results in decreased expression of PPARG mRNA, Isoniazid results in decreased expression of PPARG protein CTD PMID:24128855 isonicotinamide decreases expression ISO RGD:69169 6480464 isonicotinamide results in decreased expression of PPARG mRNA CTD PMID:16813520 isophorone multiple interactions ISO RGD:69168 6480464 isophorone binds to and results in decreased activity of PPARG protein CTD PMID:27633901 isoprenaline multiple interactions EXP 6480464 2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of PPARG protein] more ... CTD PMID:24954035 , PMID:30623541 isoprenaline decreases expression EXP 6480464 Isoproterenol results in decreased expression of PPARG mRNA, Isoproterenol results in decreased expression of PPARG protein CTD PMID:24286936 , PMID:30623541 isoprenaline multiple interactions ISO RGD:69169 6480464 osthol inhibits the reaction [Isoproterenol results in decreased expression of PPARG mRNA] CTD PMID:21854795 isoprenaline decreases expression ISO RGD:69169 6480464 Isoproterenol results in decreased expression of PPARG mRNA CTD PMID:21854795 isorhamnetin multiple interactions ISO RGD:69168 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [3-methylquercetin results in increased activity of PPARG protein], 3-methylquercetin binds to and results in increased activity of PPARG protein CTD PMID:22992727 isorhamnetin increases expression ISO RGD:69168 6480464 3-methylquercetin results in increased expression of PPARG protein CTD PMID:22992727 isotretinoin increases expression EXP 6480464 Isotretinoin results in increased expression of PPARG mRNA CTD PMID:19041696 , PMID:19212007 ivermectin multiple interactions ISO RGD:69169 6480464 Ivermectin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein], Rosiglitazone affects the reaction [Ivermectin affects the expression of PPARG mRNA] CTD PMID:31199990 ivermectin affects expression ISO RGD:69169 6480464 Ivermectin affects the expression of PPARG mRNA CTD PMID:31199990 juglone multiple interactions ISO RGD:69168 6480464 [Indomethacin co-treated with juglone] results in increased expression of PPARG mRNA, [Indomethacin co-treated with juglone] results in increased expression of PPARG protein CTD PMID:31916655 juglone increases expression ISO RGD:69168 6480464 juglone results in increased expression of PPARG mRNA, juglone results in increased expression of PPARG protein CTD PMID:31916655 kaempferol multiple interactions ISO RGD:69169 6480464 kaempferol binds to and results in increased activity of PPARG protein more ... CTD PMID:11343698 more ... kaempferol increases expression ISO RGD:69168 6480464 kaempferol results in increased expression of PPARG mRNA, kaempferol results in increased expression of PPARG protein CTD PMID:25765892 kaempferol multiple interactions ISO RGD:69168 6480464 kaempferol binds to and results in increased activity of PPARG protein CTD PMID:33049310 kresoxim-methyl multiple interactions ISO RGD:69168 6480464 kresoxim-methyl inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein] CTD PMID:30818834 L-ascorbic acid multiple interactions ISO RGD:69169 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA more ... CTD PMID:14505802 , PMID:32473317 L-ascorbic acid multiple interactions ISO RGD:69168 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA CTD PMID:25932594 L-methionine multiple interactions ISO RGD:69169 6480464 3 more ... CTD PMID:18991162 , PMID:28973532 L-methionine decreases expression ISO RGD:69169 6480464 Methionine results in decreased expression of PPARG mRNA CTD PMID:35314295 L-methionine decreases methylation ISO RGD:69169 6480464 Methionine deficiency results in decreased methylation of PPARG promoter CTD PMID:35314295 lacidipine increases activity ISO RGD:69168 6480464 lacidipine results in increased activity of PPARG protein CTD PMID:25257666 lead diacetate multiple interactions EXP 6480464 [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of and results in increased activity of PPARG protein] which results in decreased expression of GFAP protein more ... CTD PMID:24481447 , PMID:28283887 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of PPARG protein CTD PMID:28283887 lead(0) increases expression EXP 6480464 Lead results in increased expression of PPARG mRNA CTD PMID:23086611 lead(0) increases expression ISO RGD:69169 6480464 Lead results in increased expression of PPARG, Lead results in increased expression of PPARG mRNA CTD PMID:23086611 , PMID:26518054 lead(2+) increases expression EXP 6480464 Lead results in increased expression of PPARG mRNA CTD PMID:23086611 lead(2+) increases expression ISO RGD:69169 6480464 Lead results in increased expression of PPARG, Lead results in increased expression of PPARG mRNA CTD PMID:23086611 , PMID:26518054 leflunomide increases expression ISO RGD:69168 6480464 leflunomide results in increased expression of PPARG mRNA CTD PMID:28988120 letrozole multiple interactions EXP 6480464 ADM protein inhibits the reaction [Letrozole results in decreased expression of PPARG mRNA] CTD PMID:33491863 letrozole decreases expression EXP 6480464 Letrozole results in decreased expression of PPARG mRNA CTD PMID:33491863 Licarin A multiple interactions ISO RGD:69169 6480464 [licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of PPARG mRNA, [licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of PPARG protein CTD PMID:29288687 linoleamide increases activity ISO RGD:69168 6480464 linoleamide analog results in increased activity of PPARG protein CTD PMID:29288688 linoleic acid affects binding ISO RGD:69168 6480464 Linoleic Acid binds to PPARG protein CTD PMID:23843199 , PMID:35752307 linoleic acid affects binding ISO RGD:69169 6480464 Linoleic Acid binds to PPARG protein CTD PMID:12021203 linoleic acid multiple interactions EXP 6480464 Linoleic Acid binds to and results in increased activity of PPARG protein CTD PMID:16731579 linoleic acid increases expression ISO RGD:69169 6480464 Linoleic Acid results in increased expression of PPARG mRNA CTD PMID:18154422 linoleic acid multiple interactions ISO RGD:69169 6480464 Linoleic Acid binds to and results in increased activity of PPARG protein CTD PMID:16731579 linoleic acid multiple interactions ISO RGD:69168 6480464 resveratrol inhibits the reaction [Linoleic Acid results in increased expression of PPARG protein] CTD PMID:25672876 linoleic acid increases expression ISO RGD:69168 6480464 Linoleic Acid results in increased expression of PPARG protein CTD PMID:25672876 linoleic acid increases activity ISO RGD:69168 6480464 Linoleic Acid results in increased activity of PPARG protein CTD PMID:25786526 linoleic acid decreases expression ISO RGD:69168 6480464 Linoleic Acid results in decreased expression of PPARG mRNA, Linoleic Acid results in decreased expression of PPARG protein CTD PMID:11172467 , PMID:15708366 linuron multiple interactions ISO RGD:69168 6480464 Linuron binds to and results in increased activity of PPARG protein CTD PMID:33049310 linuron multiple interactions ISO RGD:69169 6480464 Linuron binds to and results in increased activity of PPARG protein CTD PMID:33049310 lipoic acid multiple interactions EXP 6480464 [Thioctic Acid co-treated with Dietary Fats] results in increased expression of PPARG mRNA CTD PMID:22464149 lipopolysaccharide multiple interactions EXP 6480464 2 more ... CTD PMID:15318101 more ... lipopolysaccharide decreases activity EXP 6480464 Lipopolysaccharides results in decreased activity of PPARG protein CTD PMID:29480285 lipopolysaccharide decreases expression ISO RGD:69169 6480464 Lipopolysaccharides results in decreased expression of PPARG mRNA, Lipopolysaccharides results in decreased expression of PPARG protein CTD PMID:16847310 more ... lipopolysaccharide decreases expression ISO RGD:69168 6480464 Lipopolysaccharides results in decreased expression of PPARG mRNA CTD PMID:12604364 lipopolysaccharide multiple interactions ISO RGD:69168 6480464 15-deoxy-delta(12 more ... CTD PMID:12604364 more ... lipopolysaccharide multiple interactions ISO RGD:69169 6480464 15-deoxy-delta(12 more ... CTD PMID:11343698 more ... lipopolysaccharide increases activity ISO RGD:69169 6480464 Lipopolysaccharides results in increased activity of PPARG protein CTD PMID:27329536 lipoxin A4 multiple interactions EXP 6480464 lipoxin A4 binds to and results in increased activity of PPARG protein CTD PMID:19321784 lithium chloride increases expression ISO RGD:69168 6480464 Lithium Chloride results in increased expression of PPARG mRNA CTD PMID:23527032 losartan multiple interactions EXP 6480464 Losartan inhibits the reaction [AGT protein results in increased expression of PPARG mRNA] CTD PMID:19109942 losartan multiple interactions ISO RGD:69169 6480464 Losartan inhibits the reaction [[Dietary Fats co-treated with Cholesterol] results in increased expression of PPARG mRNA] CTD PMID:18302760 lovastatin multiple interactions ISO RGD:69168 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Lovastatin analog affects the localization of PPARG protein] more ... CTD PMID:16425225 , PMID:26863638 lovastatin multiple interactions EXP 6480464 geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of PPARG mRNA] more ... CTD PMID:20578043 lovastatin increases expression EXP 6480464 Lovastatin results in increased expression of PPARG mRNA CTD PMID:20578043 lovastatin affects localization ISO RGD:69168 6480464 Lovastatin analog affects the localization of PPARG protein CTD PMID:26863638 lovastatin multiple interactions ISO RGD:69169 6480464 [Dietary Fats co-treated with Lovastatin] affects the expression of PPARG mRNA, PPARG affects the reaction [Lovastatin results in increased expression of PTEN protein] CTD PMID:16425225 , PMID:29852127 luteolin increases expression ISO RGD:69168 6480464 Luteolin results in increased expression of PPARG mRNA CTD PMID:34699766 luteolin multiple interactions ISO RGD:69168 6480464 Luteolin inhibits the reaction [Irinotecan results in decreased expression of PPARG mRNA] more ... CTD PMID:34699766 luzindole multiple interactions ISO RGD:69168 6480464 luzindole inhibits the reaction [Melatonin results in increased expression of PPARG protein], luzindole inhibits the reaction [Pioglitazone results in increased expression of PPARG protein] CTD PMID:29734669 LY294002 increases expression EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of PPARG mRNA, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of PPARG protein CTD PMID:17372590 lycopene increases expression ISO RGD:69169 6480464 Lycopene results in increased expression of PPARG mRNA CTD PMID:36216167 lycopene multiple interactions ISO RGD:69169 6480464 [Lycopene co-treated with Atrazine] results in increased expression of PPARG mRNA CTD PMID:36216167 m-xylene decreases expression EXP 6480464 3-xylene results in decreased expression of PPARG mRNA CTD PMID:12815608 Magnolol multiple interactions ISO RGD:69169 6480464 2 more ... CTD PMID:20064974 Magnolol multiple interactions ISO RGD:69168 6480464 magnolol binds to and results in increased activity of PPARG protein CTD PMID:20064974 manganese atom multiple interactions EXP 6480464 [1, 1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] inhibits the reaction [Manganese results in increased chemical synthesis of Nitric Oxide] CTD PMID:18041089 manganese(0) multiple interactions EXP 6480464 [1, 1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] inhibits the reaction [Manganese results in increased chemical synthesis of Nitric Oxide] CTD PMID:18041089 mangiferin multiple interactions EXP 6480464 mangiferin inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA], mangiferin inhibits the reaction [Streptozocin results in decreased expression of PPARG protein] CTD PMID:29223569 mangiferin multiple interactions ISO RGD:69169 6480464 [mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein CTD PMID:32417366 manidipine decreases activity ISO RGD:69168 6480464 manidipine results in decreased activity of PPARG protein CTD PMID:25257666 melatonin increases expression ISO RGD:69168 6480464 Melatonin results in increased expression of PPARG mRNA, Melatonin results in increased expression of PPARG protein CTD PMID:29734669 , PMID:33962019 melatonin multiple interactions ISO RGD:69169 6480464 Melatonin inhibits the reaction [Cisplatin results in decreased expression of PPARG protein] CTD PMID:34428482 melatonin multiple interactions ISO RGD:69168 6480464 GW 1929 inhibits the reaction [Melatonin results in increased expression of PPARG protein] more ... CTD PMID:29734669 melatonin decreases expression ISO RGD:69168 6480464 Melatonin results in decreased expression of PPARG mRNA CTD PMID:20738756 mercury dichloride decreases expression ISO RGD:69169 6480464 Mercuric Chloride results in decreased expression of PPARG mRNA, Mercuric Chloride results in decreased expression of PPARG protein CTD PMID:12883084 , PMID:22019852 mercury dichloride increases expression EXP 6480464 Mercuric Chloride results in increased expression of PPARG mRNA CTD PMID:30807803 mesalamine multiple interactions ISO RGD:69169 6480464 Mesalamine inhibits the reaction [Dextran Sulfate affects the localization of PPARG protein] CTD PMID:33130971 mesalamine multiple interactions ISO RGD:69168 6480464 [IL1A protein co-treated with TNF protein co-treated with IFNG protein co-treated with Mesalamine] results in increased expression of PPARG protein, Mesalamine inhibits the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein co-treated with cyanidin-3-O-beta-glucopyranoside] results in increased expression of PPARG protein] CTD PMID:27818126 metconazole multiple interactions ISO RGD:69168 6480464 metconazole binds to and results in increased activity of PPARG protein CTD PMID:33049310 metconazole multiple interactions ISO RGD:69169 6480464 metconazole binds to and results in increased activity of PPARG protein CTD PMID:33049310 metformin decreases expression ISO RGD:69168 6480464 Metformin results in decreased expression of PPARG mRNA CTD PMID:20956498 metformin multiple interactions ISO RGD:69168 6480464 Metformin inhibits the reaction [[cyhalothrin co-treated with Oleic Acid] results in increased expression of PPARG protein] CTD PMID:36529352 metformin multiple interactions ISO RGD:69169 6480464 Metformin inhibits the reaction [IL13 protein results in increased expression of PPARG mRNA] CTD PMID:26497364 metformin affects activity EXP 6480464 Metformin affects the activity of PPARG protein CTD PMID:25596134 metformin multiple interactions EXP 6480464 Metformin inhibits the reaction [[Dietary Fats co-treated with Fructose] results in decreased expression of PPARG protein], Metformin inhibits the reaction [Palmitic Acid results in decreased expression of PPARG mRNA] CTD PMID:25108154 , PMID:30256492 metformin increases expression ISO RGD:69169 6480464 Metformin results in increased expression of PPARG mRNA CTD PMID:21870829 metformin increases expression EXP 6480464 Metformin results in increased expression of PPARG mRNA CTD PMID:20724125 methamphetamine multiple interactions ISO RGD:69169 6480464 2-chloro-5-nitrobenzanilide promotes the reaction [PPARG protein results in increased susceptibility to Methamphetamine] more ... CTD PMID:17019405 , PMID:18946735 methamphetamine increases response to substance ISO RGD:69169 6480464 PPARG protein results in increased susceptibility to Methamphetamine CTD PMID:17019405 methamphetamine increases activity ISO RGD:69169 6480464 Methamphetamine results in increased activity of PPARG protein CTD PMID:17019405 methamphetamine increases expression ISO RGD:69169 6480464 Methamphetamine results in increased expression of PPARG protein CTD PMID:17019405 methamphetamine decreases expression ISO RGD:69169 6480464 Methamphetamine results in decreased expression of PPARG protein CTD PMID:18946735 methotrexate multiple interactions EXP 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of PPARG mRNA] more ... CTD PMID:25187349 more ... methotrexate decreases expression EXP 6480464 Methotrexate results in decreased expression of PPARG mRNA, Methotrexate results in decreased expression of PPARG protein CTD PMID:28414158 , PMID:34737150 methotrexate increases expression EXP 6480464 Methotrexate results in increased expression of PPARG protein CTD PMID:25187349 methyl beta-cyclodextrin multiple interactions ISO RGD:69169 6480464 methyl-beta-cyclodextrin inhibits the reaction [EGF protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]] CTD PMID:16971554 methyl laurate multiple interactions ISO RGD:69168 6480464 lauric acid methyl ester binds to and results in decreased activity of PPARG protein CTD PMID:27633901 methyl oleate multiple interactions ISO RGD:69168 6480464 methyl oleate binds to and results in increased activity of PPARG protein CTD PMID:27633901 methylglyoxal multiple interactions EXP 6480464 PPARG mutant form inhibits the reaction [monascin inhibits the reaction [Pyruvaldehyde results in decreased uptake of 2-(N-(7-nitrobenz-2-oxa-1 more ... CTD PMID:23954466 methylisothiazolinone increases expression ISO RGD:69168 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of PPARG mRNA CTD PMID:31629900 methylparaben multiple interactions ISO RGD:69168 6480464 methylparaben binds to and results in increased activity of PPARG protein CTD PMID:24155963 methylparaben increases response to substance ISO RGD:69169 6480464 PPARG protein results in increased susceptibility to methylparaben CTD PMID:28527915 methylparaben multiple interactions ISO RGD:69169 6480464 PPARG protein promotes the reaction [methylparaben results in decreased expression of BGLAP mRNA] CTD PMID:28527915 metolachlor multiple interactions ISO RGD:69169 6480464 metolachlor binds to and results in increased activity of PPARG protein CTD PMID:33049310 metolachlor multiple interactions ISO RGD:69168 6480464 metolachlor binds to and results in increased activity of PPARG protein CTD PMID:33049310 mevalonic acid multiple interactions EXP 6480464 Mevalonic Acid inhibits the reaction [Lovastatin results in increased expression of PPARG mRNA] CTD PMID:20578043 mifepristone multiple interactions ISO RGD:69169 6480464 Mifepristone inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA], Mifepristone inhibits the reaction [butylparaben results in increased expression of PPARG mRNA] CTD PMID:22956630 , PMID:27145005 mifepristone multiple interactions EXP 6480464 Mifepristone inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PPARG protein] CTD PMID:30229846 mifepristone decreases expression EXP 6480464 Mifepristone results in decreased expression of PPARG mRNA CTD PMID:25972201 miquelianin increases expression ISO RGD:69168 6480464 quercetin 3-O-glucuronide results in increased expression of PPARG mRNA CTD PMID:25765892 Mitotane multiple interactions ISO RGD:69169 6480464 Mitotane binds to and results in increased activity of PPARG protein CTD PMID:33049310 MK-2206 multiple interactions ISO RGD:69169 6480464 MK 2206 inhibits the reaction [Endrin results in increased expression of PPARG mRNA] CTD PMID:34801515 monascin decreases phosphorylation ISO RGD:69168 6480464 monascin results in decreased phosphorylation of PPARG protein CTD PMID:22381257 monascin increases response to substance EXP 6480464 PPARG protein results in increased susceptibility to monascin CTD PMID:23954466 monascin increases expression ISO RGD:69168 6480464 monascin results in increased expression of PPARG protein CTD PMID:22381257 monascin multiple interactions EXP 6480464 PPARG mutant form inhibits the reaction [monascin inhibits the reaction [Pyruvaldehyde results in decreased uptake of 2-(N-(7-nitrobenz-2-oxa-1 more ... CTD PMID:23954466 monascin affects localization ISO RGD:69168 6480464 monascin affects the localization of PPARG protein CTD PMID:23954466 mono(2-ethyl-5-oxohexyl) phthalate multiple interactions ISO RGD:69168 6480464 mono(2-ethyl-5-oxohexyl)phthalate binds to and affects the folding of and results in increased activity of PPARG protein CTD PMID:30085373 mono(2-ethylhexyl) phthalate multiple interactions ISO RGD:69168 6480464 2 more ... CTD PMID:12927354 more ... mono(2-ethylhexyl) phthalate affects expression ISO RGD:69168 6480464 mono-(2-ethylhexyl)phthalate affects the expression of PPARG mRNA CTD PMID:30810372 mono(2-ethylhexyl) phthalate affects activity ISO RGD:69168 6480464 mono-(2-ethylhexyl)phthalate affects the activity of PPARG protein CTD PMID:30810372 mono(2-ethylhexyl) phthalate multiple interactions ISO RGD:69169 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of PPARG mRNA, mono-(2-ethylhexyl)phthalate binds to and results in increased activity of PPARG protein CTD PMID:31884101 , PMID:33049310 mono(2-ethylhexyl) phthalate increases activity ISO RGD:69168 6480464 mono-(2-ethylhexyl)phthalate results in increased activity of PPARG protein CTD PMID:10581215 more ... mono(2-ethylhexyl) phthalate decreases expression ISO RGD:69169 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of PPARG mRNA CTD PMID:25543134 mono(2-ethylhexyl) phthalate affects binding ISO RGD:69168 6480464 mono-(2-ethylhexyl)phthalate binds to PPARG protein CTD PMID:23843199 , PMID:35019730 mono(2-ethylhexyl) phthalate increases activity ISO RGD:69169 6480464 mono-(2-ethylhexyl)phthalate analog results in increased activity of PPARG protein, mono-(2-ethylhexyl)phthalate results in increased activity of PPARG protein CTD PMID:10581215 more ... mono(2-ethylhexyl) phthalate decreases expression ISO RGD:69168 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of PPARG mRNA CTD PMID:23118965 mono(2-ethylhexyl) phthalate increases expression EXP 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of PPARG mRNA, mono-(2-ethylhexyl)phthalate results in increased expression of PPARG protein CTD PMID:15647598 monobenzyl phthalate affects binding ISO RGD:69168 6480464 mono-benzyl phthalate binds to PPARG protein CTD PMID:23843199 monobenzyl phthalate increases expression ISO RGD:69168 6480464 mono-benzyl phthalate results in increased expression of PPARG protein CTD PMID:29089286 monobenzyl phthalate increases activity ISO RGD:69168 6480464 mono-benzyl phthalate results in increased activity of PPARG protein CTD PMID:27551952 monobenzyl phthalate multiple interactions ISO RGD:69169 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of PPARG mRNA CTD PMID:31884101 Monobutylphthalate affects binding ISO RGD:69168 6480464 monobutyl phthalate binds to PPARG protein CTD PMID:23843199 Monobutylphthalate affects expression ISO RGD:69168 6480464 monobutyl phthalate affects the expression of PPARG mRNA CTD PMID:28381288 Monobutylphthalate increases expression ISO RGD:69168 6480464 monobutyl phthalate results in increased expression of PPARG protein CTD PMID:29089286 Monobutylphthalate multiple interactions ISO RGD:69168 6480464 monobutyl phthalate inhibits the reaction [ciglitazone binds to and results in increased activity of PPARG protein] CTD PMID:16326050 monocrotophos increases expression EXP 6480464 Monocrotophos results in increased expression of PPARG mRNA CTD PMID:32267039 monoethyl phthalate affects binding ISO RGD:69168 6480464 monoethyl phthalate binds to PPARG protein CTD PMID:23843199 monoethyl phthalate multiple interactions ISO RGD:69169 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of PPARG mRNA CTD PMID:31884101 monoethyl phthalate affects expression ISO RGD:69168 6480464 monoethyl phthalate affects the expression of PPARG mRNA CTD PMID:28381288 monohexyl phthalate affects binding ISO RGD:69168 6480464 mono-n-hexyl phthalate binds to PPARG protein CTD PMID:23843199 Monomethyl phthalate affects binding ISO RGD:69168 6480464 monomethyl phthalate binds to PPARG protein CTD PMID:23843199 monooctyl phthalate affects binding ISO RGD:69168 6480464 mono-n-octyl phthalate binds to PPARG protein CTD PMID:23843199 monosodium L-glutamate affects response to substance ISO RGD:69169 6480464 PPARG protein affects the susceptibility to Sodium Glutamate CTD PMID:15231871 monosodium L-glutamate multiple interactions ISO RGD:69169 6480464 [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PPARG mRNA CTD PMID:23783067 monosodium L-glutamate increases expression ISO RGD:69169 6480464 Sodium Glutamate results in increased expression of PPARG mRNA CTD PMID:21205225 morin affects localization ISO RGD:69169 6480464 morin affects the localization of PPARG protein CTD PMID:36121554 morin affects binding ISO RGD:69169 6480464 morin binds to PPARG protein CTD PMID:36121554 morin multiple interactions ISO RGD:69169 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [morin promotes the reaction [PPARG protein binds to SP1 protein]], morin promotes the reaction [PPARG protein binds to SP1 protein] CTD PMID:36121554 Muraglitazar multiple interactions ISO RGD:69168 6480464 muraglitazar binds to and results in increased activity of PPARG protein CTD PMID:17426106 , PMID:17675651 Muraglitazar multiple interactions ISO RGD:69169 6480464 muraglitazar binds to and results in increased activity of PPARG protein CTD PMID:17675651 Muraglitazar decreases expression EXP 6480464 muraglitazar results in decreased expression of PPARG mRNA CTD PMID:21515302 myricitrin multiple interactions ISO RGD:69168 6480464 myricitrin inhibits the reaction [Hydrogen Peroxide results in increased expression of PPARG mRNA] CTD PMID:25130202 N(gamma)-nitro-L-arginine methyl ester decreases expression ISO RGD:69169 6480464 NG-Nitroarginine Methyl Ester results in decreased expression of PPARG protein CTD PMID:34995009 N(gamma)-nitro-L-arginine methyl ester multiple interactions ISO RGD:69169 6480464 ALKBH5 protein promotes the reaction [NG-Nitroarginine Methyl Ester results in decreased expression of PPARG protein] CTD PMID:34995009 N-acetyl-L-cysteine increases expression EXP 6480464 Acetylcysteine results in increased expression of PPARG mRNA, Acetylcysteine results in increased expression of PPARG protein CTD PMID:17602960 N-acetyl-L-cysteine multiple interactions ISO RGD:69169 6480464 Acetylcysteine inhibits the reaction [[Carbon Monoxide results in increased abundance of Reactive Oxygen Species] which results in increased sumoylation of PPARG protein], Acetylcysteine inhibits the reaction [INS1 protein results in increased expression of PPARG protein] CTD PMID:22046279 , PMID:27117918 N-acetyl-L-cysteine multiple interactions ISO RGD:69168 6480464 Acetylcysteine inhibits the reaction [[[15-deoxyprostaglandin J2 results in increased activity of PPARG protein] which results in decreased expression of SOD2 protein] which results in increased abundance of Reactive Oxygen Species], Acetylcysteine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PPARG protein] CTD PMID:16945329 , PMID:23964924 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [yttrium chloride results in decreased expression of PPARG protein] more ... CTD PMID:17602960 , PMID:35088107 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases activity ISO RGD:69168 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased activity of PPARG protein CTD PMID:15707588 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:69169 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [resveratrol results in decreased expression of PPARG protein], benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [rosiglitazone results in decreased expression of PPARG protein] CTD PMID:18555852 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:69168 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [15-deoxy-delta(12 more ... CTD PMID:15707588 N-butylbenzenesulfonamide multiple interactions ISO RGD:69168 6480464 N-butylbenzenesulfonamide binds to and results in decreased activity of PPARG protein CTD PMID:27633901 N-methyl-4-phenylpyridinium affects expression ISO RGD:69168 6480464 1-Methyl-4-phenylpyridinium affects the expression of PPARG mRNA CTD PMID:24767308 N-methyl-4-phenylpyridinium decreases expression ISO RGD:69168 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of PPARG protein CTD PMID:26141122 , PMID:30965670 N-methyl-4-phenylpyridinium multiple interactions ISO RGD:69168 6480464 [1-Methyl-4-phenylpyridinium co-treated with PPARGC1A protein] results in increased expression of PPARG mRNA more ... CTD PMID:26141122 , PMID:30965670 N-methyl-N-nitrosourea increases response to substance ISO RGD:69169 6480464 PPARG gene mutant form results in increased susceptibility to Methylnitrosourea CTD PMID:15930296 N-methylnicotinate multiple interactions ISO RGD:69168 6480464 ATG7 protein affects the reaction [trigonelline inhibits the reaction [Palmitic Acid results in increased expression of PPARG protein]], trigonelline inhibits the reaction [Palmitic Acid results in increased expression of PPARG protein] CTD PMID:30208301 N-methylnicotinate multiple interactions ISO RGD:69169 6480464 trigonelline inhibits the reaction [[Cholesterol more ... CTD PMID:30208301 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of PPARG mRNA, Diethylnitrosamine results in decreased expression of PPARG protein CTD PMID:24954034 N-nitrosodiethylamine multiple interactions EXP 6480464 [Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of PPARG mRNA more ... CTD PMID:28935427 , PMID:30298849 N-nitrosodiethylamine decreases response to substance ISO RGD:69169 6480464 PPARG protein results in decreased susceptibility to Diethylnitrosamine CTD PMID:20512989 N-nitrosodimethylamine decreases expression EXP 6480464 Dimethylnitrosamine results in decreased expression of PPARG mRNA CTD PMID:12055599 , PMID:15099470 NAD zwitterion multiple interactions EXP 6480464 3-aminobenzamide inhibits the reaction [NAD results in decreased activity of PPARG protein] CTD PMID:18815186 NAD zwitterion decreases activity EXP 6480464 NAD results in decreased activity of PPARG protein CTD PMID:18815186 NAD(+) multiple interactions EXP 6480464 3-aminobenzamide inhibits the reaction [NAD results in decreased activity of PPARG protein] CTD PMID:18815186 NAD(+) decreases activity EXP 6480464 NAD results in decreased activity of PPARG protein CTD PMID:18815186 napropamide multiple interactions ISO RGD:69168 6480464 devrinol binds to and results in increased activity of PPARG protein CTD PMID:33049310 napropamide multiple interactions ISO RGD:69169 6480464 devrinol binds to and results in increased activity of PPARG protein CTD PMID:33049310 naproxen increases activity EXP 6480464 Naproxen results in increased activity of PPARG protein CTD PMID:11755111 naringin multiple interactions ISO RGD:69169 6480464 naringin affects the reaction [LEPR protein affects the expression of PPARG protein], naringin inhibits the reaction [Dietary Fats results in increased expression of PPARG mRNA] CTD PMID:16427799 , PMID:22198281 naringin multiple interactions EXP 6480464 [naringin co-treated with Pioglitazone] inhibits the reaction [Quinolinic Acid results in decreased expression of PPARG mRNA], naringin inhibits the reaction [Quinolinic Acid results in decreased expression of PPARG mRNA] CTD PMID:30130594 nevirapine increases expression ISO RGD:69168 6480464 Nevirapine results in increased expression of PPARG mRNA CTD PMID:21619898 nicardipine decreases activity ISO RGD:69168 6480464 Nicardipine results in decreased activity of PPARG protein CTD PMID:25257666 nickel atom decreases expression ISO RGD:69168 6480464 Nickel results in decreased expression of PPARG mRNA CTD PMID:24768652 , PMID:25583101 nickel sulfate increases expression ISO RGD:69168 6480464 nickel sulfate results in increased expression of PPARG mRNA CTD PMID:16314067 nicotinamide multiple interactions ISO RGD:69169 6480464 Niacinamide affects the reaction [PPARG protein binds to NCOR1 protein], resveratrol inhibits the reaction [Niacinamide results in increased expression of PPARG protein] CTD PMID:22539994 nicotinamide increases expression ISO RGD:69169 6480464 Niacinamide results in increased expression of PPARG protein CTD PMID:22539994 nicotine decreases expression ISO RGD:69169 6480464 Nicotine results in decreased expression of PPARG protein CTD PMID:33082140 nicotine increases expression ISO RGD:69169 6480464 Nicotine results in increased expression of PPARG mRNA CTD PMID:31622651 nicotinic acid multiple interactions ISO RGD:69169 6480464 [Niacin results in decreased abundance of Dinoprost] which results in increased expression of PPARG mRNA more ... CTD PMID:19797938 , PMID:21236357 nicotinic acid increases expression ISO RGD:69169 6480464 Niacin results in increased expression of PPARG mRNA CTD PMID:19797938 nicotinic acid increases expression ISO RGD:69168 6480464 Niacin results in increased expression of PPARG mRNA CTD PMID:15037193 more ... nicotinic acid multiple interactions ISO RGD:69168 6480464 4-benzhydryloxy-1-(3-(1H-tetrazol-5-yl-)-propyl)piperidine inhibits the reaction [Niacin results in increased activity of PPARG protein] more ... CTD PMID:15037193 , PMID:16386710 Niflumic acid increases expression ISO RGD:69168 6480464 Niflumic Acid results in increased expression of PPARG protein CTD PMID:21067863 nilutamide multiple interactions ISO RGD:69169 6480464 nilutamide binds to and results in increased activity of PPARG protein CTD PMID:33049310 nilutamide multiple interactions ISO RGD:69168 6480464 nilutamide binds to and results in increased activity of PPARG protein CTD PMID:33049310 nimesulide multiple interactions ISO RGD:69168 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [nimesulide promotes the reaction [PPARG binds to PPARG promoter]] more ... CTD PMID:11840453 more ... nimesulide multiple interactions EXP 6480464 nimesulide inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA] CTD PMID:19247274 nimesulide increases expression ISO RGD:69169 6480464 nimesulide results in increased expression of PPARG mRNA CTD PMID:15705899 nimesulide multiple interactions ISO RGD:69169 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [nimesulide results in increased expression of PPARG mRNA] CTD PMID:15705899 nimesulide increases expression ISO RGD:69168 6480464 nimesulide results in increased expression of PPARG protein CTD PMID:14977856 nimesulide decreases expression ISO RGD:69168 6480464 nimesulide results in decreased expression of PPARG mRNA CTD PMID:11840453 nitric oxide multiple interactions ISO RGD:69168 6480464 [rosiglitazone binds to and affects the activity of PPARG protein] which results in increased abundance of Nitric Oxide CTD PMID:16527820 nitric oxide multiple interactions EXP 6480464 [1, 1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] inhibits the reaction [Manganese results in increased chemical synthesis of Nitric Oxide] CTD PMID:18041089 nitric oxide increases expression EXP 6480464 Nitric Oxide deficiency results in increased expression of PPARG protein CTD PMID:17063326 nitric oxide multiple interactions ISO RGD:69169 6480464 15-deoxy-delta(12 more ... CTD PMID:12847270 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of PPARG mRNA, nitrofen results in decreased expression of PPARG protein CTD PMID:22595559 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of PPARG mRNA CTD PMID:33484710 nitrofen multiple interactions ISO RGD:69169 6480464 nitrofen binds to and results in increased activity of PPARG protein CTD PMID:33049310 nitrofen multiple interactions ISO RGD:69168 6480464 nitrofen binds to and results in increased activity of PPARG protein CTD PMID:33049310 Nivalenol decreases activity ISO RGD:69168 6480464 nivalenol results in decreased activity of PPARG protein CTD PMID:27481073 nonanedioic acid increases activity ISO RGD:69168 6480464 azelaic acid results in increased activity of PPARG protein CTD PMID:20545756 nonanedioic acid increases expression ISO RGD:69168 6480464 azelaic acid results in increased expression of PPARG mRNA CTD PMID:20545756 Nonylphenol multiple interactions ISO RGD:69169 6480464 nonylphenol binds to and results in increased activity of PPARG protein CTD PMID:33049310 Nonylphenol decreases expression EXP 6480464 nonylphenol results in decreased expression of PPARG protein CTD PMID:29641977 Nonylphenol multiple interactions ISO RGD:69168 6480464 nonylphenol binds to and results in increased activity of PPARG protein CTD PMID:33049310 norathyriol multiple interactions ISO RGD:69168 6480464 norathyriol inhibits the reaction [ciglitazone results in increased activity of PPARG protein] CTD PMID:18393431 norethisterone multiple interactions ISO RGD:69169 6480464 Norethindrone binds to and results in increased activity of PPARG protein CTD PMID:33049310 notoginsenoside R1 multiple interactions ISO RGD:69169 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [notoginsenoside R1 results in increased expression of PPARG] CTD PMID:25714973 notoginsenoside R1 increases expression ISO RGD:69169 6480464 notoginsenoside R1 results in increased expression of PPARG CTD PMID:25714973 NS-398 multiple interactions ISO RGD:69168 6480464 N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Cannabidiol affects the localization of PPARG protein] more ... CTD PMID:11840453 more ... NS-398 increases localization ISO RGD:69168 6480464 N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in increased localization of PPARG protein CTD PMID:12517972 NS-398 decreases expression ISO RGD:69168 6480464 N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased expression of PPARG mRNA CTD PMID:11840453 o-cresol increases expression EXP 6480464 2-cresol results in increased expression of PPARG mRNA CTD PMID:21705299 o-cresol multiple interactions EXP 6480464 Sodium Selenite inhibits the reaction [2-cresol results in increased expression of PPARG mRNA] CTD PMID:21705299 obeticholic acid increases expression EXP 6480464 obeticholic acid results in increased expression of PPARG mRNA, obeticholic acid results in increased expression of PPARG protein CTD PMID:15980055 ochratoxin A decreases expression ISO RGD:69168 6480464 ochratoxin A results in decreased expression of PPARG CTD PMID:20590410 ochratoxin A increases expression ISO RGD:69168 6480464 ochratoxin A results in increased expression of PPARG mRNA CTD PMID:32905824 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of PPARG mRNA CTD PMID:15994020 ochratoxin A multiple interactions EXP 6480464 15-deoxy-delta(12 more ... CTD PMID:15994020 ochratoxin A increases phosphorylation ISO RGD:69168 6480464 ochratoxin A results in increased phosphorylation of PPARG protein CTD PMID:20590410 ochratoxin A decreases activity ISO RGD:69168 6480464 ochratoxin A results in decreased activity of PPARG protein CTD PMID:20590410 , PMID:27481073 octadecanoic acid multiple interactions EXP 6480464 stearic acid inhibits the reaction [Hydrogen Peroxide results in decreased expression of PPARG protein] CTD PMID:17302992 octanoic acid multiple interactions ISO RGD:69169 6480464 [octanoic acid co-treated with Dexamethasone] results in increased expression of PPARG protein alternative form, [SB 203580 results in decreased activity of MAPK14 protein] inhibits the reaction [[octanoic acid co-treated with Dexamethasone] results in increased expression of PPARG protein alternative form] CTD PMID:14984747 octanoic acid affects binding ISO RGD:69168 6480464 octanoic acid binds to PPARG protein CTD PMID:35752307 octanoic acid affects binding EXP 6480464 octanoic acid binds to PPARG protein CTD PMID:35752307 Octicizer multiple interactions ISO RGD:69169 6480464 2-ethylhexyldiphenylphosphate binds to and results in increased activity of PPARG protein CTD PMID:31812418 Octicizer multiple interactions ISO RGD:69168 6480464 PPARG protein affects the reaction [2-ethylhexyldiphenylphosphate results in increased expression of HSD3B1 mRNA] CTD PMID:28282128 Octicizer increases activity ISO RGD:69168 6480464 2-ethylhexyldiphenylphosphate results in increased activity of PPARG protein CTD PMID:28282128 octocrylene affects binding ISO RGD:69168 6480464 octocrylene binds to PPARG protein CTD PMID:34864131 octocrylene increases expression ISO RGD:69168 6480464 octocrylene results in increased expression of PPARG mRNA CTD PMID:34864131 octocrylene multiple interactions ISO RGD:69168 6480464 octocrylene promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA] CTD PMID:34864131 olanzapine increases expression ISO RGD:69169 6480464 olanzapine results in increased expression of PPARG protein alternative form CTD PMID:17651982 oleamide increases activity ISO RGD:69168 6480464 oleylamide analog results in increased activity of PPARG protein CTD PMID:29288688 oleic acid increases expression ISO RGD:69169 6480464 Oleic Acid results in increased expression of PPARG mRNA CTD PMID:18154422 oleic acid affects binding EXP 6480464 Oleic Acid binds to PPARG protein CTD PMID:35752307 oleic acid multiple interactions EXP 6480464 [Oleic Acid co-treated with Palmitic Acid] inhibits the reaction [Ethanol results in increased expression of PPARG mRNA] more ... CTD PMID:25048947 more ... oleic acid multiple interactions ISO RGD:69168 6480464 [cyhalothrin co-treated with Oleic Acid] results in increased expression of PPARG protein more ... CTD PMID:24534255 more ... oleic acid affects binding ISO RGD:69168 6480464 Oleic Acid binds to PPARG protein CTD PMID:24998974 , PMID:35752307 oleic acid increases expression ISO RGD:69168 6480464 Oleic Acid results in increased expression of PPARG mRNA, Oleic Acid results in increased expression of PPARG protein CTD PMID:11172467 oleoyl-CoA multiple interactions ISO RGD:69168 6480464 oleoyl-coenzyme A binds to and results in increased activity of PPARG protein CTD PMID:11139385 oleuropein multiple interactions EXP 6480464 oleuropein inhibits the reaction [Cholesterol, Dietary results in increased expression of PPARG protein] CTD PMID:27019295 orientin multiple interactions ISO RGD:69169 6480464 orientin inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG protein] CTD PMID:32044341 orlistat increases expression ISO RGD:69168 6480464 Orlistat results in increased expression of PPARG mRNA CTD PMID:32347045 oryzalin multiple interactions ISO RGD:69169 6480464 oryzalin binds to and results in increased activity of PPARG protein CTD PMID:33049310 oryzalin multiple interactions ISO RGD:69168 6480464 oryzalin binds to and results in increased activity of PPARG protein CTD PMID:33049310 Osajin decreases expression ISO RGD:69168 6480464 osajin results in decreased expression of PPARG mRNA CTD PMID:20706672 osthole increases expression ISO RGD:69169 6480464 osthol results in increased expression of PPARG mRNA, osthol results in increased expression of PPARG protein CTD PMID:19682441 osthole multiple interactions ISO RGD:69169 6480464 osthol inhibits the reaction [Isoproterenol results in decreased expression of PPARG mRNA] CTD PMID:21854795 Oxadiazon multiple interactions ISO RGD:69169 6480464 oxadiazon binds to and results in increased activity of PPARG protein CTD PMID:33049310 Oxadiazon multiple interactions ISO RGD:69168 6480464 oxadiazon binds to and results in increased activity of PPARG protein CTD PMID:33049310 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PPARG mRNA CTD PMID:25729387 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of PPARG mRNA CTD PMID:25729387 oxaprozin increases activity ISO RGD:69168 6480464 oxaprozin results in increased activity of PPARG protein CTD PMID:12065695 oxybenzone multiple interactions ISO RGD:69168 6480464 oxybenzone binds to and results in increased activity of PPARG protein more ... CTD PMID:32407875 more ... oxybenzone increases expression ISO RGD:69168 6480464 oxybenzone results in increased expression of PPARG mRNA CTD PMID:32407875 oxybenzone affects binding ISO RGD:69168 6480464 oxybenzone binds to PPARG protein CTD PMID:32407875 oxybenzone multiple interactions ISO RGD:69169 6480464 oxybenzone binds to and results in increased activity of PPARG protein CTD PMID:33049310 ozone increases expression EXP 6480464 Ozone results in increased expression of PPARG mRNA CTD PMID:16716893 , PMID:29329427 ozone multiple interactions ISO RGD:69168 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of PPARG mRNA more ... CTD PMID:32699268 ozone multiple interactions EXP 6480464 Fish Oils inhibits the reaction [Ozone results in increased expression of PPARG mRNA] CTD PMID:29329427 ozone decreases expression EXP 6480464 Ozone results in decreased expression of PPARG mRNA CTD PMID:33524448 p-tolualdehyde multiple interactions ISO RGD:69168 6480464 4-methylbenzaldehyde binds to and results in decreased activity of PPARG protein CTD PMID:27633901 palmitoyl-CoA multiple interactions ISO RGD:69168 6480464 Palmitoyl Coenzyme A binds to and results in increased activity of PPARG protein CTD PMID:11139385 paracetamol affects expression ISO RGD:69169 6480464 Acetaminophen affects the expression of PPARG mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:69168 6480464 Acetaminophen results in increased expression of PPARG mRNA CTD PMID:29067470 paracetamol decreases expression ISO RGD:69168 6480464 Acetaminophen results in decreased expression of PPARG mRNA CTD PMID:26690555 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of PPARG mRNA CTD PMID:16701773 paraquat decreases response to substance ISO RGD:69169 6480464 PPARG gene polymorphism results in decreased susceptibility to Paraquat CTD PMID:18083318 paraquat affects expression ISO RGD:69168 6480464 Paraquat affects the expression of PPARG mRNA CTD PMID:35641671 paraquat multiple interactions EXP 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Paraquat results in decreased expression of PPARG mRNA]] more ... CTD PMID:30797787 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of PPARG mRNA, Paraquat results in decreased expression of PPARG protein CTD PMID:30797787 paraquat increases response to substance ISO RGD:69169 6480464 PPARG protein results in increased susceptibility to Paraquat CTD PMID:18083318 parathion-methyl multiple interactions ISO RGD:69169 6480464 Methyl Parathion binds to and results in increased activity of PPARG protein CTD PMID:33049310 parathion-methyl multiple interactions ISO RGD:69168 6480464 Methyl Parathion binds to and results in increased activity of PPARG protein CTD PMID:33049310 paricalcitol multiple interactions ISO RGD:69168 6480464 [Phosphorus co-treated with paricalcitol] results in increased localization of PPARG protein CTD PMID:17715259 PCB138 multiple interactions ISO RGD:69169 6480464 2 more ... CTD PMID:29704545 PCB138 increases expression ISO RGD:69169 6480464 2 more ... CTD PMID:29704545 PD 0325901 multiple interactions ISO RGD:69169 6480464 mirdametinib inhibits the reaction [Protein Kinase Inhibitors results in increased phosphorylation of and results in decreased activity of PPARG protein] CTD PMID:26670611 penconazole increases expression ISO RGD:69169 6480464 penconazole results in increased expression of PPARG mRNA CTD PMID:31733957 pendimethalin multiple interactions ISO RGD:69168 6480464 pendimethalin binds to and results in increased activity of PPARG protein CTD PMID:33049310 pentachloronitrobenzene increases activity ISO RGD:69168 6480464 quintozene results in increased activity of PPARG protein CTD PMID:20143881 perflubutane affects binding ISO RGD:69168 6480464 perfluorobutane binds to PPARG protein CTD PMID:24998974 perfluorobutanesulfonic acid increases expression ISO RGD:69169 6480464 perfluorobutanesulfonic acid results in increased expression of PPARG mRNA, perfluorobutanesulfonic acid results in increased expression of PPARG protein CTD PMID:30031040 perfluorobutanesulfonic acid affects binding EXP 6480464 perfluorobutanesulfonic acid binds to PPARG protein CTD PMID:35752307 perfluorobutanesulfonic acid affects binding ISO RGD:69168 6480464 perfluorobutanesulfonic acid binds to PPARG protein CTD PMID:35752307 perfluorobutyric acid increases activity ISO RGD:69168 6480464 perfluorobutyric acid results in increased activity of PPARG protein CTD PMID:24998974 perfluorodecanoic acid increases activity ISO RGD:69168 6480464 perfluorodecanoic acid results in increased activity of PPARG protein CTD PMID:23391484 , PMID:24998974 perfluorodecanoic acid increases expression ISO RGD:69168 6480464 perfluorodecanoic acid results in increased expression of PPARG mRNA CTD PMID:35337807 perfluorododecanoic acid increases activity ISO RGD:69168 6480464 perfluorododecanoic acid results in increased activity of PPARG protein CTD PMID:23391484 , PMID:24998974 perfluorododecanoic acid increases expression ISO RGD:69168 6480464 perfluorododecanoic acid results in increased expression of PPARG mRNA CTD PMID:35337807 perfluoroheptanoic acid increases expression ISO RGD:69168 6480464 perfluoro-n-heptanoic acid results in increased expression of PPARG mRNA CTD PMID:35337807 perfluorohexanesulfonic acid affects binding ISO RGD:69168 6480464 perfluorohexanesulfonic acid binds to PPARG protein CTD PMID:24998974 , PMID:35752307 perfluorohexanesulfonic acid increases expression ISO RGD:69168 6480464 perfluorohexanesulfonic acid results in increased expression of PPARG mRNA CTD PMID:35337807 perfluorohexanesulfonic acid increases expression ISO RGD:69169 6480464 perfluorohexanesulfonic acid results in increased expression of PPARG mRNA CTD PMID:28049043 perfluorohexanoic acid increases activity ISO RGD:69168 6480464 perfluorohexanoic acid results in increased activity of PPARG protein CTD PMID:23391484 perfluorohexanoic acid affects binding EXP 6480464 perfluorohexanoic acid binds to PPARG protein CTD PMID:35752307 perfluorohexanoic acid affects binding ISO RGD:69168 6480464 perfluorohexanoic acid binds to PPARG protein CTD PMID:35752307 perfluorononanoic acid increases expression EXP 6480464 perfluoro-n-nonanoic acid results in increased expression of PPARG mRNA CTD PMID:19196829 , PMID:19878704 perfluorononanoic acid increases expression ISO RGD:69168 6480464 perfluoro-n-nonanoic acid results in increased expression of PPARG mRNA CTD PMID:28558994 perfluorooctane-1-sulfonic acid increases activity ISO RGD:69168 6480464 perfluorooctane sulfonic acid results in increased activity of PPARG protein CTD PMID:24998974 perfluorooctane-1-sulfonic acid affects binding ISO RGD:69168 6480464 perfluorooctane sulfonic acid binds to PPARG protein CTD PMID:35752307 perfluorooctane-1-sulfonic acid affects binding EXP 6480464 perfluorooctane sulfonic acid binds to PPARG protein CTD PMID:35752307 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:69168 6480464 perfluorooctane sulfonic acid results in decreased expression of PPARG mRNA CTD PMID:32790152 perfluorooctane-1-sulfonic acid affects expression ISO RGD:69168 6480464 perfluorooctane sulfonic acid affects the expression of PPARG mRNA CTD PMID:30738844 perfluorooctane-1-sulfonic acid decreases acetylation EXP 6480464 perfluorooctane sulfonic acid results in decreased acetylation of PPARG protein CTD PMID:28973641 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:69169 6480464 [Dietary Fats co-treated with perfluorooctane sulfonic acid] results in increased expression of PPARG mRNA more ... CTD PMID:32979393 more ... perfluorooctane-1-sulfonic acid increases expression ISO RGD:69168 6480464 perfluorooctane sulfonic acid results in increased expression of PPARG mRNA CTD PMID:22269386 more ... perfluorooctane-1-sulfonic acid increases expression ISO RGD:69169 6480464 perfluorooctane sulfonic acid results in increased expression of PPARG mRNA CTD PMID:23500012 , PMID:26548598 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:69168 6480464 perfluorooctane sulfonic acid binds to and results in increased activity of PPARG protein CTD PMID:33049310 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of PPARG mRNA CTD PMID:23500012 perfluorooctanoic acid multiple interactions ISO RGD:69168 6480464 [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] which results in decreased susceptibility to perfluorooctanoic acid, perfluorooctanoic acid binds to and results in increased activity of PPARG protein CTD PMID:16731579 more ... perfluorooctanoic acid affects binding EXP 6480464 perfluorooctanoic acid binds to PPARG protein CTD PMID:35752307 perfluorooctanoic acid decreases expression ISO RGD:69168 6480464 perfluorooctanoic acid results in decreased expression of PPARG mRNA CTD PMID:32790152 perfluorooctanoic acid increases expression ISO RGD:69168 6480464 perfluorooctanoic acid results in increased expression of PPARG mRNA CTD PMID:25868421 more ... perfluorooctanoic acid affects binding ISO RGD:69168 6480464 perfluorooctanoic acid binds to PPARG protein CTD PMID:24998974 , PMID:35752307 perfluorooctanoic acid increases activity ISO RGD:69168 6480464 perfluorooctanoic acid results in increased activity of PPARG protein CTD PMID:23391484 , PMID:24998974 perfluorooctanoic acid affects expression ISO RGD:69169 6480464 perfluorooctanoic acid affects the expression of PPARG mRNA CTD PMID:22154759 perfluorooctanoic acid decreases expression ISO RGD:69169 6480464 perfluorooctanoic acid results in decreased expression of PPARG mRNA CTD PMID:22154759 perfluorooctanoic acid increases expression ISO RGD:69169 6480464 perfluorooctanoic acid results in increased expression of PPARG mRNA, perfluorooctanoic acid results in increased expression of PPARG protein CTD PMID:18281256 more ... perfluorooctanoic acid multiple interactions EXP 6480464 perfluorooctanoic acid binds to and results in increased activity of PPARG protein CTD PMID:16731579 perfluorooctanoic acid multiple interactions ISO RGD:69169 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of PPARG mRNA] more ... CTD PMID:16731579 more ... perfluoroundecanoic acid multiple interactions ISO RGD:69168 6480464 perfluoroundecanoic acid binds to and affects the folding of PPARG protein CTD PMID:24998974 perfluoroundecanoic acid increases expression ISO RGD:69168 6480464 perfluoroundecanoic acid results in increased expression of PPARG mRNA CTD PMID:35337807 perindopril multiple interactions EXP 6480464 Perindopril inhibits the reaction [Methotrexate results in decreased expression of PPARG mRNA], Perindopril inhibits the reaction [Methotrexate results in decreased expression of PPARG protein] CTD PMID:34737150 perindopril increases expression EXP 6480464 Perindopril results in increased expression of PPARG mRNA, Perindopril results in increased expression of PPARG protein CTD PMID:34737150 permethrin multiple interactions ISO RGD:69168 6480464 Permethrin binds to and results in increased activity of PPARG protein CTD PMID:33049310 permethrin multiple interactions ISO RGD:69169 6480464 [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of PPARG mRNA more ... CTD PMID:29751049 , PMID:33049310 permethrin increases expression ISO RGD:69169 6480464 Permethrin results in increased expression of PPARG mRNA, Permethrin results in increased expression of PPARG protein CTD PMID:24911977 phenethyl caffeate decreases expression ISO RGD:69169 6480464 caffeic acid phenethyl ester results in decreased expression of PPARG mRNA CTD PMID:21467634 phenobarbital multiple interactions ISO RGD:69169 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of PPARG mRNA] CTD PMID:19482888 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of PPARG mRNA CTD PMID:24090815 phenobarbital affects expression ISO RGD:69169 6480464 Phenobarbital affects the expression of PPARG mRNA CTD PMID:23091169 phenobarbital affects expression ISO RGD:69168 6480464 Phenobarbital affects the expression of PPARG mRNA CTD PMID:19159669 phenobarbital increases expression ISO RGD:69169 6480464 Phenobarbital results in increased expression of PPARG mRNA CTD PMID:19482888 phenol increases expression ISO RGD:69168 6480464 Phenol results in increased expression of PPARG mRNA CTD PMID:17547211 Phenylamil multiple interactions ISO RGD:69169 6480464 [phenylamil co-treated with Harmine] results in increased expression of PPARG mRNA more ... CTD PMID:20519739 Phenylamil increases expression ISO RGD:69169 6480464 phenylamil results in increased expression of PPARG mRNA CTD PMID:20519739 Phenylamil affects response to substance ISO RGD:69169 6480464 PPARG protein affects the susceptibility to phenylamil CTD PMID:20519739 phloretin multiple interactions ISO RGD:69169 6480464 2 more ... CTD PMID:32408695 phorbol 13-acetate 12-myristate increases activity ISO RGD:69168 6480464 Tetradecanoylphorbol Acetate results in increased activity of PPARG protein CTD PMID:15707588 phorbol 13-acetate 12-myristate increases expression ISO RGD:69168 6480464 Tetradecanoylphorbol Acetate results in increased expression of PPARG mRNA, Tetradecanoylphorbol Acetate results in increased expression of PPARG protein CTD PMID:12044893 , PMID:16945329 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:69168 6480464 [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased activity of MAP2K1 protein] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PPARG protein] more ... CTD PMID:16945329 , PMID:21511917 phosalone multiple interactions ISO RGD:69169 6480464 phosalone binds to and results in increased activity of PPARG protein CTD PMID:33049310 phosalone multiple interactions ISO RGD:69168 6480464 phosalone binds to and results in increased activity of PPARG protein CTD PMID:33049310 phosphatidylcholine increases expression ISO RGD:69169 6480464 Phosphatidylcholines results in increased expression of PPARG mRNA CTD PMID:23911798 phosphorus atom multiple interactions ISO RGD:69168 6480464 [Phosphorus co-treated with paricalcitol] results in increased localization of PPARG protein CTD PMID:17715259 phosphorus(.) multiple interactions ISO RGD:69168 6480464 [Phosphorus co-treated with paricalcitol] results in increased localization of PPARG protein CTD PMID:17715259 phoxim multiple interactions ISO RGD:69169 6480464 phoxim binds to and results in increased activity of PPARG protein CTD PMID:33049310 phoxim multiple interactions ISO RGD:69168 6480464 phoxim binds to and results in increased activity of PPARG protein CTD PMID:33049310 phthalic acid affects binding ISO RGD:69168 6480464 phthalic acid binds to PPARG protein CTD PMID:23843199 phytanic acid affects binding ISO RGD:69168 6480464 Phytanic Acid binds to PPARG protein CTD PMID:23843199 picoxystrobin multiple interactions ISO RGD:69168 6480464 picoxystrobin inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein] CTD PMID:30818834 pioglitazone multiple interactions ISO RGD:69168 6480464 [Dexamethasone co-treated with INS protein co-treated with Pioglitazone] results in increased expression of PPARG protein more ... CTD PMID:11779144 more ... pioglitazone affects expression EXP 6480464 pioglitazone affects the expression of PPARG mRNA, pioglitazone affects the expression of PPARG protein CTD PMID:28744220 pioglitazone affects binding ISO RGD:69168 6480464 Pioglitazone binds to PPARG protein CTD PMID:11779144 more ... pioglitazone increases activity ISO RGD:69168 6480464 Pioglitazone results in increased activity of PPARG protein CTD PMID:15273253 more ... pioglitazone increases expression ISO RGD:69169 6480464 pioglitazone results in increased expression of PPARG mRNA CTD PMID:11991651 more ... pioglitazone increases expression ISO RGD:69168 6480464 Pioglitazone results in increased expression of PPARG mRNA more ... CTD PMID:11172467 more ... pioglitazone increases activity EXP 6480464 pioglitazone results in increased activity of PPARG protein CTD PMID:19439812 pioglitazone affects response to substance ISO RGD:69169 6480464 PPARG protein affects the susceptibility to pioglitazone CTD PMID:16007095 pioglitazone multiple interactions EXP 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Pioglitazone affects the expression of PPARG mRNA] more ... CTD PMID:12055599 more ... pioglitazone affects expression ISO RGD:69169 6480464 pioglitazone affects the expression of PPARG, pioglitazone affects the expression of PPARG mRNA CTD PMID:19048458 , PMID:21962020 pioglitazone multiple interactions ISO RGD:69169 6480464 [ANGPT2 protein binds to and results in increased activity of AGTR2 protein] promotes the reaction [pioglitazone binds to and results in increased activity of PPARG protein] more ... CTD PMID:11991651 more ... pirinixic acid multiple interactions ISO RGD:69168 6480464 N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [pirinixic acid results in increased expression of PPARG mRNA] more ... CTD PMID:11840453 more ... pirinixic acid affects binding ISO RGD:69168 6480464 pirinixic acid binds to PPARG protein CTD PMID:35752307 pirinixic acid affects binding EXP 6480464 pirinixic acid binds to PPARG protein CTD PMID:35752307 pirinixic acid increases activity ISO RGD:69168 6480464 pirinixic acid results in increased activity of PPARG protein CTD PMID:16386710 , PMID:26135921 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of PPARG mRNA CTD PMID:22539621 pirinixic acid increases activity ISO RGD:69169 6480464 pirinixic acid results in increased activity of PPARG protein CTD PMID:12401884 , PMID:9703482 pirinixic acid multiple interactions ISO RGD:69169 6480464 [pirinixic acid results in increased activity of PPARG protein] which results in increased expression of NFKBIA mRNA more ... CTD PMID:19438714 , PMID:8700121 pirinixic acid increases expression ISO RGD:69168 6480464 pirinixic acid results in increased expression of PPARG mRNA CTD PMID:11840453 platycodin D multiple interactions ISO RGD:69169 6480464 CTNNB1 affects the reaction [platycodin D results in increased expression of PPARG mRNA] more ... CTD PMID:20024897 , PMID:21798269 platycodin D decreases expression ISO RGD:69168 6480464 platycodin D results in decreased expression of PPARG protein CTD PMID:30599906 platycodin D decreases expression ISO RGD:69169 6480464 platycodin D results in decreased expression of PPARG mRNA, platycodin D results in decreased expression of PPARG protein CTD PMID:20024897 more ... platycodin D decreases activity ISO RGD:69169 6480464 platycodin D results in decreased activity of PPARG protein CTD PMID:20024897 Pomiferin decreases expression ISO RGD:69168 6480464 pomiferin results in decreased expression of PPARG mRNA CTD PMID:20706672 potassium chromate multiple interactions ISO RGD:69169 6480464 potassium chromate(VI) inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein] CTD PMID:24576443 prallethrin multiple interactions ISO RGD:69168 6480464 d, d-T80-prallethrin binds to and results in increased activity of PPARG protein CTD PMID:33049310 prallethrin increases expression ISO RGD:69168 6480464 d, d-T80-prallethrin results in increased expression of PPARG mRNA CTD PMID:32473317 prallethrin multiple interactions ISO RGD:69169 6480464 d, d-T80-prallethrin binds to and results in increased activity of PPARG protein CTD PMID:33049310 Pranoprofen increases activity ISO RGD:69168 6480464 pyranoprofen results in increased activity of PPARG protein CTD PMID:12065695 pravastatin multiple interactions ISO RGD:69168 6480464 Pravastatin inhibits the reaction [[troglitazone binds to and results in increased activity of PPARG protein] which results in increased abundance of Cholesterol] CTD PMID:12044893 prochloraz multiple interactions ISO RGD:69169 6480464 prochloraz binds to and results in increased activity of PPARG protein CTD PMID:33049310 prochloraz decreases expression ISO RGD:69168 6480464 prochloraz results in decreased expression of PPARG mRNA CTD PMID:30879083 prochloraz multiple interactions ISO RGD:69168 6480464 prochloraz binds to and results in increased activity of PPARG protein CTD PMID:33049310 procymidone multiple interactions ISO RGD:69169 6480464 [procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of PPARG mRNA, procymidone binds to and results in increased activity of PPARG protein CTD PMID:33049310 , PMID:33246813 procymidone decreases expression ISO RGD:69169 6480464 procymidone results in decreased expression of PPARG mRNA CTD PMID:33246813 progesterone increases expression EXP 6480464 Progesterone results in increased expression of PPARG mRNA CTD PMID:16954335 propamocarb decreases expression ISO RGD:69169 6480464 propamocarb results in decreased expression of PPARG mRNA CTD PMID:29137890 propanil multiple interactions ISO RGD:69168 6480464 Propanil binds to and results in increased activity of PPARG protein CTD PMID:33049310 propanil multiple interactions ISO RGD:69169 6480464 Propanil binds to and results in increased activity of PPARG protein CTD PMID:33049310 propargite multiple interactions ISO RGD:69169 6480464 Omite binds to and results in increased activity of PPARG protein CTD PMID:33049310 propargite multiple interactions ISO RGD:69168 6480464 Omite binds to and results in increased activity of PPARG protein CTD PMID:33049310 propiconazole multiple interactions ISO RGD:69168 6480464 propiconazole binds to and results in increased activity of PPARG protein CTD PMID:33049310 propiconazole multiple interactions ISO RGD:69169 6480464 propiconazole binds to and results in increased activity of PPARG protein CTD PMID:33049310 propylparaben increases expression ISO RGD:69169 6480464 propylparaben results in increased expression of PPARG mRNA CTD PMID:22956630 propylparaben multiple interactions ISO RGD:69169 6480464 PPARG protein promotes the reaction [propylparaben binds to and results in increased activity of PPARG protein], propylparaben binds to and results in increased activity of PPARG protein CTD PMID:24155963 , PMID:33049310 propylparaben multiple interactions ISO RGD:69168 6480464 propylparaben binds to and results in increased activity of PPARG protein CTD PMID:24155963 , PMID:33049310 propyzamide multiple interactions ISO RGD:69169 6480464 pronamide binds to and results in increased activity of PPARG protein CTD PMID:33049310 propyzamide multiple interactions ISO RGD:69168 6480464 pronamide binds to and results in increased activity of PPARG protein CTD PMID:33049310 prostaglandin D2 multiple interactions ISO RGD:69168 6480464 Prostaglandin D2 affects the localization of and results in increased expression of PPARG protein CTD PMID:23943857 prostaglandin D2 affects localization ISO RGD:69168 6480464 Prostaglandin D2 affects the localization of PPARG protein CTD PMID:23220503 prostaglandin F2alpha multiple interactions ISO RGD:69169 6480464 [Niacin results in decreased abundance of Dinoprost] which results in increased expression of PPARG mRNA, [Niacin results in decreased abundance of Dinoprost] which results in increased expression of PPARG protein CTD PMID:21236357 prostaglandin J2 multiple interactions ISO RGD:69168 6480464 9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein more ... CTD PMID:11343236 more ... prostaglandin J2 increases expression ISO RGD:69168 6480464 9-deoxy-delta-9-prostaglandin D2 results in increased expression of PPARG mRNA CTD PMID:12595494 , PMID:14512786 prostaglandin J2 increases activity ISO RGD:69168 6480464 9-deoxy-delta-9-prostaglandin D2 results in increased activity of PPARG protein CTD PMID:17030193 prostaglandin J2 multiple interactions EXP 6480464 9-deoxy-delta-9-prostaglandin D2 promotes the reaction [PPARG protein alternative form results in decreased activity of SLC2A4 promoter], [9-deoxy-delta-9-prostaglandin D2 co-treated with Alitretinoin] promotes the reaction [[PPARG protein binds to RXRA protein] which binds to GSTA2 promoter] CTD PMID:12777391 , PMID:15150131 protein kinase inhibitor multiple interactions ISO RGD:69169 6480464 mirdametinib inhibits the reaction [Protein Kinase Inhibitors results in increased phosphorylation of and results in decreased activity of PPARG protein], Protein Kinase Inhibitors results in increased phosphorylation of and results in decreased activity of PPARG protein CTD PMID:26670611 psoralen multiple interactions EXP 6480464 Ficusin inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of PPARG mRNA] CTD PMID:27350165 puerarin multiple interactions EXP 6480464 puerarin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG protein] CTD PMID:23500774 puerarin decreases expression ISO RGD:69168 6480464 puerarin results in decreased expression of PPARG mRNA CTD PMID:20706672 pyocyanine decreases expression ISO RGD:69169 6480464 Pyocyanine results in decreased expression of PPARG mRNA CTD PMID:31078726 pyrene multiple interactions ISO RGD:69168 6480464 pyrene binds to and results in increased activity of PPARG protein CTD PMID:33049310 pyrene multiple interactions ISO RGD:69169 6480464 pyrene binds to and results in increased activity of PPARG protein CTD PMID:33049310 pyridaben multiple interactions ISO RGD:69169 6480464 pyridaben binds to and results in increased activity of PPARG protein CTD PMID:33049310 pyridaben multiple interactions ISO RGD:69168 6480464 pyridaben binds to and results in increased activity of PPARG protein, pyridaben inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein] CTD PMID:30818834 , PMID:33049310 Pyridostigmine bromide multiple interactions ISO RGD:69169 6480464 [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of PPARG mRNA, Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of PPARG mRNA] CTD PMID:29751049 quercetin increases expression ISO RGD:69168 6480464 Quercetin results in increased expression of PPARG mRNA, Quercetin results in increased expression of PPARG protein CTD PMID:25765892 quercetin multiple interactions EXP 6480464 [Dietary Fats co-treated with Quercetin] affects the expression of PPARG mRNA more ... CTD PMID:20580672 , PMID:24039778 quercetin multiple interactions ISO RGD:69169 6480464 Quercetin binds to and results in increased activity of PPARG protein more ... CTD PMID:18262572 more ... quercetin multiple interactions ISO RGD:69168 6480464 Quercetin inhibits the reaction [ciglitazone results in increased activity of PPARG protein], Quercetin promotes the reaction [rosiglitazone results in increased expression of PPARG protein] CTD PMID:18393431 , PMID:25765892 quinoline multiple interactions ISO RGD:69168 6480464 quinoline analog binds to and affects the activity of PPARG protein CTD PMID:17610302 quinolinic acid multiple interactions EXP 6480464 [naringin co-treated with Pioglitazone] inhibits the reaction [Quinolinic Acid results in decreased expression of PPARG mRNA] more ... CTD PMID:30130594 quinolinic acid decreases expression EXP 6480464 Quinolinic Acid results in decreased expression of PPARG mRNA CTD PMID:30130594 quinoxyfen increases expression ISO RGD:69168 6480464 quinoxyfen results in increased expression of PPARG mRNA CTD PMID:32473317 quizalofop-ethyl increases activity ISO RGD:69168 6480464 quizalofop-ethyl results in increased activity of PPARG protein CTD PMID:31086981 raspberry ketone increases expression ISO RGD:69169 6480464 raspberry ketone results in increased expression of PPARG mRNA CTD PMID:36460224 reactive oxygen species multiple interactions ISO RGD:69168 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [[[15-deoxyprostaglandin J2 results in increased activity of PPARG protein] which results in decreased expression of SOD2 protein] which results in increased abundance of Reactive Oxygen Species] more ... CTD PMID:16945329 more ... reactive oxygen species multiple interactions ISO RGD:69169 6480464 [Carbon Monoxide results in increased abundance of Reactive Oxygen Species] which results in increased sumoylation of PPARG protein, Acetylcysteine inhibits the reaction [[Carbon Monoxide results in increased abundance of Reactive Oxygen Species] which results in increased sumoylation of PPARG protein] CTD PMID:22046279 rebaudioside A multiple interactions ISO RGD:69169 6480464 rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARG mRNA] CTD PMID:25554529 resmethrin increases activity ISO RGD:69168 6480464 resmethrin results in increased activity of PPARG protein CTD PMID:20143881 resveratrol multiple interactions ISO RGD:69169 6480464 [Resveratrol co-treated with Dietary Fats] results in decreased expression of PPARG mRNA more ... CTD PMID:18555852 more ... resveratrol multiple interactions EXP 6480464 Resveratrol inhibits the reaction [Ethanol results in increased expression of PPARG mRNA] more ... CTD PMID:18793633 more ... resveratrol affects activity ISO RGD:69169 6480464 resveratrol affects the activity of PPARG protein CTD PMID:23525482 resveratrol affects response to substance ISO RGD:69169 6480464 PPARG protein affects the susceptibility to resveratrol CTD PMID:23525482 resveratrol decreases expression ISO RGD:69168 6480464 resveratrol results in decreased expression of PPARG mRNA, resveratrol results in decreased expression of PPARG protein CTD PMID:20706672 more ... resveratrol increases expression ISO RGD:69169 6480464 resveratrol results in increased expression of PPARG protein CTD PMID:24036142 resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of PPARG mRNA CTD PMID:23848300 resveratrol increases expression ISO RGD:69168 6480464 Resveratrol analog results in increased expression of PPARG mRNA more ... CTD PMID:20372816 more ... resveratrol multiple interactions ISO RGD:69168 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Resveratrol results in increased expression of PPARG mRNA] more ... CTD PMID:18776171 more ... resveratrol increases activity ISO RGD:69168 6480464 resveratrol results in increased activity of PPARG protein CTD PMID:16849586 more ... resveratrol decreases expression ISO RGD:69169 6480464 resveratrol analog results in decreased expression of PPARG mRNA more ... CTD PMID:16813520 more ... retinyl acetate multiple interactions ISO RGD:69169 6480464 [retinol acetate co-treated with 2 more ... CTD PMID:31449830 riddelliine decreases expression EXP 6480464 riddelliine results in decreased expression of PPARG mRNA CTD PMID:18047727 rifampicin increases expression ISO RGD:69169 6480464 Rifampin results in increased expression of PPARG mRNA CTD PMID:27806127 rifampicin multiple interactions ISO RGD:69169 6480464 [Rifampin affects the susceptibility to Dietary Fats] which results in decreased expression of PPARG mRNA more ... CTD PMID:27806127 , PMID:33412187 rifaximin multiple interactions ISO RGD:69168 6480464 [NR1I2 results in increased susceptibility to rifaximin] which results in increased expression of PPARG mRNA CTD PMID:22790967 rimonabant affects expression ISO RGD:69169 6480464 Rimonabant affects the expression of PPARG mRNA CTD PMID:20110567 risperidone increases expression ISO RGD:69169 6480464 Risperidone results in increased expression of PPARG mRNA, Risperidone results in increased expression of PPARG protein CTD PMID:20564506 risperidone multiple interactions ISO RGD:69169 6480464 Berberine inhibits the reaction [Risperidone results in increased expression of PPARG mRNA], Berberine inhibits the reaction [Risperidone results in increased expression of PPARG protein] CTD PMID:20564506 ritonavir multiple interactions ISO RGD:69169 6480464 Ritonavir inhibits the reaction [[INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of PPARG protein] CTD PMID:11101056 ritonavir increases expression ISO RGD:69168 6480464 Ritonavir results in increased expression of PPARG mRNA CTD PMID:17879945 Ro 41-5253 multiple interactions ISO RGD:69169 6480464 [Dexamethasone co-treated with INS protein co-treated with Ro 41-5253] results in increased expression of PPARG protein, Ro 41-5253 results in increased activity of and results in decreased expression of PPARG protein CTD PMID:17290005 Ro 41-5253 multiple interactions ISO RGD:69168 6480464 [Dexamethasone co-treated with INS protein co-treated with Ro 41-5253] results in increased expression of PPARG protein more ... CTD PMID:17290005 Rosavin decreases expression ISO RGD:69168 6480464 rosavin results in decreased expression of PPARG mRNA CTD PMID:20706672 rosmarinic acid affects expression EXP 6480464 rosmarinic acid affects the expression of PPARG mRNA, rosmarinic acid affects the expression of PPARG protein CTD PMID:28744220 rosmarinic acid multiple interactions EXP 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [rosmarinic acid affects the expression of PPARG mRNA] more ... CTD PMID:28744220 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of PPARG mRNA, Rotenone results in decreased expression of PPARG protein CTD PMID:19693701 rotenone multiple interactions ISO RGD:69168 6480464 [Rosiglitazone co-treated with Rotenone] results in increased expression of PPARG protein, Rotenone inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein] CTD PMID:24374061 , PMID:30818834 rottlerin multiple interactions ISO RGD:69168 6480464 rottlerin inhibits the reaction [[ABL1 protein results in increased phosphorylation of and results in decreased activity of PPARG protein] which results in increased expression of COL1A1 protein] CTD PMID:17030193 S-butyl-DL-homocysteine (S,R)-sulfoximine multiple interactions ISO RGD:69169 6480464 PPARG mRNA promotes the reaction [Tamoxifen inhibits the reaction [Buthionine Sulfoximine results in increased expression of CD36 protein]], S-ethyl glutathione inhibits the reaction [Buthionine Sulfoximine results in increased expression of PPARG mRNA] CTD PMID:21520053 , PMID:27358406 S-butyl-DL-homocysteine (S,R)-sulfoximine increases expression ISO RGD:69169 6480464 Buthionine Sulfoximine results in increased expression of PPARG mRNA CTD PMID:21520053 S-butyl-DL-homocysteine (S,R)-sulfoximine multiple interactions EXP 6480464 Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in increased expression of PPARG mRNA] more ... CTD PMID:17602960 salicylic acid multiple interactions EXP 6480464 Salicylic Acid inhibits the reaction [Palmitic Acid results in decreased expression of PPARG mRNA] CTD PMID:25108154 Salmeterol xinafoate multiple interactions ISO RGD:69168 6480464 Salmeterol Xinafoate promotes the reaction [15-deoxyprostaglandin J2 promotes the reaction [NR3C1 protein binds to PPARG protein]] CTD PMID:15531761 SB 203580 multiple interactions ISO RGD:69169 6480464 [SB 203580 results in decreased activity of MAPK14 protein] inhibits the reaction [[octanoic acid co-treated with Dexamethasone] results in increased expression of PPARG protein alternative form] CTD PMID:14984747 SB 203580 multiple interactions EXP 6480464 SB 203580 inhibits the reaction [Ethanol results in decreased expression of PPARG protein] CTD PMID:24412557 SB 203580 increases expression EXP 6480464 SB 203580 results in increased expression of PPARG mRNA, SB 203580 results in increased expression of PPARG protein CTD PMID:24412557 SB 203580 decreases expression ISO RGD:69169 6480464 SB 203580 results in decreased expression of PPARG mRNA, SB 203580 results in decreased expression of PPARG protein CTD PMID:23603106 SB 431542 multiple interactions ISO RGD:69168 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPARG mRNA CTD PMID:27188386 SB-239063 multiple interactions EXP 6480464 SB 239063 inhibits the reaction [25-hydroxyprotopanaxadiol results in increased phosphorylation of PPARG protein] CTD PMID:33676887 selenic acid increases expression ISO RGD:69169 6480464 Selenic Acid results in increased expression of PPARG mRNA CTD PMID:16443359 selenium atom multiple interactions ISO RGD:69169 6480464 PPARG protein promotes the reaction [Selenium inhibits the reaction [lipopolysaccharide more ... CTD PMID:17439952 serotonin multiple interactions ISO RGD:69168 6480464 [Serotonin results in increased localization of and results in increased activity of PPARG protein] which results in increased expression of AQP3 mRNA, Fluoxetine inhibits the reaction [Serotonin results in increased localization of PPARG protein] CTD PMID:25766885 serotonin increases localization ISO RGD:69168 6480464 Serotonin results in increased localization of PPARG protein CTD PMID:25766885 sildenafil citrate multiple interactions ISO RGD:69169 6480464 8-(4-chlorophenylthio)guanosine 3', 5'-cyclic monophosphorothioate inhibits the reaction [Sildenafil Citrate results in increased expression of PPARG protein] CTD PMID:20471953 sildenafil citrate increases expression ISO RGD:69169 6480464 Sildenafil Citrate results in increased expression of PPARG mRNA, Sildenafil Citrate results in increased expression of PPARG protein CTD PMID:20471953 silibinin multiple interactions ISO RGD:69169 6480464 Silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein] CTD PMID:25559859 silibinin increases expression ISO RGD:69168 6480464 Silybin results in increased expression of PPARG protein CTD PMID:27746612 silicon dioxide increases expression ISO RGD:69168 6480464 Silicon Dioxide analog results in increased expression of PPARG mRNA CTD PMID:25895662 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of PPARG mRNA CTD PMID:32721576 simvastatin multiple interactions ISO RGD:69168 6480464 [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Simvastatin results in decreased expression of CCR2 mRNA], [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Simvastatin results in decreased expression of CCR2 protein] CTD PMID:15781755 simvastatin decreases expression EXP 6480464 Simvastatin results in decreased expression of PPARG CTD PMID:19216230 simvastatin multiple interactions ISO RGD:69169 6480464 Simvastatin inhibits the reaction [[Dietary Fats co-treated with Cholesterol more ... CTD PMID:20835264 sirolimus affects expression ISO RGD:69168 6480464 Sirolimus affects the expression of PPARG protein CTD PMID:17016853 sirolimus multiple interactions ISO RGD:69169 6480464 Sirolimus inhibits the reaction [Endrin results in increased expression of PPARG mRNA] CTD PMID:34801515 sirolimus decreases expression ISO RGD:69169 6480464 Sirolimus results in decreased expression of PPARG mRNA CTD PMID:15358118 sirolimus multiple interactions ISO RGD:69168 6480464 [Sirolimus co-treated with Cyclosporine] results in decreased expression of PPARG protein, [Sirolimus co-treated with Tacrolimus] results in increased expression of PPARG protein CTD PMID:17016853 sodium arsenate decreases expression ISO RGD:69169 6480464 sodium arsenate analog results in decreased expression of PPARG mRNA CTD PMID:23221991 sodium arsenate decreases expression ISO RGD:69168 6480464 sodium arsenate analog results in decreased expression of PPARG mRNA CTD PMID:23221991 sodium arsenite decreases expression ISO RGD:69168 6480464 sodium arsenite results in decreased expression of PPARG mRNA CTD PMID:23221991 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of PPARG protein CTD PMID:28283887 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of PPARG protein CTD PMID:30551535 sodium arsenite multiple interactions EXP 6480464 [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of and results in increased activity of PPARG protein] which results in decreased expression of GFAP protein more ... CTD PMID:24481447 more ... sodium arsenite increases expression ISO RGD:69169 6480464 sodium arsenite results in increased expression of PPARG mRNA, sodium arsenite results in increased expression of PPARG protein CTD PMID:25367288 more ... sodium arsenite decreases expression ISO RGD:69169 6480464 sodium arsenite results in decreased expression of PPARG mRNA, sodium arsenite results in decreased expression of PPARG protein CTD PMID:21396911 more ... sodium arsenite multiple interactions ISO RGD:69169 6480464 [Palmitic Acid co-treated with sodium arsenite] results in decreased expression of PPARG mRNA more ... CTD PMID:11812925 more ... sodium atom affects abundance ISO RGD:69169 6480464 PPARG protein affects the abundance of Sodium CTD PMID:16007095 sodium fluoride decreases expression ISO RGD:69169 6480464 Sodium Fluoride results in decreased expression of PPARG mRNA, Sodium Fluoride results in decreased expression of PPARG protein CTD PMID:36063856 sodium fluoride multiple interactions ISO RGD:69169 6480464 Resveratrol inhibits the reaction [Sodium Fluoride results in decreased expression of PPARG protein] CTD PMID:36063856 Sodium oleate multiple interactions ISO RGD:69168 6480464 [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of PPARG mRNA CTD PMID:32613381 Sorbitan monooleate multiple interactions ISO RGD:69168 6480464 sorbitan monooleate binds to and results in increased activity of PPARG protein CTD PMID:27131391 splitomicin multiple interactions ISO RGD:69169 6480464 splitomicin promotes the reaction [resveratrol results in decreased expression of PPARG mRNA], splitomicin promotes the reaction [resveratrol results in decreased expression of PPARG protein] CTD PMID:23525482 stavudine decreases expression ISO RGD:69168 6480464 Stavudine results in decreased expression of PPARG mRNA CTD PMID:14518702 stavudine decreases expression ISO RGD:69169 6480464 Stavudine results in decreased expression of PPARG mRNA, Stavudine results in decreased expression of PPARG protein CTD PMID:15722030 , PMID:17926646 stearoyl-CoA multiple interactions ISO RGD:69168 6480464 stearoyl-coenzyme A binds to and results in increased activity of PPARG protein CTD PMID:11139385 steviol multiple interactions ISO RGD:69169 6480464 steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARG mRNA] CTD PMID:25554529 stevioside multiple interactions ISO RGD:69169 6480464 stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARG mRNA] CTD PMID:25554529 stilben-4-ol decreases expression ISO RGD:69169 6480464 4-hydroxystilbene results in decreased expression of PPARG mRNA CTD PMID:23748787 streptozocin decreases expression EXP 6480464 Streptozocin results in decreased expression of PPARG more ... CTD PMID:12967931 more ... streptozocin increases expression ISO RGD:69169 6480464 Streptozocin results in increased expression of PPARG mRNA CTD PMID:23319174 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of PPARG mRNA, Streptozocin results in increased expression of PPARG protein CTD PMID:20219977 , PMID:21450970 streptozocin decreases expression ISO RGD:69169 6480464 Streptozocin results in decreased expression of PPARG mRNA, Streptozocin results in decreased expression of PPARG protein CTD PMID:21381899 , PMID:30642005 streptozocin multiple interactions ISO RGD:69169 6480464 [Dietary Fats co-treated with Streptozocin] results in decreased expression of PPARG mRNA more ... CTD PMID:21381899 more ... streptozocin multiple interactions EXP 6480464 2 more ... CTD PMID:12967931 more ... succimer multiple interactions ISO RGD:69169 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PPARG mRNA CTD PMID:26378955 sucrose multiple interactions ISO RGD:69169 6480464 [lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of PPARG mRNA, Atrazine promotes the reaction [[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of PPARG mRNA] CTD PMID:24440342 sulfasalazine increases expression EXP 6480464 Sulfasalazine results in increased expression of PPARG mRNA CTD PMID:19365232 sulfasalazine multiple interactions EXP 6480464 Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA], Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG protein] CTD PMID:26165751 sulfasalazine increases expression ISO RGD:69169 6480464 Sulfasalazine results in increased expression of PPARG mRNA CTD PMID:31830553 sulfluramid affects binding EXP 6480464 sulfluramid binds to PPARG protein CTD PMID:35752307 sulfluramid affects binding ISO RGD:69168 6480464 sulfluramid binds to PPARG protein CTD PMID:35752307 sulfluramid increases expression ISO RGD:69168 6480464 sulfluramid results in increased expression of PPARG mRNA CTD PMID:35337807 sulforaphane increases expression ISO RGD:69168 6480464 sulforaphane results in increased expression of PPARG mRNA CTD PMID:26833863 sulfur dioxide multiple interactions ISO RGD:69169 6480464 glyceryl 2-arachidonate inhibits the reaction [Sulfur Dioxide results in decreased expression of PPARG protein] more ... CTD PMID:26209559 sulfur dioxide decreases expression ISO RGD:69169 6480464 Sulfur Dioxide results in decreased expression of PPARG protein CTD PMID:26209559 sulindac sulfide multiple interactions ISO RGD:69168 6480464 [sulindac sulfide results in increased activity of PPARG protein] which results in increased expression of PTGS2 protein more ... CTD PMID:10866999 more ... sulindac sulfide increases expression ISO RGD:69168 6480464 sulindac sulfide results in increased expression of PPARG mRNA CTD PMID:11948457 sulindac sulfide increases activity ISO RGD:69168 6480464 sulindac sulfide results in increased activity of PPARG protein CTD PMID:10866999 sulindac sulfide affects binding ISO RGD:69168 6480464 sulindac sulfide analog binds to PPARG protein CTD PMID:18665581 sulindac sulfone multiple interactions ISO RGD:69168 6480464 [sulindac sulfone results in increased activity of PPARG protein] promotes the reaction [PPARG protein binds to SAT1 enhancer], PPARG protein promotes the reaction [sulindac sulfone results in increased expression of SAT1 mRNA] CTD PMID:14506281 sulindac sulfone increases expression ISO RGD:69168 6480464 sulindac sulfone results in increased expression of PPARG mRNA CTD PMID:11948457 sunitinib decreases expression ISO RGD:69168 6480464 Sunitinib results in decreased expression of PPARG mRNA CTD PMID:31533062 T-2 toxin increases expression EXP 6480464 T-2 Toxin results in increased expression of PPARG mRNA CTD PMID:26141394 tacrolimus hydrate multiple interactions ISO RGD:69168 6480464 [Sirolimus co-treated with Tacrolimus] results in increased expression of PPARG protein CTD PMID:17016853 tamoxifen increases expression ISO RGD:69169 6480464 Tamoxifen results in increased expression of PPARG mRNA CTD PMID:25123088 tamoxifen decreases expression ISO RGD:69169 6480464 Tamoxifen results in decreased expression of PPARG protein CTD PMID:27358406 tamoxifen multiple interactions ISO RGD:69169 6480464 PPARG mRNA promotes the reaction [Tamoxifen inhibits the reaction [Buthionine Sulfoximine results in increased expression of CD36 protein]] more ... CTD PMID:27358406 , PMID:33049310 tamoxifen multiple interactions ISO RGD:69168 6480464 Tamoxifen inhibits the reaction [PPARG protein binds to CD36 promoter] more ... CTD PMID:27358406 Tanshinone I decreases expression ISO RGD:69169 6480464 tanshinone results in decreased expression of PPARG mRNA CTD PMID:20854809 taurine multiple interactions ISO RGD:69168 6480464 Taurine inhibits the reaction [Arsenic Trioxide results in decreased expression of PPARG protein] CTD PMID:30362509 taurine multiple interactions EXP 6480464 Taurine inhibits the reaction [sodium arsenite results in decreased expression of PPARG protein] CTD PMID:30551535 taurine multiple interactions ISO RGD:69169 6480464 Taurine inhibits the reaction [Arsenic Trioxide results in decreased expression of PPARG protein] CTD PMID:30362509 tebuconazole multiple interactions ISO RGD:69168 6480464 tebuconazole binds to and results in increased activity of PPARG protein CTD PMID:33049310 tebuconazole multiple interactions ISO RGD:69169 6480464 tebuconazole binds to and results in increased activity of PPARG protein CTD PMID:33049310 tebufenpyrad increases activity ISO RGD:69168 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased activity of PPARG protein CTD PMID:20143881 telmisartan multiple interactions ISO RGD:69168 6480464 PPARG mutant form inhibits the reaction [telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of NFKBIA mRNA]] more ... CTD PMID:18158351 , PMID:22124178 telmisartan multiple interactions EXP 6480464 telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA], telmisartan promotes the reaction [Daunorubicin results in increased expression of PPARG protein] CTD PMID:20888384 , PMID:24831514 telmisartan increases expression ISO RGD:69169 6480464 telmisartan results in increased expression of PPARG protein CTD PMID:20176998 telmisartan multiple interactions ISO RGD:69169 6480464 telmisartan inhibits the reaction [Streptozocin results in decreased expression of PPARG protein] CTD PMID:21381899 telmisartan increases activity ISO RGD:69168 6480464 Telmisartan results in increased activity of PPARG protein CTD PMID:22124178 , PMID:28728110 temozolomide decreases expression ISO RGD:69168 6480464 Temozolomide results in decreased expression of PPARG mRNA CTD PMID:31758290 tenofovir disoproxil fumarate affects expression ISO RGD:69168 6480464 Tenofovir affects the expression of PPARG mRNA CTD PMID:20032539 tert-butyl ethyl ether increases expression EXP 6480464 ethyl tert-butyl ether results in increased expression of PPARG mRNA CTD PMID:24090815 tert-butyl hydroperoxide multiple interactions ISO RGD:69168 6480464 tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to AMOTL2 promoter] more ... CTD PMID:20847119 tert-butyl hydroperoxide increases activity ISO RGD:69168 6480464 tert-Butylhydroperoxide results in increased activity of PPARG protein CTD PMID:16417216 Tesaglitazar multiple interactions ISO RGD:69168 6480464 tesaglitazar binds to and results in increased activity of PPARG protein CTD PMID:17610302 Tesaglitazar affects expression EXP 6480464 tesaglitazar affects the expression of PPARG mRNA CTD PMID:21270424 Tesaglitazar increases activity ISO RGD:69169 6480464 tesaglitazar results in increased activity of PPARG protein CTD PMID:12401884 Tesaglitazar increases activity ISO RGD:69168 6480464 tesaglitazar results in increased activity of PPARG protein CTD PMID:12401884 testosterone decreases expression ISO RGD:69168 6480464 Testosterone results in decreased expression of PPARG mRNA CTD PMID:21632903 , PMID:33359661 testosterone decreases expression ISO RGD:69169 6480464 Testosterone results in decreased expression of PPARG mRNA, Testosterone results in decreased expression of PPARG protein CTD PMID:12960001 , PMID:20844152 Testosterone propionate multiple interactions ISO RGD:69168 6480464 Testosterone Propionate binds to and results in decreased activity of PPARG protein CTD PMID:33049310 Tetrachlorobisphenol A increases activity ISO RGD:69168 6480464 tetrachlorodian analog results in increased activity of PPARG protein, tetrachlorodian results in increased activity of PPARG protein CTD PMID:24591153 more ... Tetrachlorobisphenol A affects binding ISO RGD:69168 6480464 tetrachlorodian binds to PPARG protein CTD PMID:25314719 Tetrachlorobisphenol A multiple interactions ISO RGD:69169 6480464 tetrachlorodian binds to and results in increased activity of PPARG protein CTD PMID:33049310 Tetrachlorobisphenol A multiple interactions ISO RGD:69168 6480464 tetrachlorodian binds to and results in increased activity of PPARG protein more ... CTD PMID:21561829 more ... tetrachloromethane multiple interactions EXP 6480464 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG mRNA] more ... CTD PMID:12055599 more ... tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of PPARG mRNA CTD PMID:31150632 tetrachloromethane multiple interactions ISO RGD:69169 6480464 [Ethanol co-treated with Carbon Tetrachloride co-treated with 4-O-methylhonokiol] results in decreased expression of PPARG mRNA more ... CTD PMID:28428136 , PMID:28689299 tetrachloromethane decreases expression ISO RGD:69169 6480464 Carbon Tetrachloride results in decreased expression of PPARG mRNA, Carbon Tetrachloride results in decreased expression of PPARG protein CTD PMID:28428136 tetrachloromethane decreases activity EXP 6480464 Carbon Tetrachloride results in decreased activity of PPARG protein CTD PMID:25858767 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of PPARG mRNA, Carbon Tetrachloride results in decreased expression of PPARG protein CTD PMID:12055599 more ... tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of PPARG protein CTD PMID:15959796 tetrachlorvinphos multiple interactions ISO RGD:69169 6480464 Tetrachlorvinphos binds to and results in increased activity of PPARG protein CTD PMID:33049310 tetrachlorvinphos multiple interactions ISO RGD:69168 6480464 Tetrachlorvinphos binds to and results in increased activity of PPARG protein CTD PMID:33049310 tetramethylpyrazine increases expression EXP 6480464 tetramethylpyrazine results in increased expression of PPARG protein CTD PMID:23022513 tetramethylpyrazine increases expression ISO RGD:69168 6480464 tetramethylpyrazine results in increased expression of PPARG mRNA CTD PMID:28034800 tetramethylpyrazine multiple interactions ISO RGD:69169 6480464 tetramethylpyrazine inhibits the reaction [Oxazolone results in increased expression of PPARG protein] CTD PMID:22200888 theophylline increases expression ISO RGD:69168 6480464 Theophylline results in increased expression of PPARG mRNA, Theophylline results in increased expression of PPARG protein CTD PMID:16569937 thiamine(1+) chloride increases activity EXP 6480464 Thiamine results in increased activity of PPARG protein CTD PMID:31419397 thiamine(1+) chloride multiple interactions EXP 6480464 Thiamine inhibits the reaction [citreoviridin results in decreased activity of PPARG protein] CTD PMID:31419397 thiazolidinediones multiple interactions EXP 6480464 [Thiazolidinediones binds to and results in increased activity of PPARG protein] which results in decreased abundance of Triglycerides, Thiazolidinediones binds to and results in increased activity of PPARG protein CTD PMID:19248225 thiazolidinediones increases expression ISO RGD:69169 6480464 Thiazolidinediones results in increased expression of PPARG mRNA CTD PMID:21870829 thiazolidinediones multiple interactions ISO RGD:69168 6480464 PPARG protein promotes the reaction [Thiazolidinediones results in increased abundance of Lipids] CTD PMID:20079722 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of PPARG mRNA CTD PMID:23411599 thymoquinone increases expression ISO RGD:69168 6480464 thymoquinone results in increased expression of PPARG protein CTD PMID:27688165 thymoquinone multiple interactions ISO RGD:69168 6480464 PRKAA1 protein promotes the reaction [thymoquinone results in increased expression of PPARG protein], thymoquinone inhibits the reaction [TGFB1 protein results in decreased expression of PPARG protein] CTD PMID:27688165 thyroxine multiple interactions ISO RGD:69169 6480464 Thyroxine inhibits the reaction [Triclosan results in decreased expression of PPARG protein] CTD PMID:28973666 tideglusib multiple interactions ISO RGD:69168 6480464 tideglusib inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of PPARG protein] CTD PMID:30965670 titanium dioxide decreases expression ISO RGD:69169 6480464 titanium dioxide results in decreased expression of PPARG mRNA, titanium dioxide results in decreased expression of PPARG protein CTD PMID:23557971 , PMID:28646487 titanium dioxide multiple interactions ISO RGD:69169 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PPARG mRNA CTD PMID:29950665 toluene 2,4-diisocyanate multiple interactions ISO RGD:69169 6480464 pioglitazone promotes the reaction [Toluene 2 more ... CTD PMID:17015710 toluene 2,4-diisocyanate increases localization ISO RGD:6 
